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1 Introduction 
Cells within multicellular organisms communicate via diffusible molecules or by direct cell-cell 
interactions. Hormones, growth factors, neurotransmitters and other external stimuli induce 
various cellular processes such as gene activation, alterations in metabolism, proliferation, 
motility or cell death (Bradshaw 2003). The mechanisms by which extracellular agents 
transmit information via specific receptors to evoke intracellular processes are known as 
‘signal transduction’ or ‘cell signaling’ or ‘transmembrane signaling’ pathways.  
In general, signals are transduced by changes in the activity and/or localization of 
proteins. Such changes can occur in a rapid and often reversible fashion by posttranslational 
modifications of the proteins involved in the respective signaling cascade. Protein 
phosphorylation on serine, threonine and tyrosine residues was the first discovered 
mechanism of posttranslational protein modification (Krebs and Beavo, 1979). Since then, 
numerous human diseases have been attributed to dysregulated protein phosphorylation 
(Hunter 2002). In addition, many other posttranslational modifications that alter protein 
functions have been found, such as protein acetylation, glycosylation, ubiquitination, 
SUMOylation, NEDDylation, methylation, biotinylation or ADP-ribosylation (Hunter 2007).  
1.1 Principles of phosphoregulation 
Protein phosphorylation (that is, the addition of a phosphate [(PO4)3-] moiety to certain amino 
acid residues) is goverened by the opposing action of protein kinases and protein 
phosphatases (Hunter 1995). The enzymatic activity of a protein kinase results in the 
covalent attachment of a phosphate group [derived from the -phosphate of adenosine 
triphosphate (ATP)], to the side chain of an amino acid that contains free hydroxyl groups 
(Hunter 1998). The discovery of the cyclic AMP (cAMP)-dependent protein kinase A (PKA) 
and its pleiotropic substrate specificity was the basis of the establishment of field called 
signal transduction (Hunter 2000).  
Proteins can be phosphorylated on nine different amino acid residues: tyrosine, 
serine, threonine, cysteine, arginine, lysine, aspartate, glutamate, and histidine (Hunter 
2004). Out of these, serine, threonine and tyrosine play key regulatory roles in eukaryotic 
cells. In humans, the relative phosphorylation on serine, threonine or tyrosine residues is 
approximately 86.4, 11.8, and 1.8% respectively (Olsen et al., 2006). Several recent 
phospho-proteomic studies have established that, along with aspartate and histidine 
residues, bacterial proteins are also phosphorylated on serine, threonine and tyrosine 
residues (Soufi et al., 2008). Thus, it appears that protein phosphorylation is a universal 
mechanism of protein regulation. Genome wide analysis has provided a means to compile 
inventories of protein kinases and phosphatases across a wide selection of organisms. 
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These efforts have supplied insights into the evolution of this group of enzymes and their 
roles in various signaling pathways (Moorhead et al., 2009). 
The reversible phosphorylation or dephosphorylation of one or more amino acid 
residues can alter the protein conformation and hence affect its function (Cohen 1992). 
Posttranslational modifications in general and reversible phosphorylations in particular add 
another level of protein regulation in addition to post transcriptional modifications, such that 
the same gene product can have specific functions under different conditions. Until recently, 
kinases were considered as the active partner of the reversible phosphorylation process and 
phosphatases as a passive housekeeping counterpart, most of the times acting as a 
negative regulator in the process of reversible phosphorylation. But now it is amply clear that 
kinase and phosphatase activities are coordinated in the regulation of signalling processes 
(Tonks 2006). Also, in contrast to initial views of signaling pathways as simple linear 
arrangements of phosphorylation cascades that function in isolation to switch protein 
activities on or off, it is now clear that there are multiple and interacting signaling networks 
that determine the physiological outcome.  
Reversible phosphoregulation can have many additional and subtle effects on the 
function and fate of a protein, such as the modulation of protein enzymatic activity and its 
subcellular localization, the generation of binding sites for interacting protein partners or for 
divalent ions such as calcium, the control of the duration of a given response, or the control 
of protein degradation, to name a few of them. In particular, by creating binding sites for 
interacting proteins and by acting as scaffolds in protein-protein complexes, protein 
(de)phosphorylation can integrate inputs from multiple signaling pathways and regulate 
synergistic responses to agonists (Cohen 2000). 
It is estimated that about thirty percent of all proteins (Hunter 2000), or 2 – 4% of the 
genes (Manning et al., 2002) are phosphorylated at any given time in most cells. In addition, 
the potential of protein regulation by phosphorylation is enhanced many fold due to multisite 
phosphorylation (that is, the phosphorylation of more than one amino acid residue in the 
same protein). This principle was first shown in the epidermal growth factor (EGF) receptor 
(Cohen 2000). The existence of phosphorylation and -dephosphorylation events on protein 
serine/threonine (Ser/Thr)-residues was identified well before the discovery of protein 
tyrosine (Tyr) phosphorylation in 1979 (Eckhart et al., 1979). It appears that the use of 
tyrosine phosphorylation as a signaling mechanism evolved along with multicellularity as a 
signaling mechanism for intercellular communication (Hunter 2002). 
The first eukaryotic protein phosphatase was identified a decade later to that of 
protein kinase (Bradshaw 2003). The initial research on protein phosphorylation was 
therefore focused on kinases. Even after the discovery of protein phosphatases, these 
enzymes were considered as passive partners merely responsible for signal termination. As 
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the field progressed, it became increasingly clear that phosphatases can no longer be 
viewed as passive partners but can play active and often dominant roles in the process of 
reversible protein phosphoregulation (Alonso et al., 2004; Hornberg et al., 2005). Whereas 
kinases appear to control the amplitude of a given signaling response, phosphatases appear 
to control the rate and duration of the response (Tonks 2006). 
1.1.1 Kinome 
The molecular analysis of kinases has revealed that all eukaryotic protein kinases (ePKs) 
contain a conserved, bilobate catalytic domain structure. Eukaryotic protein kinases with no 
apparent sequence homology to the superfamily of ePKs are grouped as atypical protein 
kinases (aPKs). Kinases are divided in 120 families of ePKs and 134 families of aPKs 
(Hanks and Hunter 1995). The human genome has 518 protein kinase genes, of which 478 
belong to the ePK and the others to aPK family. That means over 2% of the genes in the 
human genome belong to protein kinases. This number may vary, e.g. due to the expression 
of splice varients of individual genes. Out of the over 500 kinase genes, 90 are tyrosine 
kinases and the rest are serine/threonine kinases. Based on functional and phylogenetic 
analysis (http://kinase.com/), this vast numbers of kinases can be grouped into a revised 
classification scheme of 9 groups (Morrison et al., 2000) as follows: 1) Tyrosine Kinases: All 
active members phosphorylate tyrosine residues and are related by sequence similarity. 2) 
Tyrosine Kinase-like:  This is the most diverse of all groups. Families in this group are close 
to tyrosine kinases. 3) AGC: Group named after the family members PKA, PKG, PKC. 4) 
CAMK: Calcium/Calmodulin regulated kinases and structurally related kinases. 5) CK1: 
Casein kinase 1 group. 6) Others: Families that do not fit into any of the main groups. 7) 
STE: MAP kinase cascade kinases. 8) RGC: Catalytically inactive kinase family named after 
Receptor Guanylate Cyclases. 9) Atypical: Families of eukaryotic kinases whose kinase 
domains do not have significant sequence similarity to eukaryotic protein kinases. 
The protein kinase catalogue has many implications for the understanding of the 
basis for human diseases and for the development of small molecule drugs that target 
individual disease-causing protein kinases. Importantly, this kinome analysis has also paved 
the way for the analysis of the phosphatome.  
1.1.2 Phosphatome 
Like protein kinases, the study of protein phosphatases initiated in the field of glycogen 
metabolism and through biochemistry, molecular biology and now with the advent of 
genomics we are in the position to catalogue the phosphatase complement of various 
organisms (Moorhead et al., 2009). The evolution of protein kinases and phosphatases has 
been different. Whereas kinases have similar catalytic pockets and conserved ATP binding 
sites and can be traced back to a common ancestor, phosphatases are not derived from a 
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common ancestral molecule and have evolved in structurally and mechanistically distinct 
families (Alonso et al., 2004). Phosphatases are classified into three major families as 
schematically represented in figure 1. 
 
 
Figure 1: Classification of phosphatases 
Based on substrate specificity, phosphatases are classified as either Ser/Thr-phosphatases, cysteine-
based Tyr phosphatases or aspartate-based phosphatases. Numbers in the brackets represent gene 
numbers. For details of each class please refer to the text. Abbreviations used in the figure are as 
follows: PPP, Phospho Protein Phosphatase; PPM, Metallo dependent Protein Phosphatase; PP, 
Protein Phosphatase; PTP, Protein Tyrosine Phosphatase; RPTP, Receptor-like PTP; NRPTP, Non 
Receptor PTP; CDC, Cell Division Control proteins; LMWPTP, Low Molecular Weight PTP; DSP, Dual 
Specificity Phosphatases; MAKP, Mitogen Activated kinase Phosphatase; PRL, Phosphatase of 
Regenerating Liver; PTEN, Phosphatase and Tensin homolog; FCP/SCP, transcription initiation factor 
IIF (TFIIF)- associated component of C-terminal domain (CTD) phosphatase/small CTD phosphatase; 
HAD, Haloacid Dehalogenase; MDP, Magnesium dependent protein phosphatase; HDHD, Haloacid 
dehalogenase like Hydrolase Domain containing protein; PSP, Phospho Serine Phosphatase; CIN, 
Chronophin; Others, proteins that do not belong to major groups of HAD family of phosphatases. 
 
Phosphatases have acquired specificity during the course of evolution through additional 
modular domains or by the ability to dock to novel regulatory subunits (Moorhead et al., 
2009). Most of the PTP family members have evolved through domain fusion on the gene 
level (Alonso et al., 2004), whereas most of the PPP and PPM family members have evolved 
via complex formation at the protein level. The best understood example of this is the 
serine/threonine phosphatase 1 (PP1) that can associate with over 100 regulatory subunits 
(Das et al., 1996; Hendrickx et al., 2009) . 
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The PPP catalytic domain possesses the signature motif –GDxHG-GDx(V/I)DRG 
and GNHE (spread out over a region of 280 amino acids), which is crucial for binding of 
divalent metal ions. Otherwise there is no overall sequence homology among the PPP 
phosphatases. Most members of the PPP family are high molecular weight complexes 
containing one or more regulatory subunits (Bradshaw 2003). The PPM family phosphatases 
are Mn2+/Mg2+-dependent serine/threonine-specific enzymes. All eukaryotic PPM enzymes 
have 11 conserved motifs with nine highly conserved amino acids that coordinate metal ions 
necessary for catalysis (Zhang and Shi 2004).  
The PTP family is defined by the catalytic signature motif CX5R with diverse 
domain structure and substrate preferences. The three subclasses of cysteine based PTPs 
have evolved independently during evolution (Moorhead et al., 2009). Class I cysteine based 
PTP is the largest among three subclasses and the members are strictly tyrosine specific 
and evolved from common ancestor.  Class II cysteine based PTPs is represented by a 
single member in human genome which codes for low molecular weight (18 kDa) 
phosphatase. Third subclass is from rhodanese-derived PTPs comprise three cell cycle 
regulators. The human genome encodes 107 PTP genes. Taking into account inactive PTPs 
and the ones having non-protein substrate specificities, the number of active protein tyrosine 
phosphatases and protein tyrosine kinases is very similar and hence one can assume that 
both tyrosine kinases and tyrosine phosphatases have comparable substrate specificities 
(Alonso 2004). Similar to the existence of pseudokinases (Kannan and Taylor 2008), the 
phosphatome also contains phosphatase-inactive, yet conserved members, as exemplified 
by the STYX-domain proteins (Wishart and Dixon 1998).  
The most recently classified group of phosphatases are aspartate-based 
phosphatases, in which catalysis is driven by an aspartic acid residue in the signature motif 
DXDXT/V (Alonso et al., 2004). While the other families of protein phosphatases have 
been characterized for over two decades now, those utilizing aspartate-based catalysis have 
been noted only very recently (Archambault et al., 1998). This is partially due to the fact that 
aspartate-based phosphatases are insensitive to inhibitors of “classical”, thiol-based 
phosphatases. Even though aspartate-based catalysis group is divided into FCP/SCP-like 
and HAD-family phosphatases, both share the same catalytic core motif and also belong to 
different groups within the HAD superfamily.  
 
1.2 The HAD superfamily of hydrolases 
The haloacid dehalogenase (HAD) superfamily of hydrolases, named after the archetypal 
enzyme haloacid dehalogenase includes enzymes catalyzing carbonyl or phosphoryl group 
transfer reactions on a diverse range of substrates (Koonin and Tatusov 1994). 
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The HAD superfamily is represented in the proteomes of organisms from all three 
superkingdoms of life. The enzymes of this superfamily are involved in numerous disparate 
biological functions such as metabolism, membrane transport, signal transduction and 
nucleic-acid transfer, but have so far primarily been characterized in lower organisms 
(Burroughs et al., 2006). Among the over 2000 different members of this superfamily, 
ATPases (PO-P cleavage) and phosphatases (CO-P cleavage) are most prevalent, whereas 
a diversification of catalytic activities toward phosphonate hydrolysis (P-C bond), or 
dehalogenase hydrolysis (C-Cl bond) occurs less frequently (Allen and Dunaway-Mariano 
2004).  
Sequence comparisons have shown that there is no overall sequence homology 
among HAD enzymes but practically all members contain three highly conserved sequence 
motifs, called HAD domains which correspond to the catalytic pockets and determine the 
substrate specificities (Ridder and Dijkstra 1999) as shown in figure 2A. N-terminal HAD 
motif determines the enzymatic characteristics of HAD domains. Haloacid dehalogenase 
have –DXYGT, p-type ATPases have –DKTGTwhereas HAD phosphatases are 
characterized by the first N-terminal HAD motif with the signature sequence DXDX(V/T). 
All HAD phosphatases are Mg2+-dependent enzymes that share similar mechanism of 
substrate dephosphorylation, by forming a phosphoaspartate intermediate where the first 
aspartate residue in the signature sequence acts as a nucleophile (Allen and Dunaway-
Mariano 2004). A schematic representation of the enzymatic mechanism of HAD 
phosphatases is depicted in figure 1B. 
 
 
Figure 2: Characteristics of HAD phosphatases  
A: Consensus sequence of catalytic motifs. First aspartate residue in motif I act as nucleophile. X 
represents any amino acid. Ψ: represents any hydrophobic amino acid, D: aspartic acid, V: valine, T: 
threonine, K: lysine, G: glycin, E: glutamic acid  
B: Catalytic mechanism of HAD phosphatases: Moieties originating from the substrate or solvent are 
colored in blue, and those originating from the enzyme are colored in red. E: Enzyme with aspartate at 
active site, R: positive charged ion attached to phosphate (modified from Burroughs et al 2006). 
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1.2.1 Structural and functional aspects of HAD enzymes 
Over 40 X-ray crystal structures and an enormous amount of sequence data have made  it 
possible to understand the structure-function relationships of the HAD enzymes (Aravind and 
Koonin 1998). Aspartate (Asp) nucleophile dependent hydrolysis is the basic theme of HAD 
enzymes. The carboxylate group of the first Asp and the backbone C=O of the second Asp in 
motif I coordinate the Mg2+ cofactor (Fig. 1B). Second acidic residue acts as a general acid-
base which binds and protonates the substrate leaving group in the first step and 
deprotonates the nucleophile of the second step (Lahiri et al., 2002). The second motif is 
characterized by a conserved threonine along with hydrophobic amino acids. Motif II along 
with a lysine in motif III contributes to the stability of the phosphoaspartate intermediate of 
the hydrolysis reaction. Terminal acidic residues of motif III along with motif I are required for 
coordinating the Mg2+-ion in the active site (Peisach et al., 2004). Motifs I-III are spatially 
arranged around a single ‘binding cleft’ at the C-terminal end that forms the active site of 
HAD enzymes. Crystal structures of many HAD hydrolases have predicted a variable region 
around the active site, which is termed “cap domain” (Zhang et al., 2002) as shown in figure 
3. Cap domains are thought to provide the necessary ‘substrate space’ for diversification of 
the enzymes of this large family of hydrolases. 
 
Figure 3: Structure-function aspects of the HAD superfamily 
Ribbon diagram highlighting how the common catalytic core domain (cyan) and the divergent cap 
domain (magenta) contribute to the diverse catalytic mechanisms of HAD hydrolases. Letters a, b, c 
represents three classes within HAD superfamily. Class a: enzymes with C-Cl, C-P, PO-P cleavage 
mechanism, class b: enzymes with CO-P cleavage/formation mechanism, class c: CO-P cleavage 
mechanism (from Allen and Mariano 2004).  
 
Very few HAD phosphatases are so far characterized for their function in higher organisms. 
Most prominent among them are the human phosphoserine phosphatase (PSP) involved in 
the L-serine biosynthetic pathway (Collet et al., 1998), the transcription factor Eyes Absent 
(Eya), which is involved in organogenesis and immunity (Okabe et al., 2009), and the cofilin 
phosphatase Chronophin (CIN, (Gohla et al., 2005). On the basis of sequence similarity, 
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UBLCP1 was inferred to have similar functions as EYA proteins (Zheng et al., 2005) and 
TIMM50 to act as an essential regulator of mitochondrial protein translocation (Guo et al., 
2004). These examples emphasize the biological importance of this largely unexplored 
enzyme family, and support the hypothesis that HAD phosphatases are one of the major 
players in the diversification of enzymatic potential of organisms by providing the raw 
evolutionary material for the generation of novel enzymes (Burroughs et al., 2006). Hence it 
appears to be interesting to characterize the biologial roles of HAD phosphatases in higher 
organisms, which is one of the focus areas in our research group. 
 
1.3 Identification of a novel HAD-type phosphatase related to Chronophin 
Our group has identified Chronophin (CIN), an actin cytoskeletal regulatory phosphatase of 
the HAD-familiy. CIN was found to dephosphorylate the actin severing protein cofilin on its 
inhibitory serine residue and thereby activate it (Gohla et al., 2005). Cofilin is a ubiquitously 
expressed and essential protein that accelerates actin filament turnover (Bamburg and 
Bloom 2009). The stimulus-dependent cofilin phosphoregulation is one of the key 
convergence points in cellular signaling networks that regulate actin cytoskeletal dynamics 
under both physiological and pathophysiological conditions such as tumor initiation, 
progression and metastasis (Bamburg and Wiggan 2002). It can thus be expected that CIN 
functions in these processes as well. 
1.3.1 Identification and bioinformatic analysis of AUM, a novel Chronophin-related 
HAD phosphatase 
In order to better understand the biological roles of mammalian HAD-type phosphatases, one 
focus of our group is to characterize CIN-related enzymes. By performing a saturating search 
of the non-redundant database for human phosphatases that contain HAD domains (using a 
datamining approach similar to the one described by (Andersen et al., 2005), we were able to 
identify a previously undescribed, putative CIN homolog (Fig. 4). We initially referred to this 
novel protein as CIN-2, but later renamed it AUM (acronym for actin remodeling, ubiquitously 
expressed, magnesium-dependent HAD phosphatase), because it turned out not to be a 
CIN-isoform, but rather a distinct protein tyrosine phosphatase. The basic characterization of 
this novel enzyme was conducted during my diploma thesis work. The following sections 
summarize as yet unpublished information that provided the basis for my present Ph.D. 
thesis work.  
Human AUM is 46% identical and 59% similar in its amino acid sequence to human CIN; 
mouse AUM and CIN proteins share 45% identity and 61% similarity. A full amino acid 
sequence alignment of mouse CIN and AUM is shown in figure 5. As highlighted, three HAD 
domains (HAD I-III) can be found in AUM. Thus, AUM contains all the invariant residues 
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characteristic of HAD phosphatases, and these residues are almost identical to the 
respective residues contained in the equivalent positions in CIN.  
Mouse AUM has a predicted molecular weight of 34.5 kDa, and its calculated isoelectric 
point (pI) is 5.35 (as compared to mouse CIN with a molecular weight of 31.5 kDa and a pI of 
5.53). Mouse AUM contains seven serine-, as well as three threonine- and three tyrosine 
residues, which may serve as regulatory phosphorylation sites (Fig. 4). No additional 
posttranslational modifications were predicted for AUM, using the scansite database 
(http://scansite.mit.edu/).  
 
Figure 4: Sequence of murine AUM  
Nucleotide and deduced amino acid sequence of a full length cDNA encoding for a hypothetical 
murine CIN homolog, which we refer to as AUM (GenBank accession number NM_025954). Possible 
phosphorylation motifs are underlined. No other posttranslational modification sites were predicted for 
this protein. The numbers on the left refer to nucleotide positions. 
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Figure 5: Amino acid sequence alignment of murine AUM and CIN  
Both sequences share 45% identity (141/312 residues) and 61% similarity (193/312 residues).This 
alignment was performed using the ‘multiple sequence alignment’ tool of the program ClustalW 
(Version 1.83) program. Identical residues are highlighted in black. Most of the essential amino acid 
residues in three HAD motifs are conserved. Numbers given on right refer to amino acid positions. 
 
 
Human and mouse CIN are known to map to chromosome 22q12.3 and 15E1, respectively. 
Using AUM cDNA as a query sequence, a BLAST analysis of the genomic sequence 
available through the NCBI Web site mapped the human AUM gene to chromosome 16. The 
murine AUM gene is located on chromosome 17A3.3. Thus, CIN and AUM are located on 
different chromosomes in humans and mice. The genomic organization of the human and 
murine CIN and AUM genes is very similar, with the open reading frames encoded by two 
exons, as shown in figure 6. 
 
        
 
AUM : MAEAEAGGDEARCVRLSAERAKLLLAEVDTLLFDCDGVLWRGETAVPGAPETLRALRARG99i 
CIN : M---------ARCERLRGAALRDVLGQAQGVLFDCDGVLWNGERIVPGAPELLQRLARAGjkjk 
       
   
AUM : KRLGFITNNSSKTRTAYAEKLRRLGFGGPVGPEAGLEVFGTAYCSALYLRQRLAGVPDPK 
CIN : KNTLFVSNNSRRARPELALRFARLGFAGLRA----EQLFSSALCAARLLRQRLSGPPDAS 
       
 
AUM : --AYVLGSPALAAELEAVGVTSVGVGPDVLHGDGPSDWLAVPLEPDVRAVVVGFDPHFSY 
CIN : GAVFVLGGEGLRAELRAAGLRLAGDPG---------------EDPRVRAVLVGYDEQFSF 
         
 
AUM : MKLTKAVRYLQQPDCLLVGTNMDNRLPLENGRFIAGTGCLVRAVEMAAQRQADIIGKPSR 
CIN : SRLTEACAHLRDPDCLLVATDRDPWHPLSDGSRTPGTGSLAAAVETASGRQALVVGKPSP 
        
 
AUM : FIFDCVSQEYGINPERTVMVGDRLDTDILLGSTCSLKTILTLTGVSSLEDVKSNQESDCM 
CIN : YMFQCITEDFSVDPARTLMVGDRLETDILFGHRCGMTTVLTLTGVSSLEEAQAYLT---A 
            
 
AUM : FKKKMVPDFYVDSIADLLPALQG 
CIN : GQRDLVPHYYVESIADLMEGLED 
        
 
motif I 
motif II 
motif III 
298 
269 
238 
212 
178 
152 
120 
107 
 60 
 51 
321 
292 
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Figure 6: Genomic organization of mouse CIN and AUM genes. 
Mouse CIN and AUM are located on chromosomes 15E1 or 17A3.3, respectively. The open reading 
frames of CIN and AUM are encoded by two exons. AUM has a very small intron as compared to CIN.  
 
The distribution of AUM across species was analyzed in multiple sequence alignments using 
the program ClustalW. Figure 7 demonstrates that orthologs of AUM are present in species 
ranging from bacteria to mammals, as shown here by the presence of three HAD 
phosphatase motifs. In addition, the HAD motifs are similarly distributed in the protein (the 
adjacent motifs I and II are located at the N-terminus and are separated by a relatively large 
insert from the bipartite motif III in the C-terminus). The amino acid sequence 
identities/similarities of mouse AUM to the respective hypothetical proteins from Rattus 
norvegicus, Homo sapiens, Danio rerio, Drosophila melanogaster, Caenorhabditis elegans, 
Arabidopsis thaliana, Saccharomyces cerevisiae, Anopheles gambia, Dictyostelium 
discoideum and Escherichia coli are 99/99.6, 90/94, 57/76, 39/60, 33/55, 39/56, 33/51, 
40/59, 33/53 and 32/43%, respectively. These results suggest that AUM has been highly 
conserved throughout evolution.  
                 Motif I     Motif II             Motif III 
 
 
M.musculus       30TLLFDCDGVL  60GKRLGFITNN   234DIIGKPS……………… 259VMVGDRLDTD BC040100 
R.norvegicus     30TLLFDCDGVL  60GKRLGFITNN   234DIIGKPS……………… 259VMVGDRLDTD XP_213235   
H.sapiens        30TLLFDCDGVL  60GKRLGFITNN   234DIIGKPS……………… 259VMVGDRLDTD XP_208887.1 
B.taurus         30TLLFDCDGVL  60GKRLAFITNN   234DIIGKPS……………… 259VMVGDRLTDD ENSBTAG00000009951 
X.tropicalis     24TVLFDCDGVL  54NKRVFFLTNN   228QVIGKPS……………… 253VMVGDRLDTD ENSXETG00000016097 
D.rerio          23CVLFDCDGVI  53GKQVFFVTNN   227QVVGKPS……………… 252LMVGDRLDTD AAH45860 
S.cerevisiae     26TFLFDCDGVL  56GKQLIFVTNN   230SYCGKPN……………… 255CMVGDRLNTD YDL236W 
A.gambiae        38TVLTDCDGVI  68GKKLFFVTNN   242IVMGKPN……………… 257LMIGDRCNTD XP_309300   
D.melanogaster   41SVITDCDGVL  71GKSIYFCTNN   245VVIGKPN……………… 270LMIGDRANTD CG5567    
C.elegans        31TFIFDADGVL  61NKQIIVLTNN   235LTVGKPC……………… 260MMIGDRTNTD NP_504509 
D.discoideum     24TFIFDCDGVL  54GKKILFVTNN   228ITIGKPE……………… 253LFVGDRLDTD DDB0186160 
E.coli           05NVICDIDGVL  35GLPLVLLTNY   172FYVGKPS……………… 197VIVGDNLRTD NP_752680 
A.thaliana       28TFIFDCDGVI  58GKRLVFVTNN   204LVVGKPS……………… 229CMVGDRLDTD BAA97552 
 
Consensus             DXDXV            T           K(Xn)…………      GD(Xn) D 
Figure 7: Sequence alignment of putative AUM orthologs  
Sequence alignment of putative AUM orthologs in various species with respect to conserved HAD 
motifs. The numbers preceeding the HAD motifs I-III designate the respective amino acid number. The 
catalytically essential residues of HAD motifs I-III are identical in the aligned proteins, and are 
indicated by a black box. GenBank accession numbers are shown on the right. 
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1.3.2 RT-PCR expression analysis of AUM 
A search in the UniGene EST Profile Viewer (http://www.ncbi.nlm.nih.gov/unigene) indicated 
that AUM may be widely expressed in mammals, but with marked tissue-specific differences 
in transcript abundance. The major AUM expression sites in the mouse were predicted to be 
male genitals, mammary gland, skeletal muscle and brain stem. Interestingly, the AUM and 
CIN expression patterns are predicted to be partially non-overlapping (see also Gohla et al. 
2005). 
In order to examine the expression of AUM experimentally, we first used the cDNA 
preparations provided in a mouse multiple tissue cDNA panel as a template, and PCR-
amplified AUM with gene-specific primers. In this panel, the mRNA expression levels of 
several housekeeping genes such as α-actin, glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), phospholipase A2 and the ribosomal protein S29 are used to standardize the 
amount of cDNA present in each tissue sample. This normalization procedure accounts for 
tissue specific differences in the levels of transcription, thus allowing estimating the relative 
abundance of a gene of interest. GAPDH is known to be expressed at high levels in skeletal 
muscle and at low levels in testes. As shown in the upper panel of figure 8, the principal 
expression sites of AUM appear to be testes and skeletal muscle. AUM expression during 
embryonic development was maximal at E17. Interestingly, testicular development 
commences at around 18 days post conception (Livera et al., 2006). To investigate AUM 
expression in more detail, total RNA was isolated from various adult mouse tissues, and 
subjected to RT-PCR analysis with AUM gene-specific primers. The lower panel in figure 8 
shows that relative to the housekeeping gene GAPDH, AUM is differentially expressed in a 
tissue-specific manner. Highest transcript levels were found in brain stem, cerebellum, brain 
cortex, and the eye.  
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Figure 8: RT-PCR expression analysis of AUM 
A:  Expression analysis of AUM in cDNA preparations provided in a mouse multiple tissue cDNA panel 
AUM is widely expressed, with highest levels found in testes, skeletal muscle, 17 days-old embryo, 
brain and eye. B: Total RNA was isolated from the indicated mouse tissues and reverse transcribed. 
AUM message is prominently expressed in the eye and in certain brain regions a well as in pancreas. 
Comparable amounts of cDNA were loaded in each lane. The amplicon size for AUM is 780 bp. 30 
cycles of PCR amplification were used for both panels. The expression of the housekeeping gene 
GAPDH is shown as an internal control. Densitometeric quantitation of the AUM expression plotted as 
fold expression relative to GAPDH. 
 
1.3.3 Subcloning of AUM into bacterial and mammalian expression vectors 
As a basis for the initial characterization of AUM, we generated AUM expression constructs. 
A full-length mouse AUM cDNA clone (pCMV-SPORT6 IRAVp968H1184D) was obtained 
from the German Resource Centre for Genome Research (RZPD). AUM was PCR-amplified 
with gene-specific primers, and subcloned into the bacterial expression vector pTrc-His 
(containing an N-terminal His6-tag for the purification of the recombinant enzyme on 
immobilized metal affinity matrices), as well as into the mammalian expression vector 
pcDNA4-myc/His (containing a C-terminal myc-tag for subcellular localization analysis, in 
addition to an adjacent His6-tag inserted for purification purposes). Positive clones were 
verified to be full-length and error-free by sequencing.  
1.3.4 Catalytic properties of recombinant AUM 
Murine AUM was expressed as a His6-tagged protein in bacteria and subsequently affinity-
purified by IMAC. We then tested the enzymatic activity of purified AUM in in vitro 
phosphatase assays. We first employed the broad-spectrum phosphatase substrate para-
nitrophenylphosphate (p-NPP). p-NPP is a colorless compound that can be enzymatically 
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dephosphorylated to the yellow substance p-nitrophenol. This conversion can be 
spectrophotometrically measured over time, and both the kinetics and the endpoint of the 
reaction can be determined. Figure 9 demonstrates that purified AUM dose-dependently 
dephosphorylates p-NPP.  
 
Figure 9: Concentration dependent AUM activity in p-NPP assay  
Purified AUM concentration-dependently dephosphorylates p-NPP (3.5 mM final concentration). The 
absorbance of the product p-nitrophenyl was continuously measured at 405 nm over 30 min at 30°C. 
Samples were measured in duplicates, and the mean values of the end points are plotted. 
 
1.3.5 AUM phosphatase inhibitor profile 
Further evidence for the HAD-phosphatase nature of AUM was obtained by testing its 
susceptibility profile to various standard phosphatase inhibitors in a p-NPP assay. Figure 10, 
upper panel, shows that AUM was insensitive to inhibitors of classical thiol-based 
serine/threonine phosphatases, such as the PP2A-inhibitor okadaic acid, the PP1-inhibitor 
calyculin A, and the PP2B-inhibitor cypermethrin. These results support the idea that AUM 
utilizes an unconventional catalytic mechanism. In agreement with these findings, AUM was 
insensitive to the commercial phosphatase inhibitor cocktail I (containing the PP2A/PP1-
inhibitor microcystin LR, the PP2A/PP1-inhibitor cantharidin and the alkaline phosphatase 
inhibitor (-)-p-bromotetramisole), but was inhibited by the phosphatase inhibitor cocktail II 
(containing sodium vanadate, an inhibitor of tyrosine and alkaline phosphatases; sodium 
molybdate and sodium tartrate, inhibitors of acid phosphatases, and imidazole, an inhibitor of 
alkaline phosphatases). Figure 10, lower panel, shows that AUM was effectively and 
concentration-dependently blocked by molybdate and orthovanadate, which act as 
phosphate analogs. Furthermore, AUM was strongly inhibited by NaF, which inactivates 
magnesium-dependent phosphatases. In addition, Zn2+, Ca2+ and Mn2+, which may compete 
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with the catalytically essential Mg2+, inhibited AUM activity. The Mg2+-chelator EDTA 
completely abolished AUM activity.  
The inhibitor profile of AUM thus closely resembles CIN (Gohla et al., 2005). Thus, 
the homology between the AUM and CIN phosphatase domains, the high extent of 
conservation of the active-site residues among AUM orthologs across evolution, together 
with the observed AUM inhibitor profile suggest that AUM is a CIN-related, Mg2+-dependent 
HAD-type phosphatase.  
 
Figure 10: Phosphatase inhibitor analysis of AUM 
Eight hundred nanograms of AUM were preincubated with the indicated inhibitors for 30 min at 30°C. 
Subsequently, the kinetics of p-NPP-dephosphorylation was followed at 405 nm for 30 min at 30°C. 
Two independent experiments were performed in duplicate. In the initial, linear phase of the reaction, 
the slopes of mean values were calculated and compared to the appropriate controls. The 
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percentages of the activities as compared to the control are shown. The inhibitor cocktail II (containing 
vanadate, molybdate, tartrate and imidazole), but none of the tested PP1-, PP2A or PP2B-inhibitors 
blocks AUM phosphatase activity. DMSO was included as a solvent control for Calyculin A and the 
inhibitor cocktail I. AUM was inhibited by phosphate analogs like vanadate, molybdate and fluoride. 
Various cations that may compete with Mg2+ during the enzymatic reaction were tested. Calcium dose-
dependently inhibits AUM activity with 30% inhibition at 0.5 mM. Mn2+ leads to 40% inhibition, whereas 
AUM activity is completely inhibited in the presence of Zn2+. 
 
 
Taken together, the basic characterization of AUM identifies an evolutionarily conserved 
novel phosphatase in higher organisms with yet unknown physiological function. AUM is 
found to be a novel HAD-type phosphatase with similarities to CIN, but with a distinct, tissue-
specific expression pattern.  
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2 Aim of the study 
 
The haloacid dehalogenase (HAD) superfamily of hydrolases represents a ubiquitous 
enzyme family with approximately 2000 members, the majority of which are magnesium-
dependent phosphatases. Although the existence of 58 human HAD enzymes has been 
predicted (Allen and Dunaway-Mariano 2004), our understanding of their cellular and 
physiological functions remains rudimentary.  
 
By database mining of human HAD phosphatases, we have recently discovered a previously 
undescribed enzyme with homology to Chronophin, a cytoskeletal regulatory HAD 
phosphatase. The aim of this study was the characterization of this novel enzyme using 
phylogenetic, biochemical and cell biological approaches.  
 
The following questions were addressed:  
 
1) Is AUM an isoform of Chronophin?  
2) What are the substrate preferences of AUM? 
3) What are the cellular functions of AUM? 
 
Answering these questions is expected to enhance our understanding of the biological 
importance of an emerging class of poorly understood human phosphatases. 
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3 Materials 
3.1 List of manufacturers and distributors 
1)  Abgent, San Diego, CA, USA 
2)  Abnova, Taipei, Taiwan 
3)  Addgene Inc. Cambridge, MA, USA 
4)  Amersham Biosciences, Little Chalfont, UK 
5)  AnaSpec Inc. San Jose, CA, USA 
6)  AppliChem, Darmstadt 
7)  Applied Biosystems, Foster city, CA 
8)  ATCC, Manassas, VA, USA 
9)  BD Becton Dickinson GmbH, Heidelberg 
10)  Beckman Coulter, Krefeld 
11)  Biomol Research Lab, Plymouth Meeting, PA, USA 
12)  Bio-Rad, Munich 
13)  BMG Labtech, Offenburg 
14)  Calbiochem, Darmstadt 
15)  Carl Zeiss AG, Jena 
16)  Cell Signaling Technologies, Danvers, CO, USA 
17)  Charles River Laboratories, Kisslegg 
18)  Clontech, Palo Alto, CA, USA 
19)  Cytoskeleton Inc., Denver, CO, USA 
20)  Dako, Glostrup, Denmark  
21)  Dharmacon RNAi Technologies, Schwerte 
22)  Fermentas, St. Leon-Rot  
23)  Fujifilm, Düsseldorf 
24)  GE Healthcare, Munich 
25)  Genaxxon Bioscience, Biberach 
26)  GeneTex, Irvine, CA, USA 
27)  Hartmann Analytic GmbH, Braunschweig 
28)  Invitrogen, Karlsruhe 
29)  JPT Peptide Technologies GmbH, Berlin 
30)  Leica micosystems, Wetzlar 
31)  Medicult, Jylling, Denmark 
32)  Merck, Darmstadt 
33)  Millipore, Billerica, MA, USA 
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34)  MP Biomedicals, Eschwege 
35)  Operon Biotechnologies, Cologne 
36)  PAN Biotech GmbH, Aidenbach 
37)  Pierce, Rockford, USA 
38)  Promega, Heidelberg 
39)  Qiagen, Hilden 
40)  Raytest, Straubenhardt 
41)  Roche Applied Science, Mannheim 
42)  Roth, Karlsruhe 
43)  German Science Center for Genome Research (RZPD), Berlin 
44)  Santa Cruz, Heidelberg 
45)  Serva, Heidelberg 
46)  Sigma Aldrich, Munich 
47)  Stratagene, La Jolla, CA, USA 
48)  Thermo Scientific, Rockford,IL 
49)  TPP, Trasadingen, Switzerland 
50)  Upstate, Lake Placid, NY, USA 
51)  US Biological, Swampscott, MA, USA 
 
3.2 Chemicals 
 
-Mercaptoethanol 6 
2-Propanol  42 
Acetic acid 32 
Acrylamide/bisacrylamide 42 
Ammonium persulfate 46 
Aprotinin 46 
Bovine serum albumin 45 
Bromophenol Blue 46 
Calcium chloride (CaCl2 · 6 H2O) 32 
Calyculin A 15 
Crystal Violet 46 
Cypermethrin 15 
Difco Agar Noble 9 
DMSO 6 
DNase 46 
DTT 46 
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EDTA  46 
EGTA  46 
Ethanol 42 
Ethidium bromide 46 
Gelatin 46 
Glycerol 6  
Glycine 32 
Hepes 46 
Hydrochloric acid (HCl) 42 
Isopropanol 42 
LB agar  6 
LB powder 6 
Leupeptin 42 
Low-melting agarose 46 
Magnesium acetate [Mg(CH3COO)2 · 4 H2O] 46 
Magnesium chloride (MgCl2) 46 
Methanol 42 
Okadaic acid 46 
Paraformaldehyde 32 
Phosphatase Inhibitor Cocktail I 46 
Phosphatase Inhibitor Cocktail II 46 
Pepstatin 46 
PMSF 46 
Polybrene  
(1,5-dimethyl-1,5-diazaundecamethylene polymethobromide) 
46 
Ponceau S 28 
Potassium acetate (CH3COO-K+) 42 
Protease Inhibitor Cocktail Tablets (complete, EDTA-free) 39 
Puromycin 15 
RNase A 38 
SDS 42 
Sodium azide (NaN3) 46 
Sodium chloride (NaCl)  6, 32 
Sodium deoxycholate 32 
Sodium hydroxide (NaOH) 32 
TEMED 42 
Tris base / Tris-HCl 42 
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Triton X-100 46 
Tween 20 46 
Water (PCR quality) 32 
 
3.3 Nucleotides, nucleic acids and primers 
 
 
3.4 Plasmids 
 
pCMV-SPORT6- IRAVp968H1184D  43 
pcDNA4-myc/His6 28 
pTrcHis-A 28 
pECFP-N1 18 
pEYFP-C1 18 
pGEX-4T-1 24 
pGEX-4T1 SHP1 wt 3 
pGEX-4T1 SHP2 wt 
pLKO.1-puro 
psPAX2 (packaging vector) 
 
pCR-VSV-G (envelop vector) 
3 
46 
Trono laboratory 
http://tronolab.epfl
.ch/ 
pcDNA4-myc/His6-mAUM D34N                                   present work 
pcDNA4-myc/His6-mAUM wt present work 
pCR 2.1-TOPO-AUM present work 
pECFP-C1- mAUM wt present work 
pEYFP-C1- mAUM D34N present work 
CoT Human DNA 41 
Custom primers 35 
DIG-labeled dNTP mix 41 
DNA ladder 22 
dNTPs  47 
[ -32P]ATP 27 
On-Target Plus, set of individual siRNA oligonucleotides  
(targeting human or mouse AUM) 
21 
RNA ladder 22 
Salmon testes DNA (sodium salt) 46 
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pEYFP-C1- mAUM wt present work 
pGEX-4T-1-mAUM wt present work 
pTrcHis A-mAUM D34N present work 
pTrcHis A-mAUM wt present work 
 
3.5 Antibodies 
 
AlexaFlour-488-conjugated goat anti-mouse, highly cross absorbed 28
AlexaFlour-488-conjugated goat anti-rabbit, highly cross absorbed 28
AlexaFlour-546-conjugated goat anti-mouse, highly cross absorbed 28
AlexaFlour-546-conjugated goat anti-rabbit, highly cross absorbed 28
AlexaFlour-633-conjugated goat anti-mouse, highly cross absorbed 28
AlexaFlour-633-conjugated goat anti-rabbit, highly cross absorbed 28
Anti-DIG-AP Fab fragments  41
Anti-phosphotyrosine, clone 4G10, mouse monoclonal 50
Anti-phosphotyrosine, pTyr100, mouse monoclonal 16
AUM, rabbit polyclonal  17 
EGF receptor, rabbit polyclonal 16
EGF receptor, rabbit polyclonal 51
EGFR (for immunoprecipitation), mouse monoclonal 16
FAK, rabbit polyclonal 16
FAK (clone 4.47), mouse monoclonal 33
GAPDH, mouse monoclonal 26
Goat anti-mouse IgG (Fc), peroxidase conjugated 48 
Goat anti-rabbit IgG (Fc), peroxidase conjugated 48
HER2/ErbB2 (clone 29D8), rabbit monoclonal 16
HER2/ErbB2, rabbit polyclonal 16
Immobilized phosphotyrosine antibody (pTyr -100) 16
Paxillin, mouse monoclonal 9
Paxillin, rabbit polyclonal 16
Phospho-EGFR (clone 1H12), mouse monoclonal (Tyr 1068) 16
Phospho-EGFR (clone 53A5), rabbit monoclonal (Tyr 1173) 16
Phospho-EGFR, rabbit polyclonal (Tyr 1045) 16
Phospho-EGFR, rabbit polyclonal (Tyr 992) 51
Phospho-EGFR, rabbit polyclonal (Tyr 1045) 51
Phospho-EGFR, rabbit polyclonal (Tyr 1068) 51
Phospho-HER2/ErbB2,  rabbit polyclonal (Tyr 877) 16
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Phospho-HER2/ErbB2, rabbit polyclonal (Tyr 1221/1222) 16
Phospho-FAK, mouse monoclonal (Tyr 397)  9
Phospho-FAK, rabbit polyclonal (Tyr 576/577) 16
Phospho-p130 Cas, rabbit polyclonal (Tyr 165) 16
Phospho-Paxillin, rabbit polyclonal (Tyr 118) 16
Phospho-Src Family, rabbit polyclonal (Tyr 416) 16
Phospho-Src, rabbit polyclonal (Tyr 527) 16
Progesterone receptor, mouse monoclonal 2
Src (clone 36D10), rabbit monoclonal 16
Src (clone 17AT28) mouse monoclonal 1
Tubulin (clone DM1A), mouse monoclonal 46
Vinculin (clone hVIN-1), mouse monoclonal 46
β-Actin (clone C4) mouse monoclonal 33
 
3.6 Animals and cell lines 
 
C57BL/6 mice 17 
E. coli TOP 10 28 
E. coli DH5α  28 
E. coli BL21(DE3) pLysS 32 
HeLa (CCL-2) 8 
HEK 293T/F (CRL-1573) 8 
GC1 (CRL-2053) 8 
A431 (CRL-2592) 8 
 
3.7 Tissue culture reagents and materials 
 
Culture dishes/flasks 49
DMEM 36
Fetal bovine serum 36
L-Glutamine 36
Lipofectamine 2000 28
Opti-MEM 28
Penicillin G, sodium salt 36
Phosphate buffered saline 10X (with/without MgCl2/CaCl2) 36
Streptomycin sulphate 36
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Trypsin/EDTA 36
 
3.8 Other materials 
 
5-Bromo-4-chloro-3-indolyl-phosphate (BCIP) 41 
Abl protein tyrosine kinase, bacterial recombinant protein 15 
Alexa Fluor -488 phalloidin 28 
Alexa Fluor -546 phalloidin 28 
Alexa Fluor -633 phalloidin 
Apyrase 
28 
46 
BD CELL-TAK 9 
Biomol Green reagent 11 
Centricons, 10 MWKO 33 
c-Kit, His6-tagged, recombinant human protein 16 
Consensus phosphopeptide (CAAEQPLY*LNPLDP) 5 
Coomassie Brilliant Blue (G250) 48 
Csk kinase, recombinant human protein 16 
Enterokinase (from calf intestine) 41 
Epidermal growth factor, recombinant protein  15 
Ethidium bromide 46 
FAK, GST-tagged, recombinant human protein 16 
Fibronectin from bovine plasma 46 
FITC-PNA 46 
HER/ErbB2 kinase, recombinant protein 16 
Hybond C nitrocellulose membrane 24 
IPTG 42 
Kanamycin 46 
Latrunculin A 28 
Lysozyme 42 
Nitroblue tetrazolium chloride (NBT) 41 
PageRuler prestained protein ladder 22 
Phospholipase C 1, human recombinant protein 16 
Phospholipase C 2, human recombinant protein 16 
Phospholipase C 2, phosphopeptide (CRDINSLY*DVSRMY) 5 
Phospholipid scramblase 1, human recombinant protein 1 
Phosphopeptide scramblase 4, phosphopeptide (CRYQPGKY*PMPNQS) 5  
PP2 (Src kinase inhibitor) 16 
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Progesterone 46 
Prolong gold, antifade medium 28 
Puromycin 15 
QIAzol 39 
Restriction enzymes 22 
RNase free DNase I 38 
Signal transduction peptide, biotinylated (core sequence EGIY*DVP) 16 
Sodium butyrate 46 
Sperm preparation medium 31 
Src, GST-tagged, recombinant human protein 16 
Streptolysin O 46 
SYBR Green mix 7 
 
3.9 Commercial kits 
 
DIG Wash & block buffer set 41 
JPT phosphopeptide panel 29 
Micro BCA kit 38 
Mouse epididymis cDNA library 44 
Mouse tissue cDNA panel 9 
Omniscript RT kit 39 
PCR purification kit 39 
PiPER phosphate detection kit 28 
Plasmid purification kit 39 
Gel extraction kit 39 
p-NPP assay kit 15 
Src Kinase Assay kit 16 
TOPO cloning kit 
Quickchange XL site directed mutagenesis kit 
28 
47 
 
3.10 Software and Databases 
 
BLAST NCBI;NLM, Bethesda, MD 
ClustalW EMBL, Hinxton, Cambridge, UK 
ClustalX EMBL, Heidelberg, Germany 
ExPASy Server Swiss Institute of Bioinformatics 
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GraphPad Prism version 4.00 GraphPad software, San Diego, CA, USA 
Metamorph version 7.1.3.0 MDS Analytical Technologies, Downingtown, PA, USA 
Primer express 
Proweb.org 
PhyloDraw version 0.8 
Applied Biosystems, Foster City, CA, USA 
http://www.proweb.org/ 
Graphics Application Lab, Pusan National University, 
Pusan, South Korea 
SDS v1.3 Applied Biosystems, Foster City, CA, USA 
 
 
3.11 RNA Interference tools 
All siRNA oligoribonucleotides were purchased from Dharmacon. Four different synthetic 
siRNA oligoribonucleotides for mouse and human AUM were ordered as ON-TARGET plus 
set of four (catalog # LQ-041844-01-0002 or # LQ-022877-00-0002, respectively). ON-
TARGET plus siCONTROL non-targeting siRNA (catalog # D-001810-01-05) was used as a 
control in all siRNA experiments. 
Lentiviral vectors used for establishing stable cell lines expressing shRNA for stable AUM 
depletion were purchased from Sigma-Aldrich as bacterial glycerol stocks from the MISSION 
shRNA Program (catalog # SHCLND-NM_025954). The corresponding control shRNA 
plasmid (catalog # SHC002) was obtained as a DNA stock. 
 
3.12 Solutions & Buffers 
 
(in alphabetical order)   
   
ABC mix  5 ml TBS 
 50 μl Avidin 
 50 μl Biotin 
   
Antibody diluent 10 mM Hepes, pH 7.4 
 0.5 M NaCl 
 1% BSA 
 0.2% Tween-20 
 0.2% NaN3 
   
Blocking buffer 50 mM Tris-HCl , pH 8.0 
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 2 mM CaCl2 
 80 mM NaCl 
 5% (w/v) nonfat milk powder 
 0.2% NP-40 
   
DAB solution 50 ml 0.05 M Tris-HCl, pH 7.6 
 1 tablet DAB (10 mg) 
 50 μl nickel sulfate (13 mg/ml) 
 6.5 μl 30% H2O2 
   
dNTP stock solutions (PCR) 25 mM of dATP, dCTP, dGTP, dTTP (each) 
   
Laemmli buffer 62.5 mM Tris-HCl, pH 6.8 
(SDS-PAGE sample buffer) 10% (v/v) glycerol 
 5% (v/v) -mercaptoethanol 
 2% (w/v) SDS 
 0.02% (w/v) Bromophenol Blue 
   
Lysis buffer I 50 mM Tris-HCl, pH 7.4 
(for lysis of mouse tissues) 150 mM NaCl 
 1% (v/v) Triton X-100 
 0.1% (w/v) SDS 
 1% (w/v) sodium deoxycholate 
 1 mM EDTA 
 0.5 mM sodium orthovanadate 
 1 mM sodium fluoride 
 1x protease inhibitor cocktail 
   
Lysis buffer II 20 mM Tris-HCl, pH 7.5 
(for immunoprecipitation) 150 mM NaCl 
 1% (v/v) Triton X-100 
 1 mM β-glycerophosphate 
 2.5 mM  sodium pyrophosphate 
 1 mM  sodium orthovanadate 
 1x phosphatase inhibitor cocktail 1 
 1x phosphatase inhibitor cocktail 2 
 1x protease inhibitor cocktail 
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RIPA buffer 50 mM Tris-HCl, pH 8.0 
(for cell lysis) 150 mM NaCl 
 1 % (v/v) NP-40  
 0.1% (w/v) SDS 
 0.5% (w/v) sodium deoxycholate 
 1x protease inhibitor cocktail 
   
Running buffer (10x), pH 8.7 250 mM Tris base 
(SDS-PAGE) 2 M glycine 
 10% SDS 
   
Stripping buffer 62.5 mM Tris-HCl, pH 6.7 
(for immunoblotting) 2% SDS 
 100 mM -mercaptoethanol,  
added immediately before use 
   
TAE (50x) 2 M Tris-Acetate, pH 8.0 
(for DNA gels) 100 mM EDTA 
   
TBS (10x) 0.5 M Tris-HCl, pH 7.5 
 1.5 M NaCl 
   
TBS-T 50 mM Tris-HCl, pH 7.5 
 150 mM NaCl 
 0.1% Tween 20 
   
Transfer buffers  
(for semi-dry blotting) 
  
Anode buffer I 0.3 M Tris base 
 40% methanol 
   
Anode buffer II 25 mM Tris base 
 40% methanol 
   
Cathode buffer 25 mM Tris base 
 40 mM glycine 
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 10% methanol 
  For high molecular weight proteins, 
20% methanol was used in Anode 
buffers I and II. Whereas additional 
0.005% SDS was used in cathode 
buffer  
 
All other compounds used in this work were purchased from Roth or Sigma-Aldrich with “pro 
analysi” (pA) grade. 
Confocal images were taken on LSM 510 Meta or Leica TCS SP5 confocal microscopes.  
TIRF images were taken on Leica AM TIRF MC microscope. 
Epifluorescence images were taken on a Nikon TE 2000 Eclipse. 
All oligonucleotides/primers used in this work were synthesized by Operon.  
DNA bands in agarose gels were detected with the DIANA III Camera System (Raytest, 
Straubenhardt). In some cases, protein bands detected by Western blotting were 
semiquantitatively measured on X-ray films using the DIANA III Camera System and 
quantitated using ImageJ software. For the quantitative analysis of Western blot signals, 
membranes were analyzed on Alpha Innotech (San Leandro, CA, USA).  
DNA and RNA photometrical analysis was performed on a DU800 spectrophotometer.  
Measurement of protein concentration and in vitro kinase and phosphatase assays were 
performed on a FLUOstar OPTIMA microplate reader and on a Perkin Elmer Envision 2104 
multilabel reader. 
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4 Methods 
4.1 Identification of a Chronophin-related, hypothetical protein by database 
analysis 
In a search for previously uncharacterized, Chronophin (CIN)-related haloacid dehalogenase 
(HAD)-type phosphatases, an EST database search was performed according to the method 
described by Anderson  (Andersen et al., 2005). A text search was performed in Entrez and 
Swiss-Prot using the terms "haloacid dehalogenase AND phosphatase AND human" to 
retrieve a protein master set. These protein sequences were used to query NCBI's non-
redundant database with TBLASTN searches, using a cut-off value of E<10-4 in addition to a 
manual inspection of the obtained sequences for the presence of HAD motifs. Using the 
Proweb.org server, the obtained sequences were blasted against each other to sort out 
overlapping/redundant sequences. The remaining hits were included in PSI-BLAST 
searches. This approach revealed the presence of a Chronophin (CIN)-related, hypothetical 
protein that we termed AUM, for actin remodeling, ubiquitously expressed, magnesium-
dependent phosphatase. 
The basic physical characteristics, genomic organization, primary structural analysis 
of AUM and its sequence similarities with CIN were determined using the NCBI database 
and bioinformatic tools available on the Expasy Server (http://expasy.org/).  
4.1.1 Phylogenetic analysis of HAD phosphatases  
Based on the presence of the characteristic HAD motif I, HAD phosphatases from model 
organisms across the animal kingdom were retrieved using BLAST searches (Altschul et al., 
1990). The phylogenetic analysis of AUM orthologs as well as of HAD phosphatases in 
species ranging from slime mold to human beings was performed using ClustalX (ftp.embl-
heidelberg.de) and PhyloDraw, version 0.8 ).  
 
4.2 Molecular biology methods  
4.2.1 Transformation of competent E. coli  
For the transformation of chemically competent E. coli TOP10, DH5α, or BL21(DE3)pLysS 
cells, 50 µl of thawed competent cells were mixed with either 50 ng of plasmid DNA or 5 µl of 
ligation reaction and incubated on ice for 30 min. After a heat shock (2 min, 42°C in 
waterbath) and successive incubation on ice (2 min), 250 μl of preheated SOC-medium (2% 
tryptone, 0.5% yeast extract, 10 mM NaCl, 10 mM MgCl2, 10 mM MgSO4 and 20 mM 
glucose, pH 7) was added to the bacteria, and the cells were incubated at 37°C for 30 – 60 
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min. Use of SOC-medium in the final step of E. coli cell transformation was shown to yield 
maximal transformation efficiency (Hanahan 1983). This was followed by incubation for one 
hour at 37°C in a shaker (120 rpm). Cells were then centrifuged (10,000 x g, 1 min, RT) and 
the supernatant was removed. Cells were resuspended in 100 μl of LB medium and plated 
on LB agar plates containing the appropriate antibiotics. Plates were incubated at 37°C 
overnight. Antibiotic resistant colonies were screened for the expression of the respective 
plasmid and positive strains were stored as glycerol stocks (LB medium supplemented with 
25 % (v/v) glycerol) at –70°C or as DNA stock at –20°C. The verification of positive clones 
was carried out by plasmid isolation (see 4.2.2), restriction digestion (see 4.2.4), and, when 
appropriate, by sequencing (GATC, Konstanz). 
4.2.2 Plasmid preparation  
Small scale plasmid isolation  
For the screening of positive colonies and preparation of small amounts of DNA, the Mini-
prep DNA extraction kit (Qiagen) was used. Plasmids were isolated according to the 
manufacturer’s instructions. Briefly, 3 ml LB medium containing the appropriate antibiotic was 
inoculated with a single bacterial colony and was incubated overnight at 37°C with constant 
agitation. Cultures were transferred into 2 ml Eppendorf tubes and cells were pelleted by 
centrifugation (Centrifuge 5415 D, Eppendorf, Hamburg; 12,000 rpm, 1 min, RT). The DNA 
was eluted from the columns by the addition of 50 μl of elution buffer (10 mM Tris-HCl, pH 
8.0) and subsequent centrifugation (12,000 rpm, 2 min, RT). Following the 1:100 dilution of 
DNA in elution buffer, the DNA concentration was determined photometrically (see 4.2.3). 
DNA was stored at –20°C. 
Large scale plasmid isolation 
For preparation of large quantities of DNA, the Maxi-prep DNA extraction kit (Qiagen) was 
used according to the instructions of the manufacturer. A single bacterial colony was 
inoculated in 2 ml LB medium containing appropriate antibiotics, and cells were grown at 
37°C for 6-8 h with constant agitation. Afterwards, this culture was added to 100 ml of LB 
medium with appropriate antibiotics and the culture was incubated at 37°C with constant 
agitation overnight. Cells were pelleted by centrifugation (Avanti J-20 XP Centrifuge, 
Beckman Coulter, Krefeld; 6,000 x g, 15 min, 4°C), and DNA was isolated as described in 
the manufacturer’s protocol. Finally, the DNA pellet was resuspended in 500 μl of Tris-HCl 
(10 mM Tris-HCl, pH 8.0), and the DNA concentration was determined. After that, the DNA 
was diluted 1:100, and the concentration was determined photometrically (see 4.2.3). DNA 
samples were adjusted to a concentration of 0.5 – 1 g/l, aliquoted and stored at –20°C.  
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4.2.3 Quantification of nucleic acids by photometric measurement 
The photometric determination of nucleic acid concentrations was carried out using a DU 800 
spectrophotometer (Beckman Coulter). The absorbance A was measured in quartz cuvettes 
(d = 1 cm) at 260 and 280 nm (A260 and A280) against H2O. The nucleic acid concentration 
was calculated based on of the fact that an absorbance of 1 at 260 nm corresponds to an 
average DNA concentration of 50 µg/ml, and that an absorbance of 1 at 280 nm corresponds 
to an average RNA concentration of 40 µg/ml. The purity of isolated DNA was determined 
using the ratio A260/A280. Ratio of 1.8 to 1.9 is considered to be of optimum purity for most of 
the downstream applications. 
4.2.4 Restriction digests of plasmid DNA 
The enzymatic digestion of DNA with restriction endonucleases was carried out using the 
manufacturer's recommended buffers for single and double digestions (Fermentas, St. Leon-
Rot). 10 U of enzyme was used to digest 1 µg of DNA at 37°C in a ThermoMixer 
(ThermoMixer compact, Eppendorf) for one hour. The efficiency of digestion was checked by 
agarose gel electrophoresis (see 4.2.5). 
4.2.5 DNA gel electrophoresis 
Agarose gels were prepared by heating 1% (w/v) agarose (Sigma or Genaxxon) in 1xTAE 
buffer in a microwave oven, followed by the addition of ethidium bromide (0.5 µg/ml). DNA 
sample buffer (orange DNA loading dye or bromophenol blue) was added to the DNA 
samples, and the gel was run at constant voltage. The separation was evaluated on a UV 
table and documented using the DIANA III Camera System (Raytest, Straubenhardt). 
4.2.6 Elution of DNA from agarose gels 
The extraction of DNA from the agarose gel was carried out with the QIAquick Gel Extraction 
Kit (Qiagen) according to manufacturer's instructions. Briefly, the agarose gels were 
illuminated with UV light and the appropriate DNA bands were excised from the gel with a 
scalpel and transferred into Eppendorf tubes. The gel slices were weighted and three 
volumes of the supplied buffer were added to each gel slice, followed by incubation at 50°C 
for 10 min to solubilize the agarose. Afterwards, one volume of isopropanol was added to the 
samples, and the DNA was separated from the obtained mixture by binding it to the supplied 
columns and subsequently washing it one time with washing buffer. Afterwards, the DNA 
was eluted from the columns by the addition of 20 – 30 μl of elution buffer (10 mM Tris-HCl, 
pH 8.0) and subsequent centrifugation (12,000 rpm, 1 min, RT). DNA was stored until use at 
–20°C. 
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4.2.7 Isolation of RNA from murine tissues 
Total RNA from HeLa cells or mouse tissues was isolated with the QIAzol reagent according 
to the manufacturer’s protocol. This method is a single-step RNA isolation with slight 
modifications from the original method, described by Chomczynski and Sacchi (Chomczynski 
and Sacchi 1987). Basically, an appropriate amount of QIAzol reagent (one ml of QIAzol per 
50 to 100 mg tissue or per one 3.5 cm dish with adherent cells) was added to samples. 
Tissue samples were uniformly homogenized before proceeding further. After sample 
dissociation, an appropriate amount of chloroform (0.2 ml per 1 ml of QIAzol) was added, 
and samples were centrifuged to separate the organic and the RNA-containing aqueous 
phases. RNA was precipitated from the aqueous phase by mixing it with isopropanol (0.5 
ml of isopropanol per 1 ml of QIAzol reagent that was used for the initial 
homogenization). The resulting RNA pellet was washed once with 1 ml of 75% ethanol, 
was briefly air-dried, and was then redissolved in 20 l of DEPC-treated water. To reduce the 
contamination of the RNA with genomic DNA, the dissolved RNA was subjected to a 
digestion with RNase-free DNase. The reaction was set as follows: 20 l RNA, 2.5 μl 10 x 
DNase buffer and 2.5 l DNase. The reaction was carried out for 30 min at 37°C. After that, 
the enzyme was heat inactivated at 65°C for 15 min. The extracted RNA was subjected to a 
photometric concentration determination (see 4.2.3). The ratio of A260/A280 was used to 
determine the purity of the RNA sample. Ideally, a value of 1.8 to 2 indicates sufficiently pure 
samples for downstream applications. The RNA was stored at –80°C. 
4.2.8 Polymerase Chain Reaction 
The polymerase chain reaction (PCR) was used for the amplification of DNA regions, which 
were defined by specific oligonucleotides (primers). As part of this work, different 
thermostable polymerases were used for PCR. For the reverse transcriptase-PCR (see 
below) the reverse transcriptase of the high fidelity RNA PCR kit (Takara Bio Inc.) was used. 
For synthesizing DNA fragments, where the accuracy of the sequence is of particular 
importance, a proof-reading DNA polymerase from Thermococcus sp. (Platinum Pfx DNA 
polymerase, Invitrogen) was used, which has a 5'3' exonuclease activity. For real-time 
PCR, a commercially available SYBR Green PCR Master Mix was purchased from Applied 
Biosystems. All PCR reactions were performed in the PCR cycler (Eppendorf or Applied 
Biosystems) in a single tube or in a 96-well plate. The analysis of the PCR results was 
carried out on agarose gels (see 4.2.5). 
Standard PCR 
The standard PCR reaction was set in 25 µl of reaction volume by a 5 min initial denaturation 
of DNA at 95°C, and followed by 25 reaction cycles of denaturation, annealing of primers and 
elongation. The elongation of the primers for 1 min was carried out at a temperature which is 
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usually calculated 3°C below that of the melting temperature of both oligonucleotides. The 
elongation was carried out for 1 min at a temperature of 68°C. After a terminal elongation of 
1 min the PCR products were analyzed by agarose gel electrophoresis (see 4.2.5). 
Reverse transcriptase-PCR (RT-PCR) 
PCR can be used for the production of cDNA from tissue or cell lysates. For this purpose, the 
RNA is reverse transcribed (RT) using reverse transcriptase and specific primers. In this 
study, RT-PCR was performed for the generation of AUM cDNA from murine tissues. Total 
RNA was isolated as described in Section 4.2.7, and the reaction was set as follows: 1 µg of 
RNA, 0.25 µl RNase inhibitor (40 U/µl), 1.25µl dNTPs (10mM), 1µl random hexamer 
concentration (Roche, Mannheim) 2 l 10x  RT buffer. The total reaction volume was 
adjusted to 20 µl with DEPC-treated water.  RNA was reverse transcribed at 37°C for 1 hr 
followed by 95°C for 5 min.    
One microlitre of cDNA generated in the RT reaction was used as a template in the 
subsequent PCR reaction using Platinum Pfx DNA polymerase with the forward primer  5’-
CTGCTGTTCGACTGCGATGG-3’ and the reverse primer 5’-CTCTTCACATCCTCAAGA 
CTG-3’. The mixture was initially denatured for 5 min at 95°C, followed by 30 amplification 
cycles (95°C for 1 min, 58°C for 1 min, 72°C for 1 min). After the terminal elongation step 
(72°C for 2 min), the PCR product was analyzed by agarose gel electrophoresis. 
Real-time PCR 
Real time PCR allows quantification and analysis of amplified product in real time. In this 
study we quantified the AUM signal in various mouse tissues using SYBR Green chemistry 
(Applied Biosystems). SYBR green dye present in master mix binds to each newly 
synthesized double stranded DNA in the minor groove and the fluorescence can be 
measured in real time during the exponential phase of the amplification. Real Time PCR 
primers for AUM and GAPDH were designed with Primer express software (Applied 
Biosystems). For AUM, forward primer sequence is  
5’-ACCGCCTGGACACAGACATC-3’ and the reverse primer sequence is  
5’-CCGGTGAGGGTCAGGATAGTC-3’, whereas for GAPDH, forward primer sequence is  
5’-CGAGAATGGGAAGCTTGTCATC-3’ and the reverse primer sequence is  
5’-CGGCCTCACCCCATTTG-3’. The PCR cycling conditions were 95°C for 15 s, 62°C for 1 
min. The reaction was set as follows: 12.5 µl of 2x SYBR mix, 1 µl of 10 µM primer mix, 
template 2 µl (100 ng of RNA equivalent cDNA). The reaction volume was adjusted to 25 µl 
with DEPC-treated water. Real-time fluorescence data were captured during the elongation 
(62°C) step of the cycle on 7500 Real Time PCR system (Applied Biosystems). A crossing-
point threshold cycle (CT) value was obtained for each well as the fractional cycle number at 
which the measured fluorescence crossed the threshold, a value chosen by the software 
such that all reactions in all plates were in log phase. The signal was quantified using System 
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Detection Software (SDS v1.3) relative to GAPDH and calibrated against signal in testis. 
Software allows us to calibrate the signal with respect to any sample in the given dataset and 
also to integrate different experiments together. 
4.2.9 Site-directed mutagenesis 
The catalytic aspartate in AUM was point mutated to asparagine (AUM D34N) using site-
directed mutagenesis according to the Quickchange XL site directed mutagenesis kit 
purchased from Stratagene (La Jolla, USA). Briefly, 100 ng of pTrcHis-mAUM plasmid was 
employed as a template in the mutagenesis reaction with the primer 5’-
GTGGACACGCTGCTGTTCAACTGCGATGGCGTGCTGTGG-3’ and its reverse 
complement. The PCR reaction was performed with Platinum Pfx Polymerase (5 min at 
94°C, 12 cycles at 94°C for 30 sec, 58°C for 1 min, and at 68°C for 5 min, followed by 1 min 
at 68°C). One µl of DpnI enzyme was added to the PCR mix for digestion of the methylated 
template. The PCR product was transformed into competent DH5α cells (see 4.2.1), and the 
obtained colonies were screened for the desired mutation by sequencing (see 4.2.11).  
4.2.10 DNA constructs and cloning procedures 
The full length clone (pCMV-SPORT6- IRAVp968H1184D) encoding for mouse AUM 
(1700012G19Rik) was obtained from the German Resource Centre for Genome Research 
(RZPD, Berlin). The full length AUM cDNA was amplified using Platinum Pfx Polymerase 
(PCR conditions 5 min at 95°C, 25 cycles at 95°C for 1 min, 60°C for 1 min, and 68°C for 1 
min followed by 30 sec at 68°C) and the forward primer 5’- 
CTTCCGGATCCATGGCAGAGGCGGAAGCC-3’ and the reverse primer 5’- 
CTTCCGAATTCTTATCTAGAACCTTGAAGGGCAGGCAAG-3’. The PCR product was 
cloned into pCRII-TOPO vector and sequenced. As a part of my diploma work, AUM was 
subcloned into the bacterial expression vector pTrcHis A (Invitrogen) via the BamH1-EcoRI 
sites to allow the expression of N-terminally His6-tagged AUM, and into the eukaryotic 
expression vector pcDNA4-myc/His6 (Invitrogen) via the BamH1-XbaI sites to generate C-
terminally myc/His6-tagged AUM . 
As part of this thesis work, AUM wt and AUM D34N were subcloned into pECFP-N1 to 
generate  AUM-CFP, into pEYFP-C1 to generate YFP-AUM (both vectors from Clontech, 
Palo Alto, CA, USA) and into pGEX-4T-1 (GE Healthcare, Munich) to generate GST-AUM for 
bacterial expression. YFP and CFP-AUM were cloned via BamH1-XbaI sites whereas GST-
AUM was cloned via BamH1-Not1 restriction sites.under the identical PCR conditions as 
described above. All generated plasmids were verified by sequencing (GATC Biotech) and 
stored as glycerol stocks at –80°C and as plasmid DNA at –20°C. 
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4.2.11 Computer-assisted analysis of DNA sequences 
The analysis of sequences and their graphic representation was carried out with the 
programs ContigExpress and AlignX from the program package VectorNTI Suite 10 
(Invitrogen) as well as with the Chromas program, version 1.43 (C. McCarthy, Brisbane, 
Australia). 
4.2.12 Digoxigenin-labeled riboprobe synthesis 
An AUM RNA probe (riboprobe) was generated for the detection of AUM expression at the 
RNA level in Northern blots. To that end, 300ng of the pCMV-Sport6-AUM plasmid were 
amplified using the forward primer 5’-CTTCCGGATCCATGGCAGAGGCGGAAGCC-3’ and 
the reverse primer with the T7 polymerase promoter sequence 5’-CTAATACGACTCA 
CTATAGGGAGAGAATTCTTATCTAGAACCTTGAAGGGCAGGCAAG-3’ with platinum Pfx 
polymerase (5 min at 94°C, 25 cycles of 94°C for 1 min, 60°C for 1 min, and at 68°C for 1 
min followed by final extension for 1 min at 68°C). After a terminal elongation of 1 min, the 
PCR products were analyzed by agarose gel electrophoresis (see 4.2.5).  
Amplified DNA was purified from the gel as detailed in section 4.2.6. Gel-extracted 
DNA was precipitated in 3 M ammonium acetate, vacuum-dried and resuspended in 5 µl of 
DEPC-treated water. The purified plasmid DNA was used as a template for the synthesis of 
the digoxigenin-labeled riboprobe. The in vitro transcription was carried out with T7 RNA 
polymerase at 37°C for 2 hrs (2 µl of 5x transcription buffer, 2 µl of digoxigenin-labeled dNTP 
mix containing 10 mM of each nucleotide, 2 µl of 0.1 M DTT, 1 µl (40 U/µl)) of RNasin). 
Transcription buffer was provided along with polymerase. DIG labeled dNTP mix was 
purchased from Roche. To remove plasmid DNA, the reaction mix was treated with 2 µl of 
RNase-free Dnase RQ1 (Promega, Madison, WI, USA) at 37°C for 15 min. Unincorporated 
dNTPs were removed by LiCl (4M) purification. The pellet was washed in 70% ethanol, dried 
under vacuum and resuspended in 50 µl of 10mM TE (10 mM Tris-HCl, pH 7.5, 1 mM 
EDTA). 
The purified AUM riboprobe was analyzed in a 1% denaturing agarose gel. The 
sample was prepared in 2x orange DNA loading dye, heated at 70°C for 10 min, chilled on 
ice and loaded on the gel along with an appropriate RNA ladder. The riboprobe was 
visualized under an UV illuminator and documented. 
4.2.13 Northern blot 
A commercial dot blot containing membrane-bound total RNA from various mouse tissues 
(BD Biosciences, San Jose, CA, USA) was used to analyze the AUM tissue expression 
pattern. The array was incubated in 10 ml of prehybridization solution containing 1.5 mg of 
salmon testes DNA at 65°C for 1 hr. The hybridization solution contained the denatured AUM 
riboprobe (10 ng/ml), 30 µg of COT DNA and 150 µg of salmon testes DNA and was 
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prepared in 20x SSC. The array was transferred into the hybridization solution and was 
incubated at 65°C overnight with gentle shaking. Afterwards, the array was washed twice in 
low stringency buffer (1x SSC, 0.5% SDS) and 2x each in low and high stringency buffer (0.1 
x SSC, 0.5% SDS). After washing, the array was blocked in blocking buffer at RT for 1 hr. 
Ready to use blocking, washing and detection buffers were purchased from Roche (Cat. No. 
11585762001). 
Alkaline phosphatase (AP)-labeled anti-digoxigenin antibody (150 U/200µl, Roche) 
was prepared at a dilution of 1:10,000 in blocking buffer, and the array was incubated for 30 
min at RT in the antibody solution. After washing twice in 1x washing buffer for 15 min at RT, 
the array was equilibrated in 1x detection buffer for 10 min at RT. Bound antibodies were 
detected in a chemiluminescent reaction using the CDP-star solution (Roche) for 5 min at 
RT. The array was then exposed to X-ray film for 20 min at RT and developed. For future 
use, the array was stored in 2x SSC at –20°C after stripping in 0.5% SDS for 10 min.    
 
4.3 Cell biology methods 
4.3.1 Cell lines 
All cell lines used in this work (HeLa, GC1-sp, A431, and HEK293T) were purchased from 
ATCC (Manassas, VA, USA), cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
containing 4.5 g/l glucose, supplemented with 10% FCS (PAN Biotech GmbH, Aidenbach), 2 
mM L-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin at 7% CO2 and 37°C in a 
standard cell culture incubator. All cell lines were grown on standard cell culture dishes (TPP, 
Trasadingen, Switzerland and Nunc, Roskilde, Denmark) and passaged for further cultivation 
every 3-4 days at a ratio of 1:5 to 1:10. To passage cells, the culture medium was removed, 
cells were briefly washed with calcium- and magnesium-free D-PBS (Dulbecco’s phosphate 
buffered saline; PAN Biotech) and incubated with trypsin-EDTA (0.05% trypsin/EDTA) for 5 
min at 37°C. Trypsin was neutralized by the addition of FCS-containing culture medium and 
detached cells were then brought into a single cell suspension by repeated pipetting. Cells 
were counted under the microscope Axiovert 25 (Carl Zeiss, Jena) using a Neubauer 
chamber. The average cell numbers per square were multiplied with 104 in order to 
determine the number of cells per millilitre of cell suspension. 
4.3.2 Transient transfection 
The day preceding the transfection, cells were seeded at the appropriate density in 6-well 
plates or 6 cm dishes. For immunofluorescence experiments, cells were seeded at a density 
of 1 – 1.5 x 105 cells on a round 22 mm glass coverslip. For immunoblotting assays in 
overexpression experiments, cells were seeded at a density of 4 – 4.5 x 105 cells per well of 
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a 6-well plate; for RNAi experiments, 2 – 2.5 x 105 cells were seeded per well of a 6-well 
plate.  
Next day, plasmids or siRNA oligoribonucleotides and the Lipofectamine™ 2000 reagent 
were mixed separately with OptiMEM in polystyrene tubes. In case of 6-well plates, 3 l of 
Lipofectamine™ 2000 reagent and 0.1 – 0.5 g of the respective plasmids or 12.5 to 50 nM 
of siRNA oligoribonucleotides were each mixed with 250 µl of OptiMEM medium and were 
incubated for 5 min at room temperature. Afterwards, DNA (or siRNA) and Lipofectamine™ 
2000 solutions were combined and incubated for another 20 min at room temperature to form 
transfection complexes. In the meanwhile, cells were washed 3 times with DMEM without 
any additives and the medium was then replaced with 1 ml of OptiMEM. The transfection mix 
(500 µl in case of 6-well plates) was added, and the cells were incubated in a cell culture 
incubator for 4 hours. After that, the transfection medium was replaced with 2 ml of standard 
growth medium. Eighteen hours (for overexpression experiments) or 48 – 72 h (for RNAi 
experiments) after transfection, cells were either used for further experiments, fixed for 
immunofluorescence or lyzed with RIPA buffer for immunoblotting (see 4.4.6). 
When plates other than 6-well plates were used, the number of cells was adjusted 
proportionally to the effective growth area of the employed plates. The volume of transfected 
solutions was increased (e.g., to 1 ml for a 6 cm plate, to 2 ml for a 10 cm plate), along with 
proportional increase of the transfection mix. 
4.3.3 Immunofluorescence 
To determine the subcellular localization of endogenous or transiently (over)expressed 
proteins, cells were fixed for 20 min at RT in 4% paraformaldehyde, followed by 
permeabilization with 0.5% Triton X-100 for 10 min. The permeabilized cells were blocked for 
one hour in 3% BSA prepared in Ca2+/Mg2+-free D-PBS, and were subsequently incubated 
for 2 h with appropriate primary antibodies (diluted 1:100-1:400 in 1% BSA prepared in 
Ca2+/Mg2+-free D-PBS). The cells were washed twice in 1% BSA, and were incubated for 1 h 
at RT with appropriate secondary, Alexa Fluor-labeled anti-rabbit or anti-mouse IgG (1:400, 
prepared in 1% BSA). To stain filamentous actin, samples were incubated in Alexa Fluor-
labeled phalloidin (1:400) along with the secondary antibodies. Phalloidin is a bicyclic 
heptapeptide isolated from the death cap (Amanita phalloides) that specifically binds to actin 
filaments. After washing the samples three times with Ca2+/Mg2+-free D-PBS, cell nuclei were 
counterstained with DAPI (1 µg/ml in D-PBS) for 5 min and the specimen were embedded in 
ProLong Gold Antifade reagent. When fluorescent proteins were overexpressed (e.g., AUM-
YFP), the cells fixed and were embedded directly in ProLong Gold Antifade reagent. Cells 
were analyzed using confocal microscopy (see 4.3.4). 
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4.3.4 Confocal Laser-Scanning Microscopy 
The subcellular localization of endogenous or exogenous proteins was examined with a 
confocal laser scanning microscope. Confocal microscopy allows the analysis of defined 
optical slices by minimizing scattered fluorescence from out-of-focus cell areas. A laser beam 
passes through a light source aperture which is then focused by an objective lens into a 
small focal volume at optimum depth of the specimen. A beam splitter which divides light into 
two portions separates off fluorescent wavelengths from original excitation wavelength. After 
passing a pinhole, the light intensity is detected by a photodetection device which converts 
the light signal into an electrical signal that is then recorded by a computer. The out of focus 
light is suppressed by a pinhole, which results in sharper images than those of conventional 
epifluorescene microscope. The detector aperture obstructs the light that is not coming from 
the focal point permits one to obtain images of planes at various depths within the sample 
(Taylor and Wang 1980). The live or fixed and antibody-labeled cells were analyzed under 
the confocal laser scanning microscope LSM 510 Meta (Carl Zeiss, Jena) or TCS SP5 
(Leica, Wetzlar) with a Plan-Apochromat 40x/NA1.3 or 63x/NA1.4 objectives. The confocal 
aperture was set so that the optical film thickness was in between 0.5 – 1.0 µm.  Focal 
adhesion structures in fixed cells were imaged under TIRF microscope with 100x objectives. 
4.3.5 RNA interference 
Gene knockdown through RNA interference (RNAi) has developed into a widely used 
method for gene silencing (Elbashir et al., 2001). Two types of small RNA molecules – 
microRNA (miRNA) and small interfering RNA (siRNA) are central to RNA interference. 
These small RNA molecules bind to RNA and regulate its stability. Among various post 
transcriptional modifications of RNA, molecules involved in RNAi shows great potential as 
drug targets in future medicine.    
Double stranded RNA (dsRNA) is RNA with two complementary strands which form 
the genetic material of some viruses. DsRNA can trigger RNA interference in eukaryotes 
(Blevins et al., 2006). When dsRNA whose antisense strand is complementary to the 
transcript of a targeted gene is introduced into cells, it results in the degradation of the 
targeted mRNA and the consequential silencing of the target gene. Two distinct steps are 
involved in this process. In the first step, the enzyme Dicer recognizes and cleaves long 
dsRNA into siRNA molecules, which are between 21 and 23 nucleotides in length. In the 
second step, these oligoribonucleotides become incorporated in a multicomponent RNA-
induced silencing complex (RISC), which uses these siRNAs to guide the sequence-specific 
cleavage of the RNA transcripts of the target gene at sites homologous to siRNA sequences 
(Stewart et al., 2003). As a result, the synthesis of the encoded protein is largely suppressed, 
without its gene being affected (Tuschl and Borkhardt 2002). 
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Synthetic small interfering RNA (siRNA) and retroviral short hairpin RNA (shRNA) 
libraries covering most of the known and predicted human and mouse genes are 
commercially available. To trigger RNA interference-mediated gene silencing, synthetic 
siRNA oligoribonucleotides can be directly introduced into cells, e.g., by transfection. 
Alternatively, siRNA oligoribonucleotides can be generated in cells from short hairpin RNA 
(shRNA). DsRNA molecules consist of a sense and an anti-sense sequence, connected by a 
short loop of several nucleotides. That allows complementary base-pairing and the 
production of a hairpin structure. ShRNA oligoribonucleotides can be introduced into cells 
through transfection or via expression vectors and are processed by cellular enzymes into 
active siRNA oligoribonucleotides through removal of the loop sequence (Fig. 11). 
siRNAs
RISC
Target mRNA
Target mRNA cleavage
AAAA
shRNAs
cellular processing
 
Figure 11: A model for gene inactivation via RNA interference. 
Short hairpin (sh)RNA oligoribonucleotides are processed to 21-23-nt long short interfereing (si)RNA 
duplexes by intracellular enzymes. The siRNA duplexes are incorporated into an siRNA containing 
ribonucleoprotein complex, forming the RNA-induced silencing complex (RISC). The RISC mediates 
sequence-specific target RNA degradation by targeting homologous mRNAs for degradation due to its 
endonuclease activity (modified from Tuschl and Borkhardt, 2002). 
 
4.3.6 Lentiviral transduction of shRNA 
Lentiviruses were generated by transient transfection of human embryonic kidney 293F cells 
(HEK293 cells constitutively expressing the simian virus 40 (SV-40) F antigen). The cells 
were seeded the day prior to the transfection at a density of 4.5 x 106 cells per 10 cm dish. A 
lentiviral shRNA expression vector containing the respective shRNAs of interest (pLKO.1-
puro), a packaging vector (psPAX2) and an envelope vector (pCR-VSV-G) were 
simultaneously transfected (10 µg of each plasmid). For that, DNA at a concentration of 1 
µg/µl was dissolved in 533 µl ddH2O, and 62.5 µl of a 2.5 M calcium chloride solution was 
added. Building of precipitate complexes of calcium and DNA phosphate residues was 
induced by the addition of 625 µl of 2x BES-buffered saline solution (50 mM BES, 280 mM 
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NaCl, 1.5 mM Na2HPO4, pH 7.02). Transfection mixtures were incubated at room 
temperature for 5 min and pipetted into the culture medium of 293F cells. Cells were then 
incubated for approximately 16 hours. Afterwards, the medium was replaced by fresh 
medium supplemented with 10 mM sodium butyrate for 6 hours in order to enhance lentivirus 
production. Sodium butyrate is known to increase protein expression from CMV promoter-
driven vectors by stimulating the enhancer element of the promoter. Furthermore, sodium 
butyrate was shown to increase lentivirus titer even when the transfection conditions were 
not optimal (Kolokoltsov et al., 2005). The medium with sodium butyrate was then replaced 
with fresh growth medium and recombinant lentiviral particles were allowed to form during a 
24 h incubation period in a cell culture incubator. Afterwards, the medium was collected with 
a 20 ml syringe and cellular debris was removed by filtration through sterile 0.45 μm filters. 
Virus-containing supernatants were directly used to transduce target cells, which had been 
seeded the day before transduction. The growth medium of the target cells was changed to 
virus-containing medium and cells were incubated in a cell culture incubator for 24 h. 
(pLKO.1-puro lentiviral plasmids containing AUM shRNA contain the ampicillin and 
puromycin antibiotic resistance genes for selection of inserts in bacterial or mammalian cells, 
respectively.) Afterwards, transduced cells were incubated in selection medium containing 1 
µg/ml puromycin for 2 – 3 days. 
Cryostocks were made from the obtained puromycin-resistant cells by trypsinizing the 
cells and by supplementing the cell suspensions with 10% (v/v) DMSO, followed by a slow 
freeze down to –80°C and subsequent storage in liquid nitrogen. To bring cells back in 
culture, cryostocks were rapidly thawed in a 37°C waterbath, diluted 1:10 with 37°C 
prewarmed medium and centrifuged for 5 min at 1000 x g. Cell pellets were then 
resuspended and seeded in the appropriate medium onto culture dishes. 
4.3.7 Validation of the RNAi tools 
Cellular AUM expression was downregulated using two different methods. First, a transient 
transfection of synthetic siRNA oligoribonucleotides into the host cells was used. The 
corresponding sequences of the employed oligoribonucleotides are presented in Table 1. 
Host cells were seeded at low density on the day before transfection. Next day, the cells 
were transfected (see 4.3.2) with four different individual siRNA oligoribonucleotides or a 
combination of two of them. Forty-eight – 72 h after transfection, cells were lyzed in RIPA 
buffer and lysates were tested for AUM downregulation by immunoblotting with AUM-specific 
antibodies (see 3.5). 
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Table 1: siRNA sequences used to downregulate mAUM expression 
Construct Sense Sequence (5’- 3’) Antisense Sequence (5’- 3’) 
J-041844-09 UCACCAAGGCCGUGCGGUAUU PUACCGCACGGCCUUGGUGAUU 
J-041844-10 CCAAGUUGCUGCUGGCCGAUU PUCGGCCAGCAGCAACUUGGUU 
J-041844-11 AGGCGGACAUCAUCGGGAAUU PUUCCCGAUGAUGUCCGCCUUU 
J-041844-12 GCGGAGAAGCUAAGGCGCUUU PAGCGCCUUAGCUUCUCCGCUU     
 
The second way of AUM knock-down used in this work is the MISSION lentiviral shRNA 
expression system developed by the RNAi consortium (TRC). The lentiviral plasmid pLKO.1-
Puro (Moffat et al., 2006) carries the puromycin-resistance gene and drives shRNA 
expression from a human U6 promoter. This system allows the production of lentiviral 
particles and the delivery of shRNA expression cassettes into the target cells by lentiviral 
transduction. The lentivirus used here is derived from human immunodeficiency virus (HIV). 
The unique infectious capacity of this retrovirus is due to the fact that it can permeate the 
nucleus of the target cell, and is therefore capable of delivering its genetic information even 
to non-dividing or primary cells. Several shRNA sequences of 21 nucleotides in length 
targeting mouse AUM were tested for their ability to downregulate AUM protein expression 
levels in GC1-spg cells, after lentiviral transduction (see 4.3.6). The shRNA sequences 
employed are presented in Table 2. 
 
Table 2: Sequences of shRNA used to specifically down-regulate mAUM expression 
Construct Insert sequence (5’- 3’) 
TRCN0000081473 CCGGCGTGGGCACCAACATGGACAACTCGAGTTGTCCATGTTGGTGCCCACGTTTTTG 
TRCN0000081474 CCGGCGGACATCATCGGGAAGCCTACTCGAGTAGGCTTCCCGATGATGTCCGTTTTTG 
TRCN0000081475 CCGGCCCACACTTCAGCTACATGAACTCGAGTTCATGTAGCTGAAGTGTGGGTTTTTG 
TRCN0000081476 CCGGACGCTGCTGTTCGACTGCGATCTCGAGATCGCAGTCGAACAGCAGCGTTTTTTG 
TRCN0000081477 CCGGCTGTAGCCTGAAGACTATCCTCTCGAGAGGATAGTCTTCAGGCTACAGTTTTTG 
  
As a control, the MISSION non-targeting shRNA control SHC002 was used, which contains a 
shRNA insert that does not target any known human or mouse genes, due to a minimum of 
four base pair mismatches to any known human or mouse gene. Following diagram gives an 
overview of the si/shRNA sequences enlisted above in ORF of mAUM.  
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Figure 12: Localization of the mAUM siRNA/shRNA in open reading frame of mouse AUM. 
Refer to tables 1 and 2 for the designations used in the figure 
 
4.4 Protein biochemical methods 
4.4.1 Bacterial expression and purification of recombinant AUM 
Recombinant AUM was expressed in competent bacterial system BL21 (DE3) pLysS from 
Invitrogen (Carlsbad, CA, USA) as described. Proteins were expressed for 4 hrs at 37°C 
upon induction with 1 mM isopropyl ß-D-thiogalactopyranoside (IPTG), and purified under 
native conditions by standard affinity chromatography on a Talon matrix (Clontech). Purified 
AUM was stored at 4°C in  40 mM triethanolamine, 5 mM MgCl2, 150 mM NaCl, 0.002% 
Triton X-100, 50% glycerol; pH 7.4.  
The purity of the eluted protein was evaluated by 12% SDS-PAGE using Coomassie 
blue staining. Calf intestine Enterokinase (EK) from Roche (Nutley, NJ, USA) was used to 
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cleave fusion protein. EK was dissolved in milipore water to a final concentration of 1 µg/µl. 
His6-tagged protein was digested for 48 hrs at room temperature on a shaker. 30 µg of EK 
was used to digest 200 µg of purified protein as recommended by the manufacturer. Extent 
of cleavage was checked on 12% SDS-PAGE and protein was stored at 4°C.  
Further purification was facilitated by the anion exchanger column (Resource Q) on 
an Äkta purifier (Amersham Pharmacia Biotech AB, Uppsala, Sweden). A gradient of 0-500 
mM NaCl was used for elution of proteins in  fractions of 300 µl. Appropriate fractions were 
pooled and checked for the extent of purification on 12% SDS-PAGE. 
4.4.2 Design of AUM peptide antibody 
An AUM-specific peptide antibody was designed by comparing the amino acid sequences of 
human and mouse CIN and AUM (see Fig. 13). The highlighted amino acid sequence in 
AUM was selected for peptide generation, because a corresponding region in CIN (boxed 
region in Fig. 13) was already known to yield a CIN-specific antibody that does not 
crossreact with AUM. The AUM peptide was synthesized by Squarix biotechnology (Marl, 
Germany) and two female New Zealand White (NZW) rabbits were immunized with this 
peptide by Charles River Laboratories (Kisslegg, Germany). Crude sera were purified by 
Squarix biotechnology using (NH4)2SO4-precipitation and affinity chromatography on 
immobilized AUM peptide, followed by gelfiltration on a Superdex 200, HR 10/30 column. 
The specificity and sensitivity of the antibody was analyzed using Western blotting of purified, 
recombinant as well as of endogenously expressed CIN and AUM (see Figs. 24, 25, 31, 32). 
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CLUSTAL W (1.83) multiple sequence alignment 
 
 
mCIN          ---------MARCERLRGAALRDVLGQAQGVLFDCDGVLWNGERIVPGAP 41 
hCIN          ---------MARCERLRGAALRDVLGRAQGVLFDCDGVLWNGERAVPGAP 41 
mAUM          MAEAEAGGDEARCVRLSAERAKLLLAEVDTLLFDCDGVLWRGETAVPGAP 50 
hAUM          MAAAEAGGDDARCVRLSAERAQALLADVDTLLFDCDGVLWRGETAVPGAP 50 
                        *** ** .   : :*. .: :*********.**  ***** 
 
mCIN          ELLQRLARAGKNTLFVSNNSRRARPELALRFARLGFAGLR----AEQLFS 87 
hCIN          ELLERLARAGKAALFVSNNSRRARPELALRFARLGFGGLR----AEQLFS 87 
mAUM          ETLRALRARGKRLGFITNNSSKTRTAYAEKLRRLGFGGPVGPEAGLEVFG 100 
hAUM          EALRALRARGKRLGFITNNSSKTRAAYAEKLRRLGFGGPAGPGASLEVFG 100 
              * *. *   **   *::*** ::*.  * :: ****.*      . ::*. 
 
mCIN          SALCAARLLRQRLSGPPDASGAVFVLGGEGLRAELRAAGLR-LAGDP--- 133 
hCIN          SALCAARLLRQRLPGPPDAPGAVFVLGGEGLRAELRAAGLR-LAGDPSAG 136 
mAUM          TAYCSALYLRQRLAGVPDPK--AYVLGSPALAAELEAVGVTSVGVGPDVL 148 
hAUM          TAYCTALYLRQRLAGAPAPK--AYVLGSPALAAELEAVGVASVGVGPEPL 148 
              :* *:*  *****.* * .   .:***. .* ***.*.*:  :. .*    
 
mCIN          -GEDPR----------VRAVLVGYDEQFSFSRLTEACAHLRDPDCLLVAT 172 
hCIN          DGAAPR----------VRAVLVGYDEHFSFAKLREACAHLRDPECLLVAT 176 
mAUM          HGDGPSDWLAVPLEPDVRAVVVGFDPHFSYMKLTKAVRYLQQPDCLLVGT 198 
hAUM          QGEGPGDWLHAPLEPDVRAVVVGFDPHFSYMKLTKALRYLQQPGCLLVGT 198 
               *  *           ****:**:* :**: :* :*  :*::* ****.* 
 
mCIN          DRDPWHPLSDGSRTPGTGSLAAAVETASGRQALVVGKPSPYMFQCITEDF 222 
hCIN          DRDPWHPLSDGSRTPGTGSLAAAVETASGRQALVVGKPSPYMFECITENF 226 
mAUM          NMDNRLPLENGRFIAGTGCLVRAVEMAAQRQADIIGKPSRFIFDCVSQEY 248 
hAUM          NMDNRLPLENGRFIAGTGCLVRAVEMAAQRQADIIGKPSRFIFDCVSQEY 248 
              : *   **.:*   .***.*. *** *: *** ::**** ::*:*::::: 
 
mCIN          SVDPARTLMVGDRLETDILFGHRCGMTTVLTLTGVSSLEEAQAYLTAG-- 270 
hCIN          SIDPARTLMVGDRLETDILFGHRCGMTTVLTLTGVSRLEEAQAYLAAG-- 274 
mAUM          GINPERTVMVGDRLDTDILLGSTCSLKTILTLTGVSSLEDVKSNQESDCM 298 
hAUM          GINPERTVMVGDRLDTDILLGATCGLKTILTLTGVSTLGDVKNNQESDCV 298 
              .::* **:******:****:*  *.:.*:******* * :.:    :.   
 
mCIN          -QRDLVPHYYVESIADLMEGLED 292 
hCIN          -QHDLVPHYYVESIADLTEGLED 296 
mAUM          FKKKMVPDFYVDSIADLLPALQG 321 
hAUM          SKKKMVPDFYVDSIADLLPALQG 321 
               ::.:**.:**:*****  .*:. 
 
  
Figure 13: Amino acid sequence alignment of CIN and AUM and sequence used for the 
generation of an AUM-specific peptide antibody. 
This alignment was performed using the ‘multiple sequence alignment’ tool of the program ClustalW 
(Version 1.83) program. The highlighted amino acid sequence was selected for antibody generation. 
Numbers given on the right refer to amino acid positions. (*) means that the residues or nucleotides in 
that column are identical in all sequences in the alignment, (:) indicates conserved substitutions, (.) 
indicates semi-conserved substitutions. 
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4.4.3 Sample preparation for immunoblot analysis 
Preparation of cell lysates  
GC-1 spg cells or HeLa cells were washed with Ca2+/Mg2+-free D-PBS, and then lyzed in ice-
cold lysis buffer (50 mM Tris-HCl, pH 7.2; 150 mM NaCl; 0.1% SDS; 1% NP -40; 1% sodium 
deoxycholate; 1 µg/ml pepstatin; 1 g/ml leupeptin; 10 µg/ml aprotinin; 1 mM PMSF and 1x 
phosphatase inhibitor cocktails I and II). The cells were scraped from the plate on ice and 
were homogenized by repeatedly drawing into a syringe with a 20 gauge needle. Insoluble 
cell components were removed by centrifugation at 15,000 rpm for 10 min at 4°C and the 
lysate was stored in aliquots at –20°C. 
 
Preparation of mouse tissue lysates  
An adult wild type male mouse (C57BL/6) was sacrificed by cervical dislocation and then 
dissected to obtain various tissues. The tissues were immediately snap-frozen in liquid 
nitrogen and stored at –80°C until use. Tissue samples were pulverized in liquid nitrogen by 
grinding with a pistil in a mortar, and were then transferred to pre-cooled Eppendorf tubes on 
ice. Tissue lysates were prepared by homogenizing 100 mg of tissue in 1ml of lysis buffer [50 
mM Tris-HCl, pH 7.2; 150 mM NaCl; 0.1% SDS; 1% Triton X-100; 1 mM EDTA; 0.5 mM 
sodium orthovanadate; 1 mM sodium fluoride; 1% sodium deoxycholate with freshly added 
protease inhibitors: 10 µg/ml aprotinin; 10 µg/ml leupeptin; 1mM pepstatin; 1 mM PMSF and 
phosphatase inhibitor cocktail I (1:1000) and II (1:1000)]. The samples were further 
homogenized by repeatedly drawing them into a syringe through a 20 gauge needle. 
Subsequently, particulate matter was removed by centrifugation at 15,000 rpm for 10 min at 
4°C, and the lysates were stored in aliquots at –20°C. 
4.4.4 Mouse sperm preparation and analysis 
Preparation of sperm suspension 
An adult wild type male mouse (C57BL/6) was sacrificed by cervical dislocation and then 
dissected to obtain mature spermatozoa from different parts of the sperm carrying duct, the 
epididymis. Caput and cauda epididymis were cut by clearing adjoining fatty tissue and were 
immediately put in to a drop of sperm preparation medium (Medicult, Jylling, Denmark) and 
were incubated at 37°C for 15 min. Motile spermatozoa from caput and cauda epididymis 
were collected by the swim-up method (Yamashita et al., 2007) and subsequent 
centrifugation at 1000 rpm for 10 min. Live sperms were counted under the microscope and 
were adjusted to 1x106/ml in sperm preparation medium.  
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Sperm capacitation and permeabilization 
Mature cauda sperms were capacitated in 2x TYH medium (119 mM NaCl, 4.8 mM KCl, 1.7 
mM CaCl2, 1.2 mM KH2PO4, 1 mM MgSO4, 25 mM NaHCO3, 5.6 mM glucose, 0.5 mM sodium 
pyruvate, 4 mg/ml BSA) by incubating at 37°C for 30 min. Capacitated sperms were washed 
in 1X PBS and treated with 10 U of streptolysin O (SLO) prepared in TYH at 37°C for 30 min 
for permeabilization (Yamashita et al., 2007). 
 
Sperm fixation 
Sterile coverslips were coated with BD cell Tak (BD biosciences) as per the manufacturar’s 
instructions. Briefly, a drop of cell Tak was put on sterile coverslip and spread evenly by 
putting another coverslip on it at RT. After 20 min, the coverslip was washed with distilled 
water and allowed to air dry. The sperm suspension was spread evenly on the coated 
coverslip and was allowed to air dry for 1 hr at RT. Coverslip was washed with 1x PBS and 
sperms were fixed in 70% methanol at -20°C for 5 min. After blocking in 10% BSA, sperms 
were stained for microscopic analysis (see 4.3.3). 
 
Sperm lysis 
Sperm suspensions were prepared in sperm preparation medium that was treated either with 
pervanadate (for overlay assay), SLO (for permeabilization) or progesterone (for acrosome 
reaction) before lysing in 2x lysis buffer containing 20 mM Tris-HCl, pH 7.4; 150 mM NaCl; 
1% NP40; 1 mM sodium orthovanadate; 10 µg/ml aprotinin; 10 µg/ml leupeptin; 1 mM 
pepstatin; 1 mM PMSF) and  phosphatase inhibitor cocktails I & II (1:1000 dilutions, Sigma-
Aldrich). Subsequently, the particulate matter was removed by centrifugation at 15,000 rpm 
for 10 min at 4°C and the lysates were stored in aliquots at -20°C. 
4.4.5 Estimation of protein concentration 
The protein concentration of cell or tissue lysates was determined using the Micro BCA 
Protein Assay Kit. This assay allows the colorimetric detection and quantification of the total 
protein content. The assay is based on the reduction of Cu2+ to Cu1+ by the proteins 
contained in the reaction under alkaline conditions (the Biuret reaction) and the colorimetric 
detection of the generated Cu1+ by a reagent containing bicinchoninic acid, BCA (Smith et al., 
1985). Chelation of two molecules of BCA with one cuprous cation (Cu1+) leads to the 
formation of a water-soluble, purple-colored product with maximal absorbance at 562 nm. 
To measure the protein concentration, the BCA solution was prepared by mixing 
together components of the Micro BCA Protein Assay Kit according to manufacturer’s 
instructions. Cell or tissue lysate (5 μl) was diluted in a microtitre plate with water to make a 
volume of 150 μl of protein solution. Then, 150 μl of BCA solution was added to each probe, 
and samples were incubated for 2 hours at 37°C. A BSA standard curve ranging from 2 to 10 
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μg of BSA per well was supplemented with 5 μl of lysis buffer to take into account the 
absorbance of compounds of the lysis buffer. The extinction of the samples was determined 
at 560 nm in a FLUOstar OPTIMA microplate reader. 
4.4.6 SDS-Polyacrylamide Gel Electrophoresis 
SDS-PAGE is a commonly used method for separating proteins according to their molecular 
masses using polyacrylamide gels as a support medium (see Table 3) and sodium dodecyl 
sulfate (SDS) for protein denaturation and charge (Laemmli 1970). The technique of SDS-
PAGE followed by immunoblotting (see 4.4.5) is a commonly used method for protein 
expression and phosphorylation analysis. 
Protein samples were adjusted to equal protein concentrations, mixed with Laemmli 
buffer, denatured at 95°C for 5 min and loaded onto SDS-PAGE gels. The electrophoresis 
was carried out in running buffer at a constant current (25 – 30 mA). Proteins were first run in 
the stacking gel [4.5 % (v/v) acrylamide solution] to concentrate them, and then they were 
separated in the running gel [12% (v/v) acrylamide solution]. To separate low molecular 
weight proteins, running gels with 8% (v/v) acrylamide solution were used. SDS-PAGE was 
performed on the Bio-Rad mini gel apparatus (Bio-Rad, Munich). 
 
Table 3: Polyacrylamide gel recipe  
 Stacking gel Running gel 
   
30% Acrylamid/Bisacrylamid (37,5:1) 4,5% 8 or 12%  
SDS 0,1% 0,1% 
APS 0,1% 0,1% 
TEMED 0,1% 0,1% 
Tris-HCl 125 mM, pH 6.8 375 mM, pH 8.8 
 
4.4.7 Detection of proteins in SDS-polyacrylamide gels 
The proteins in SDS-polyacrylamide gels were stained with Coomassie dye (2.5 g/l 
Coomassie Serva Blue R in 10% acetic acid and 45% methanol) at room temperature 
directly after electrophoresis for a minimum of one hour or overnight. For destaining, the gels 
were incubated in the destainer (10% acetic acid and 20% methanol in H2O) with gentle 
shaking until the background was clear. The gel was stored in 0.1% sodium azide or was 
vacuum-dried. The stained gels were scanned (HP Scanjet 8300, Hewlett-Packard, CA, 
USA) for documentation or further analysis. 
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4.4.8 Immunoblot analysis 
Immunoblotting is an analytical technique commonly used for semiquantitative detection of 
specific proteins in a given sample of cell or tissue homogenates or lysates. A standard 
method for the quantitative transfer of proteins from polyacrylamide gels to nitrocellulose 
membranes, first described in 1979 (Towbin et al., 1979), was used. Briefly, proteins are 
electrophoretically transferred on membranes, and target proteins are specifically detected 
using primary antibodies. Bound primary antibodies can then be detected by using 
secondary antibodies coupled with horseradish peroxidase (HRP).  
Proteins were transferred from the SDS-PAGE gels onto nitrocellulose membranes 
using a TRANSBLOT semidry blotting apparatus (Bio-Rad, Munich). After equilibration of the 
SDS-PAGE gel in cathode buffer for 5 min, the blotting sandwich was assembled. For that, 
two lower sheets of Whatman paper were equilibrated in anode buffer I, one sheet of 
Whatman paper together with the nitrocellulose membrane in anode buffer II and three other 
sheets of Whatman paper in cathode buffer. Proteins were transferred electrophoretically at 
constant current (70 mA for 1 mini-gel) for variable times depending on the molecular mass 
of the proteins of interest. A prestained protein marker was used as a molecular weight 
marker and to monitor electrophoretic transfer. Western blot membranes were stained for 
equal protein loading with Ponceau S (0.2% in 5% acetic acid) and were copied for 
documentation. Afterwards, membranes were blocked in blocking buffer for 30 min at room 
temperature under constant agitation. Primary antibodies (see 3.5) were applied at dilutions 
of 1:500-1:1,000 (or 1:10,000 for -tubulin and -actin) in antibody diluent, and membranes 
were incubated overnight at 4°C under constant agitation in primary antibody solution. 
Afterwards, membranes were washed (3 x 5 min) with TBS-T or rinsing in water and probed 
for 1 – 2 h with horseradish peroxidase (HRP)-labeled secondary antibodies, diluted 
1:10,000 in blocking buffer. After washing (3 x 5 min) with TBS-T or rinsing in water, Western 
blot membranes were treated with the enhanced chemiluminescent (ECL) Western Blotting 
Detection System and exposed to X-ray films.  
 
Reprobing of nitrocellulose membranes 
In some cases, the same membranes were probed for several different antigens. For this 
purpose, nitrocellulose membranes were placed in stripping buffer and incubated at 55°C for 
30 min under constant agitation to remove primary and secondary antibodies. After that, 
membranes were washed three times in a large excess of TBS-T, blocked again with 
blocking buffer for 30 min at room temperature under constant agitation and then reprobed 
with other primary antibodies to detect the other antigen. 
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Densitometric analysis of immunoblot bands 
For semiquantitative Western blot analysis, Western blot signals from the membranes were 
directly detected on the DIANA III Camera System, or exposed films were scanned and 
obtained images were densitometrically evaluated using the ImageJ software (version 1.41, 
National Institutes of Health, MD, USA. http://rsbweb.nih.gov/ij/). Alternatively, digital images 
of membranes were taken on Alpha Innotech (San Leandro, CA, USA) for quantification of 
the signal. 
4.4.9 Immunoprecipitation 
Immunoprecipitation is the antibody-mediated isolation of overexpressed or endogenously 
expressed proteins from cell or tissue lysates for downstream applications. 
AUM overexpressing or stably AUM depleted GC1 cells were washed with Ca2+/Mg2+-
free D-PBS, and then lyzed in ice-cold lysis buffer (see 3.12) supplemented with freshly 
added protease inhibitors [10 µg/ml aprotinin; 10 µg/ml leupeptin; 1 mM pepstatin; 1 mM 
PMSF) and a 1:1,000 dilution of the phosphatase inhibitor cocktails I & II (Sigma)]. The cells 
were scraped from the plate on ice and homogenized by repeatedly drawing into a syringe 
through a 20 gauge needle. Insoluble cell components were removed by centrifugation at 
15,000 rpm for 10 min at 4°C and the lysate was stored in aliquots at –20°C. Total protein 
content of the cell lysate was estimated (see 4.4.3) and lysate containing 250 µg–1 mg of 
protein was incubated with 2-4 µg (or as recommended by manufacturer) of the 
immunoprecitating antibody for 2 hrs at 4°C.   
Protein A/G sepharose beads (GE Healthcare, Munich) were equilibrated in lysis 
buffer and blocked in 5% BSA prepared in lysis buffer for 2 hrs at 4°C. After 2 hrs of 
incubation with antibody, the complex was incubated in the presence of beads (30 µl of 
beads for 1 mg of total protein) for another 2 hrs at 4°C with rotation. After washing beads 
thrice in lysis buffer at 4°C, protein complexes were either released by 5 min of boiling in 
SDS-PAGE sample buffer or the immunoprecipitates were used in in vitro activity assays. 
The efficiency of immunoprecipitation was assessed by immunoblotting (see 4.4.6) with 
appropriate controls. It is necessary to examine the nonspecific binding of protein of interest 
to beads instead of immunoprecipitate complex in an individual experiment. Also, the 
efficiency of immunoprecipitation was assessed by running an aliquot of the total lysate along 
with the beads on SDS-PAGE gels followed by immunoblotting. 
4.4.10 Immunohistochemistry 
Immunohistochemistry refers to the process of localizing proteins in tissue sections exploiting 
the principle of antibody specificity in biological samples. The principle is that a specific 
primary antibody is employed to detect an antigen. A biotinylated secondary antibody is then 
used to detect the bound primary antibody. A horseradish peroxidase (HRP)-coupled 
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avidin/biotin-complex (ABC) is formed upon addition of HRP-labeled avidin, which can be 
detected with a HRP substrate, for example 3, 3’-diaminobenzidine tetrahydrochloride (DAB). 
To perform immunohistochemical analysis, 14 μm sections were cut from paraffin-embedded 
mouse testis tissue or embryos on a cryostat and mounted on poly-L-lysine coated glass 
slides. To block the effect of endogenous peroxidase, sections were incubated for 20 min at 
RT with H2O2 (0.3% in TBS). To prevent unspecific binding of the primary antibodies, 
sections were incubated in the blocking buffer for 30 min at RT. Sections were incubated with 
the primary antibodies in a humidified chamber at 4°C for 48 hrs. All further steps were done 
at RT. Sections were washed 3 x 5 min with TBS to remove unbound primary antibodies and 
then, sections were incubated for 1 h with secondary biotinylated antibodies. Sections were 
washed 3 x 5 min with TBS to remove unbound secondary antibodies and incubated for 1 h 
with freshly prepared ABC mix. After 3 x 5 min washing with TBS, sections were placed for 3 
– 15 min in DAB-solution and the reaction was stopped in water. After that, sections were 
washed again in TBS and dehydrated (2 x 70% EtOH for 2 min, 80% EtOH – 2 min, 90% 
EtOH – 2 min, 100% EtOH – 2 min, Xylene – 2 min, Xylene – 15 min). Dehydrated sections 
were mounted with Entellan and stored at RT. 
4.4.11  Enzymatic activity assays 
The phosphatase activity of CIN and AUM towards the broad-spectrum substrate, para-nitro 
phenylphosphate (p-NPP, Calbiochem) was measured spectrophotometrically in a 96-well 
microtitre plate according to the manufacturer’s instructions. Briefly, 1 µg of AUM and 2 µl of 
substrate (final concentration, 3.5 mM) were incubated in a total reaction volume of 100 µl 
prepared in assay buffer (40 mM TEA, 30 mM NaCl, 0.1% Triton X-100). The release of 
inorganic phosphate converts the colorless p-NPP into the yellow colored para-nitrophenyl, 
which can be measured spectrophotometrically at 405 nm. Thus, the absorbance at 405 nm 
is proportional to the phosphate release due to phosphatase activity in the reaction.The 
kinetics of the reaction were followed for 30 min at 405 nm.  
Pyridoxal 5’-phosphate (PLP) was used as a CIN substrate (Gao and Fonda 1994; 
Jang et al., 2003). To detect free inorganic phosphate (Pi) generated in the reaction of PLP 
dephosphorylation driven by CIN, we employed the PiPer Phosphatase Assay Kit 
(Invitrogen) according to the manufacturer’s instructions.Briefly, the detection of Pi in this 
assay is based on a cascade of coupled enzymatic reactions. In the presence of Pi, maltose 
phosphorylase converts maltose to glucose 1-phosphate and glucose. Afterwards, glucose 
oxidase converts the glucose to gluconolactone and hydrogen peroxide. Finally, received 
H2O2 reacts with the Amplex Red reagent to generate the highly fluorescent product, 
resorufin. Horseradish peroxidase catalyzes the last reaction. Thus, the resulting increase in 
fluorescence is proportional to the amount of Pi in the reaction mix. 
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Michaelis–Menten–Henri kinetics 
Enzymatic parameters (Km & Vmax) of AUM were calculated by fitting data obtained with 
various p-NPP concentrations into the Michaelis-Menten equation where the rate is plotted 
as a function of the concentration of substrate: 
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m 
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(v is reaction rate, S is substrate concentration, Km is Michaelis constant and Vmax is 
maximum reaction rate). 
4.4.12 High throughput phosphopeptide screen 
To investigate the peptide substrate preferences of AUM, we performed a high throughput 
peptide screen at the Max Planck Institute for Physiological Chemistry in Dortmund in the 
group of Prof. Herbert Waldmann. Phosphatase substrate sets encompassing peptides from 
720 human proteins phosphorylated on serine (174), threonine (58) or tyrosine (488) were 
purchased from JPT Peptide Technologies, Berlin. These peptides were supplied lyophilized 
in 384-well microtitre plates, each containing 360 phosphopeptides (250 pmol/well) together 
with 10 calibration standards. To determine the appropriate concentration of recombinant 
AUM protein under the conditions of this screen, AUM activity was first assayed against p-
NPP (10 nM): 0.2 mg/ml (5.8 µM) of AUM was diluted 1:60 in assay buffer (40 mM TEA, 30 
mM NaCl, 0.1% Triton X-100), and 25 µl of the diluted protein were pipetted in each well of a 
384-well microtitre plate with the help of a robotic system. The plate was incubated for 45 
min at 37°C with shaking and the reaction was stopped by adding 25 µl malachite green 
solution. Free phosphate released in solution was detected by malachite green. After 
allowing color development for 10 min at RT, absorbance was measured at 620 nm and raw 
data was analyzed. Hits up to 66% of highest optical density (OD) were considered specific. 
4.4.13  In vitro protein phosphatase activity assays 
In vitro phosphatase assay 
Immunoprecipitated or recombinant proteins were phosphorylated in vitro with either [γ-32P] 
ATP (1000 Ci/mmol; for autoradiography) or with unlabeled ATP (for immunoblotting with 
phosphospecific antibodies) in kinase assay buffer (50 mM HEPES, pH 7.6; 10 mM MgCl2; 2 
mM MnCl2; 2 mM DTT) at 30°C for 30 min. To remove the unincorporated ATP, the 
phosphorylated proteins were afterwards either dialyzed against phosphatase assay buffer 
(50 mM HEPES, pH 7.6; 5 mM MgCl2; 1 mM DTT) or they were centrifuged in 10 kDa MWCO 
Centricon tubes (Millipore). For this, the protein was washed 3x in 500 µl of phosphatase 
assay buffer and finally collected in a volume of 50 µl in the Centricon tubes.   
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For in vitro phosphatase assays, the phosphorylated protein was then incubated with 
1 µg of recombinant AUM (active or catalytically dead) at 30°C for 30 min in phosphatase 
assay buffer (50 mM HEPES, pH 7.6; 5 mM MgCl2; 1 mM DTT). The phosphatase reaction 
was stopped by adding sample buffer; samples were boiled for 5 min at 95°C and loaded 
onto SDS-PAGE gels. Proteins were either stained with Coomassie and the dried gel was 
exposed to X-ray films, or the proteins were blotted onto nitrocellulose membrane and the 
dephosphorylation pattern was analyzed by phosphospecific antibodies. 
In vitro kinase activity assay 
Src kinase activity towards commercial biotinylated peptide (cell signling Technologies, 
Danvor) was measured according to manufacturar’s instructions. Briefly, 50 ng of 
recombinant GST-Src was incubated with 1.5 µM substrate peptide in kinase buffer (60 mM 
HEPES pH 7.5, 5 mM MgCl2, 5 mM MnCl2, 3 µM Na3VO4, 1.25 mM DTT, 20 µM ATP) for 40 
min at RT. After terminating reaction by adding 50 mM EDTA, pH 8.0, reaction mix was 
transferred to streptavidin coated plate and binding of biotynilated peptide to streptavidin was 
continued for 60 min at RT. Strepatavidin plate was washed extensively with PBS/T (1x PBS, 
0.05% Tween-20) and then incubated with primary antibody (1:1000, pTyr-100 prepared in 
PBS/T with 1% BSA) for 60 min at RT. After incubation with appropriate HRP-linked 
secondary antibody for 30 min, phosphorylation of biotiylated peptide was measured by 
colorimteric determination as readout of kinase activiy. 
4.4.14  Cell biological assays  
Phosphatase overlay assays 
To determine the effect of the purified AUM phosphatase on the pool of denatured cellular 
tyrosine phosphorylated proteins, cells were treated with pervanadate. Pervanadate is 
plasma membrane permeable, and nonspecifically blocks cellular phosphatases due to its 
structural similarity with phosphate (Gordon 1991). This treatment serves to increase the 
pool of tyrosine phosphorylated proteins in cells, which is typically very small as compared to 
serine or threonine phosphorylated proteins (Alonso et al., 2004).  
Pervanadate was prepared by mixing equal volumes of 100 mM hydrogen peroxide 
and 100 mM sodium orthovanadate (pH 10). Cells were treated with 100 µM freshly prepared 
pervanadate solution for 15 min at 37°C (Selengut 2001). After pervanadate treatment, cells 
were washed with Ca2+/Mg2+-free D-PBS, and then lyzed in ice-cold lysis buffer (see 3.12) 
containing freshly added protease inhibitors (10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 mM 
pepstatin, 1 mM PMSF) and phosphatase inhibitor cocktails I & II (1:1000; Sigma). The cells 
were scraped from the plate on ice and homogenized by repeatedly drawing into a syringe 
with a 20 gauge needle. Insoluble cell components were removed by centrifugation at 15,000 
rpm for 10 min at 4°C and the lysate was stored in aliquots at –20°C. The total protein 
content of the cell lysate was estimated using the BCA assay (4.4.5). 
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The pervanadate-treated cell lysates were separated by SDS-PAGE and transferred 
onto nitrocellulose membranes by electroblotting. Sample was loaded in one coherent well 
produced by taping the comb. This procedure ensures a homogenous protein distribution on 
the gel. Different concentrations of recombinant, purified AUMwt or AUMD34N protein were 
prepared in phosphatase assay buffer (40 mM TEA, 30 mM NaCl, 0.1% Triton X-100) 
supplemented with 0.5% non-fat milk powder and 2 mM MgCl2. The nitrocellulose membrane 
was cut into vertical strips, the strips were placed in sterile polystyrene tubes, containing 
either buffer alone as a control, or the respective concentrations of AUMwt or AUMD34N 
protein. For the phosphatase overlay reaction, the tubes were incubated for 1 hr at 37°C with 
gentle rotation in incubator. The tyrosine phosphorylation pattern was then analyzed by using 
the phosphotyrosine-specific antibodies 4G10 or pTyr100 (see 4.4.8).     
 
Analysis of actin cytoskeletal dynamics 
Cellular actin exists in a tightly regulated equilibrium between monomeric, globular (G)-actin 
and polymeric, filamentous (F)-actin pools. This tight regulation poses an experimental 
hurdle when the effect of a protein on the actin cytoskeleton needs to be visualized. 
Latrunculin A is a toxin produced by various species of sponge (e.g., Negombata magnifica) 
that binds to and sequesters G-actin. Therefore, de novo actin polymerization is inhibited by 
blocking the incorporation of free actin monomers in actin filaments (Pardo and Nurse 2005). 
As a result, the use of latrunculin A can uncover direct or indirect effects of a protein on actin 
dynamics.  
Cell overexpressing AUMwt or AUMD34N (see section 4.3.2 or cells stably depleted of 
endogenous AUM (see section 4.3.6) were treated with 20 nM – 2 µM latrunculin A 
(Hotulainen et al., 2005) prepared in dilution buffer (5 mM Tris, pH 7.8; 2 mM MgCl2; 0.1 mM 
CaCl2; 0.2 mM ATP; 0.2 mM DTT; 0.05% sodium azide) for different time points. The 
treatment was terminated by fixing the cells in 4% PFA (see 4.3.3). As the latrunculin A stock 
solution was prepared in DMSO, control cells were treated with the corresponding 
concentrations of DMSO as a vehicle control. F-actin was stained as described under section 
4.3.3, and the cytoskeleton was analyzed by confocal microscopy (section 4.3.4). 
 
Fibronectin stimulation of cells 
Cell adhesion to extracellular matrix (ECM) proteins such as fibronectin, collagen, or laminin 
triggers signaling cascades involving rapid tyrosine phosphorylation and dephosphorylation 
events (Sieg et al., 1998). To initiate fibronectin mediated signaling cascades, cells were 
starved overnight in DMEM containing 0.5% FBS. Serum starved cells were harvested by 
limited trypsinization (0.05% trypsin/EDTA) for 5 min at 37°C. Trypsin was inactivated by 
soybean trypsin inhibitor (0.5 mg/ml in DMEM containing 0.25% BSA). The cell suspension 
was centrifuged at 1,000 rpm for 5 min, and the pellet was resuspended in DMEM containing 
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0.1% BSA. To avoid sedimentation of cells in tube and to keep them in suspension until 
spreading on fibronectin coated surface, cell suspension was incubated on rotor at 37°C for 1 
hr with gentle rotation. 
In parallel, cell culture dishes or 22 mm coverslips were coated with 10 µg/ml of 
fibronectin (diluted freshly in Ca2+/Mg2+-free D-PBS) for 1 hr at RT. Excess fibronectin 
solution was aspirated, and fibronectin-coated dishes/coverslips were dried at 37°C for 1 hr 
before use. Equal numbers of cells (see 4.3.1) were spread on fibronectin-coated surfaces 
for different time points. Cells were then either lyzed in lysis buffer (see 3.12) containing 
freshly added protease inhibitors (10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 mM pepstatin, 1 
mM PMSF) and phosphatase inhibitor cocktails I & II (1:1000 dilution) for immunoblotting 
(4.4.8), or fixed and processed for microscopic analysis (see 4.3.3). 
 
EGF stimulation of cells 
Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase which upon 
stimulation with epidermal growth factor (EGF) initiates signaling cascades and thereby 
modulates the response of a cell towards its environment (Biscardi et al., 2000). EGFR itself 
and many of its downstream effector proteins are tyrosine phosphorylated and hence after 
pervanadate stimulation (see previous paragraph) we used EGF to understand effect of AUM 
on cells in culture. 
To initiate the EGFR signaling cascade, cells were starved in DMEM containing 0.5% 
FBS either overnight or for a minimum of 6 hrs at 37°C. Upon overnight starvation in DMEM, 
cells were stimulated with 100 ng/ml (85 nM) EGF for various time points ranging from 1 min 
to 20 min at 37°C and then washed with ice cold D-PBS containing Ca2 +/Mg2+ on ice. Cells 
were then lyzed in ice cold RIPA buffer (see 3.12) containing freshly added protease 
inhibitors (10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 mM pepstatin, 1 mM PMSF) and 
phosphatase inhibitor cocktails I & II (1:1000 dilution). Cells were lyzed for 20 min on a rotor 
at 4°C, and were then centrifuged at maximum speed in a table top centrifuge at 4°C. The 
supernatants were collected in fresh precooled tubes, and were stored at –20°C. 
4.4.15 Cell area determination of fixed cells 
For an unbiased and quantitative determination of the cell area of cultured cells, we 
employed software called Metamorph (version 7.1.3.0) from MDS analytical technologies, 
Downingtown, PA, USA. To start with, 20,000 cells with stable knock down of AUM were 
seeded on fibronectin-coated (see 4.4.11) 96-well microtitre plate (15 µ-plate, ibidi, 
Martinsried) for 10, 20 or 40 min at 37°C and then stain for F-actin with phalloidin (1:400)  
and nuclei with DAPI (1 µg/ml in D-PBS) after PFA fixation (see 4.3.3). Cells were scored 
under an epifluorescence microscope with a 10x objective and analyzed with Metamorph. 
Briefly, the software takes four random pictures per well for nuclei and F-actin. By overlaying 
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the nuclei and the cell area (stained for F-actin), a single image was created which was then 
used for segmentation. During segmentation, software recognizes individual cells by nuclei 
as the center and F-actin as the periphery, and calculates the cell area in arbitrary units from 
measuring the circumference of all cells in the image. The final value that can be obtained is 
the average cell area of all cells in a given image.  
For validation, the overlay and segmentation files were correlated to ensure correct software 
operations, especially the correct segmentation of two adjacent cells. The average area of a 
high number of measured cells gives an unbiased quantitation of a heterogeneous 
population of cells with different knock down levels of AUM. The cell area of at least 1000 
cells per condition was measured in two independent experiments, and the effect of AUM 
knock down on cell area was plotted as fold increase with respect to control shRNA 
transduced cells. 
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5 Results  
5.1 Phylogenetic analysis of AUM orthologs and of its evolutionary 
relationship with CIN 
Database searches have predicted the existence of 58 human HAD enzymes (including 
phosphatases, ATPases, phosphonatases, dehalogenases, sugar phosphomutases ) with 
largely unknown functions (Allen and Dunaway-Mariano 2004). 
In order to identify the complement of human HAD phosphatases and to understand 
the evolutionary relationships among them, we performed extensive database searches (see 
4.1.1 section in methods) and constructed phylogenetic trees based on the multiple 
alignment of the identified phosphatases using the program ClustalX 2.0 (Larkin et al., 2007). 
A phylogenetic tree is a way of describing evolutionary relationships between proteins that 
are assumed to have a common ancestor. Thus, the basic assumption behind the tree 
construction is that the respective proteins are evolved over time from a common ancestor.  
There are three basic steps in the phylogenetic analalysis of proteins. 1) Multiple 
alignment of amino acid sequences 2) distance calculations depending upon data set and 3) 
construction of a tree. In the present study we have used the most common program Clustal 
W to generate multiple alignments of CIN and AUM orthologs. The letter ‘W’ in Clustal W 
stands for ‘weighted’, meaning that different weights are given to sequences and parameters 
in different parts of the alignment e.g., by inserting gaps to produce biologically significant 
alignments. The second step towards the tree construction is the calculation of distances 
between the species on the basis of multiple alignments. There are various methods for 
distance calculations, depending upon the overall similarity among the sequences. As a first 
approach we used ‘neighbour joining method’ for calculations using Clustal X 2.0.  The final 
step of analysis is the tree construction and the data display in various formats.  
We used PhyloDraw (version 0.82) for the construction of a tree. Each node of the 
tree is called a taxonomic unit. Dendrogram is the broad term used for diagrammatic 
representation of phylogenetic tree. Phylogram is a tree where the branch length is 
proportional to the character change or to evolutionary distance. In contrast, a cladogram 
does not represent the evolutionary distance and all branches are of equal length. Trees can 
be displayed as either rooted or unrooted. Rooted tree shows root as a common ancestor of 
the given dataset. Root is generally defined as the least related sequence of the given data 
set which is also called an operational taxonomic unit (OUT). Unrooted tree can be displayed 
as either radial or slated or rectangular. We choose to display the data as radial, unrooted 
trees. 
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We employed phylogenetic analysis for two distinct reasons. One, two understand 
evolutionary relationship among known human HAD phosphatases and second, to analyze 
CIN related proteins and their relationship in higher organisms.  Figure 14 shows that we 
could identify a total of 23 human phosphatases (including isoforms) containing HAD motifs. 
The radial tree of human HAD phosphatases represents the relative sequence similarity 
among the members at the amino acid level and grouped them in three hypothetical 
branches. These branches may suggest probable functional similarity between closely 
related members as it is evident from having all isoforms in single branch. CIN and AUM are 
close homologs and are grouped with PSP, the only functionally characterized protein in 
higher organisms (Collet et al., 1998). The green dot represents the root of the tree. As 
discussed above, the branch distance of radial tree does not correspond to evolutionary 
distance but merely represents the branching pattern of the members.  
 
 
 
Figure 14: Phylogenetic analysis of human HAD phosphatases. 
This radial phylogenetic tree comprises the identified human HAD phosphatases and predicts the 
probable path of divergence from common ancestors. The tree was constructed by multiple alignment 
of entire protein sequence and the distance was calculated by neighbour joining (NJ) algorithm. 
Human HAD phosphatases are grouped in evolutionarily three distinct branches probably with similar 
function. AUM is the closest CIN relative when compared to all other human HAD members.The 
following proteins are included (Swiss-Prot identifiers are given in brackets):  
AUM, actin-remodeling, ubiquitously expressed, magnesium-dependent HAD phosphatase (A6NDG6) 
also designated as PGP, phosphoglycolate phosphatase;  
CIN, Chronophin (Q96GD0), also known Pdxp, Pyridoxyl phosphate phosphatase (pdxp); 
PHOSPHO1, phosphatase, orphan 1 (Q8TCD6);  
EYA1, eyes absent 1 (Q99502); 
FCP1a, CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase subunit 1 
(Q9Y5B0); 
DEM1, differentially expressed in malignancies protein (no Swiss-Prot Id, AF120499_1); 
UBLCP, ubiquitin-like domain containing CTD phosphatase 1(Q8WVY7); 
MDP1, magnesium-dependent phosphatase 1 (Q86V88); 
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SCP, small C-terminal domain (carboxy-terminal domain, RNA polymerase II, polypeptide A) 
phosphatase 1 (Q9GZU7); 
Dullard, (O95476); 
TIMM50, translocase of inner mitochondrial membrane 50 homolog (Q3ZCQ8); 
HDHD1A, haloacid dehalogenase-like hydrolase domain containing 1A (Q08623); 
PSP, phosphoserine phosphatase (P78330); 
LHPP, phospholysine phosphohistidine inorganic pyrophosphate phosphatase (Q9H008). 
 
AUM was discovered bioinformatically as the closest relative of the cofilin phosphatase 
Chronophin (CIN; Gohla et al., 2005). Murine AUM shares 45% sequence identity and 61% 
sequence similarity on the amino acid level with murine CIN when aligned using PSI BLAST 
(see also Fig. 5). To understand the evolutionary relationship between AUM and CIN, a 
combined phylogenetic tree of AUM and CIN orthologs was constructed (Fig. 15). We used 
the entire protein sequence as input for alignment of CIN and AUM orthologs. These data 
show that both proteins co-evolved closely in lower organisms. Interestingly, the evolution of 
AUM and CIN diverged in vertebrates and was found to be localized in separate 
chromosomes in mice and humans (see section 1.3.1). 
 
 
 
Figure 15: Phylogenetic comparison of primary amino acid sequence of AUM and CIN  
This radial phylogenetic tree comprises the identified AUM and CIN orthologs and predicts the 
probable path of divergence from common ancestors. The tree was constructed by multiple alignment 
of entire protein sequence and the distance was calculated by the neighbour joining (NJ) algorithm. 
AUM and CIN orthologs (shown in blue and red, respectively) are closely related in lower organisms, 
but have evolved independently in vertebrates. The green dot represents the root of the tree. As the 
tree representation is in radial form, root was not considered while drawing the tree. 
The following CIN and AUM orthologs are included (Name of species and accession numbers are 
given in brackets for CIN and AUM): Human (NP_064711, NM_001042371); Mouse (NM_064667, 
NM_025954); Rat (AAL37168, XP_213235); Gallus (XP_001234473, NM_001030638); Danio rerio 
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(NP_848524, AAH45860); Anopheles mosquito (XP_309300; XP_309300.4); Fruitfly (NP_611656, 
CG5567); Yeast (NP_010045, NP_596255.1); Slime mould (XP_638376.1, XP_638376); Worm ( 
NP_504511; NP_504509.1). 
  
Next we investigated phylogenetic relationship of HAD phosphatases in model organisms. 
We constructed phylogenetic trees for individual organisms and analyzed how individual 
isoforms of single protein or two closely related proteins were evolved from prokaryotes to 
humans. Here we only show trees of yeast and human HAD phosphatases (Fig. 16). Such 
phylogenetic studies may be helpful to predict probable functions of novel proteins. This 
analysis can be extended for individual human HAD phosphatases with respect to other 
family members. We have restricted ourselves only to understand evolution of CIN and AUM. 
So far, the initial characterization of AUM shows striking differences with CIN (see section 
1.3). This may be attributed to differences in primary amino acid sequences in higher 
organisms as shown in figure 16. Yeast was chosen for comparison with human HAD 
phosphatases because there no tyrosine kinases were predicted until premetazoans (Pincus 
et al., 2008).  
                        
                                                                   
Figure 16:  Phylogenetic analysis of human and yeast HAD phosphatases 
This radial phylogenetic tree comprises the identified human and yeast HAD phosphatases and 
predicts the probable path of divergence from common ancestors in this two model organisms. The 
tree was constructed by multiple alignment of the entire protein sequences and the distance was 
calculated by neighbour joining (NJ) algorithm. AUM evolved independently of CIN in multicellular 
organisms. For abbreviations used in this figure, please refer (Fig. 14). 
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5.2 AUM is a magnesium-dependent HAD phosphatase 
Phosphatases of the ancient and evolutionarily conserved HAD superfamily constitute an 
emerging, yet poorly understood class of enzymes. As of now, very few HAD phosphatases 
in higher organisms are characterized in terms of their physiological roles (Kim et al., 2007) 
and even their cognate substrates frequently remain unknown. 
Given the sequence similarity between AUM and CIN, we first analyzed the AUM 
phosphatase activity towards a low molecular weight CIN substrate, pyridoxal phosphate 
(PLP; (Gao and Fonda 1994; Jang et al., 2003) in comparison to para-nitrophenylphosphate 
(p-NPP), a non-specific, broad range phosphatase substrate.  
5.2.1 Enzymatic activity assay 
To examine the catalytic properties of AUM, murine AUM was recombinantly expressed in 
bacteria as a His6-tagged protein (see section 4.4.1), and was subsequently purified by 
affinity chromatography.  
We first tested the activity of AUM against the broad-spectrum phosphatase substrate 
p-NPP. p-NPP is a colorless compound that can be enzymatically dephosphorylated to 
generate inorganic phosphate (Pi) and the yellow-colored p-nitrophenol. This conversion can 
be spectrophotometrically measured over time, and both the kinetics and the endpoint of the 
reaction can be determined. Figure 17A shows that AUM dephosphorylates p-NPP much 
more efficiently than CIN. A likely explanation for this result is that the phosphorylated phenyl 
residue of p-NPP is structurally similar to a phosphorylated tyrosine residue. This relatively 
bulky residue may not be easily accommodated in the narrow catalytic pocket of the serine 
phosphatase CIN (Almo et al., 2007).  
As PLP is a known substrate for CIN, we next compared the CIN and AUM activities 
toward PLP. Free inorganic phosphate (Pi) generated in the reaction of PLP 
dephosphorylation was detected fluorimetrically as described in section 4.4.11. As this assay 
is based on coupled enzymatic reactions, picomolar concentrations of released inorganic 
phosphate can be amplified and detected. But due to its high sensitivity the assay is prone to 
amplification of experimental errors as well. Figure 17A suggests that AUM can 
dephosphorylate PLP, but that it is a relatively weak PLP phosphatase as compared to CIN.  
The enzymatic characteristics of AUM were determined for p-NPP as a substrate as 
shown in figure 17B. Various substrate concentrations were used to calculate the reaction 
rate. The data was fitted into a Lineweaver-Burk plot and found to follow Michaelis-Menten 
kinetics. The Km and Vmax values for p-NPP were calculated with GraphPad Prism software, 
version 4.00. Km is the Michaelis-Menten constant. It is defined as the substrate 
concentration that is required to achieve a half-maximal enzyme velocity. Vmax is the 
maximum velocity of the enzyme extrapolated to very high concentrations of substrate. 
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Usually, either Vmax or Kcat is calculated along with Km to describe enzyme efficiency. Enzyme 
kinetics of AUM as shown in figure 17B indicates that AUM efficiently dephosphorylate p-
NPP, as half of the maximal velocity is attained with 370 µM of p-NPP.  
 
 
 
Figure 17: AUM is an efficient p-NPP phosphatase 
A: Comparison of AUM and CIN enzymatic activities. 
Left panel: One microgram of purified, untagged CIN or AUM was incubated with p-NPP (3.5 mM) at 
30°C, and the dephosphorylation of p-NPP was continuously measured for 40 min at 405 nm. Samples 
were in duplicates. AUM shows a higher activity against p-NPP than CIN.  
Right panel: One microgram of purified, untagged CIN or AUM was incubated with PLP (50 µM) at 
37°C, and the production of inorganic phosphate was continuously measured for 120 min at 544 nm, 
using the formation of the fluorescent product resorufin as a readout. Samples were in duplicates. PLP 
is a better substrate for CIN than for AUM. In both the panels, open circles indicate blank reading 
without protein. 
B: Characerization of the AUM enzyme kinetics towards p-NPP.  
One microgram of AUM was incubated with the indicated concentrations of p-NPP for 30 min at 30°C 
and the kinetics of p-NPP-dephosphorylation was followed at 405 nm. Data obtained for the individual 
substrate concentrations were fitted into the Michaelis-Menten equation to calculate Km and Vmax of 
AUM for p-NPP.  
 
5.2.2 AUM is an aspartate-dependent HAD phosphatase 
In contrast to conventional cysteine-based phosphatases, HAD phosphatases employ an 
unusual catalytic mechanism whereby an aspartate in the catalytic pocket acts as a 
nucleophile in a phosphoaspartate transferase reaction (Burroughs et al., 2006). After having 
confirmed that recombinant, purified AUM functions as an active phosphatase in vitro (Fig. 
17), our next step was to examine whether it was an aspartate-based phosphatase, as 
suggested by the primary structure and the presence of three HAD-type phosphatase motifs.  
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To address this question, we generated a point mutant by site-directed mutagenesis as 
detailed in section (4.2.9). The aspartate at position 34 in the HAD motif I of murine AUM, 
which is predicted to act as a nucleophile, was mutated to asparagine (AUMD34N). The mutant 
and the wildtype AUM were then expressed in bacteria and purified by affinity 
chromatography.  
Figure 18A shows a Coomassie Blue-stained SDS-PAGE gel of the purified His6-
tagged AUMD34N and AUMwt proteins. Subsequently, the in vitro phosphatase activities of 
AUMD34N and AUMwt were analyzed against p-NPP. In contrast to AUMwt, which efficiently 
dephosphorylated p-NPP in a concentration-dependent manner, even the highest employed 
AUMD34N concentration of 2 g only demonstrated only 1-2% of residual activity against p-
NPP as compared to the same concentration of AUMwt (Fig. 18B).  
These data clearly show that AUM is an aspartate-dependent phosphatase. Since 
aspartate is also known to be needed for Mg2+-coordination, AUM is a Mg2+-dependent 
phosphatase. AUMD34N is catalytically massively impaired, indicating that the contribution of 
other residues to catalysis is secondary to the contribution of aspartate at position 34 in motif 
I of AUM.  
 
Figure 18: Generation of a catalytically impaired AUM mutant 
A: Bacterially expressed and affinity-purified His6-tagged AUMwt and AUMD34N proteins were run on a 
12% SDS-PAGE gel and were stained with Coomassie Brilliant Blue.  
B: In vitro phosphatase assay using the artificial phosphatase substrate p-nitrophenyl phosphate (p-
NPP). The indicated concentration of the recombinant proteins were incubated with 3.5 mM p-NPP  for 
30 min at 30°C, and the kinetics of the dephosphorylation were followed at 405 nm for 30 min. AUMwt 
dose-dependently dephosphorylates p-NPP, whereas AUMD34N has only residual phosphatase activity 
towards this substrate.  
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5.3 High throughput peptide screen 
As a first step towards understanding the substrate preference of AUM, we decided to 
analyze its phosphatase activity against a panel of peptides derived from human proteins 
experimentally found to be phosphorylated on serine, threonine or tyrosine residues. To that 
end, we screened a total of 720 commercially available serine-, threonine- or tyrosine-
phosphorylated peptides (JPT peptide technologies, Berlin; see section 4.4.12).   
Figure 19 shows that AUM was found to be a specific phosphotyrosine (pTyr) peptide 
phosphatase in this screen, as it dephosphorylated only 17 out of the 488 phosphotyrosine-
containing peptides present in the assay (when applying a cutoff at 66% of the maximal 
reading. The full list of peptides that were dephosphorylated by AUM is given in the 
Appendix, see 10.1). Interestingly, there was not a single hit for the 232 serine (pSer) - and 
threonine (pThr)-phosphorylated peptides present in the assay. Although this peptide-based 
information may not be translated directly to AUM substrate preferences at the protein level, 
the data clearly indicated that AUM prefers tyrosine-phosphorylated residues. Furthermore, 
these results are in accordance with the efficient dephosphorylation of p-NPP (see Fig. 17). 
Figure 19 shows a graphical representation of the AUM peptide substrates identified 
in this peptide screen, together with a list of the putative substrates.  
 
 
 
Figure 19: AUM preferentially dephosphorylates tyrosine phosphorylated peptides 
720 phosphopeptides derived from human phosphorylation sites were screened for putative AUM 
substrates using a malachite green assay. 17 pTyr but no pSer or pThr peptides were 
dephosphorylated by AUM. Putative AUM substrates belong to following signalling pathways: 
Receptor tyrosine kinase signalling, Metabolism, Cell adhesion, Cytoskeleton, Nuclear signalling, 
Vesicular traffic, Second messenger, Differentiation, Apoptosis, Voltage gated channels, Growth 
factors.  
Abbreviations used in the figure: PLC2 (Phospholipase gamma 2); Grb2 (Growth factor receptor 
binding 2); IkB kinase (Inhibitor of nuclear factor kappa B kinase); CAAX (motif of one ‘cysteine, two 
‘aliphatic amino acids’ and one any amino acid at the end); TRAF4 (tumor necrosis factor (TNF) 
receptor associated factor 4); 10FTHFDH (10-formyltetrahydrfolate dehydrogenase); Kv 1.3 
(Potassium voltage-gated channel subfamily A member 3); Met (Hepatocyte growth factor receptor 
precursor); NY-REN-26 (Breakpoint cluster region protein); Dok1 (Docking protein 1); Neu (C-erbB-2 
(epidermal growth factor receptor) precursor) 
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5.4 AUM is a protein tyrosine phosphatase 
So far, we have proved at peptide level that AUM prefers phosphotyrosine residues over 
phosphoserine or phosphothreonine residues. Next step was to show it on protein level and 
in also under physiological settings. We decided to emply phosphatase overlay assay and in 
vitro phosphatase assays to address these questions as described in subsequent sections.  
5.4.1 Phosphatase overlay assay 
In order to investigate whether AUM also acts as a protein tyrosine phosphatase, we 
performed phosphatase overlay assays. In cells, only a very small fraction of proteins is 
tyrosine phosphorylated at any given time as compared to the relative abundance of serine- 
or threonine-phosphorylated proteins (Alonso et al., 2004). Secondly, the dynamic balance 
between kinase and phosphatase activities generally makes it difficult to assess cellular 
tyrosine dephosphorylation. To circumvent these difficulties, HeLa cells were stimulated with 
freshly prepared pervanadate, a nonspecific phosphatase inhibitor that induces an increase 
in the levels of cellular tyrosine phosphorylation (Gordon 1991). To avoid the effects of 
kinases that may obscure phosphatase activities, cells were lyzed, and cell lysates were 
separated by gel electrophoresis and were transferred onto nitrocellulose membranes. 
Finally, the denatured proteins were overlayed with recombinant AUMwt or AUMD34N as 
detailed in Methods (see 4.4.14). As shown in figure 20, catalytically active AUM was able to 
dephosphorylate phosphotyrosine-containing proteins in a concentration-dependent manner, 
whereas the catalytically impaired AUMD34N point mutant did not show detectable 
phosphatase activity even when 100 µg of recombinant protein were used. Even though the 
employed amounts of enzyme appear very high, these concentrations are typically required 
for phosphatase overlay assays, and represent the standard practice in the field 
(Rayapureddi et al., 2003). Taken together, these results indicate that that AUM acts as 
protein tyrosine phosphatase in cells 
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Figure 20: AUM dephosphorylates tyrosine phosphorylated proteins in phosphatase overlay 
assays.  
HeLa cells were stimulated with 100 µM pervanadate to increase the levels of cellular tyrosine 
phosphorylation (see 4.4.14). Unstimulated HeLa cells were used as a control for the efficiency of the 
pervanadate treatment. 20 µg of the cell lysates were subjected to SDS-PAGE with taped combe to 
ensure equal loading across the gel and blotted onto a nitrocellulose membrane. The membrane was 
then cut into vertical strips, and the strips were incubated with the indicated amounts of purified AUMwt 
or AUMD34N or with assay buffer as a control. Protein tyrosine phosphorylation was analyzed by 
Western blotting with the phosphotyrosine specific antibody (4G10 clone). AUMwt concentration-
dependently dephosphorylated tyrosine-phosphorylated proteins. In contrast, even the highest 
employed concentration of the catalytically impaired AUMD34N mutant did not induce a detectable 
protein tyrosine dephosphorylation.  
 
5.4.2 Role of AUM for epidermal growth factor-induced tyrosine phosphorylation in 
cells 
In order to test whether AUM can act as a cellular tyrosine phosphatase, we stimulated cells 
with epidermal growth factor (EGF) as detailed under Methods (see 4.4.14). EGF was used 
as a typical growth factor that is well-known to trigger cellular tyrosine phosphorylation 
cascades (Schlessinger 2002). In addition, the EGF receptor itself and proteins involved in 
EGF-induced signaling were detected as putative AUM phosphatase substrates in the 
peptide substrate screen (see 4.4.12).  
GC1 or HeLa cells transiently overexpressing AUMwt and AUMD34N were stimulated 
with 85 nM of EGF for various time points and were probed for global changes in tyrosine-
phosphorylated proteins as shown in figure 20. These data suggest that AUM seems to 
transiently act on tyrosine-phosphorylated proteins, in particular during the initial phase after 
EGF stimulation. The effect is most prominent around one min of EGF stimulation in GC1 
cells and five min of EGF stimulation in HeLa cells. AUMD34N overexpressing cells did not 
show reversal of the effect, which might be due to the presence of endogenous AUM. In 
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contrast, the depletion of AUM by shRNA clearly showed that AUM affects tyrosyl 
phosphorylation upon EGF induction (see section 5.7). Upon reprobing the blot for total 
EGFR as shown in figure 21B, we observed changes in the total amount of EGFR, 
suggesting a potential role of AUM in EGFR degradation pathways. 
 
 
Figure 21: Effect of AUM on cellular tyrosine phosphorylation in EGF-stimulated cells 
A: GC1 cells transiently transfected with the indicated plasmids were starved overnight in serum-free 
culture medium. Cells were stimulated with 85 nM of EGF for the indicated time points, and were 
subsequently lyzed in lysis buffer. Equal protein amounts (20 μg) of the lysates were separated by 
SDS-PAGE, transferred onto nitrocellulose membranes and tyrosine-phosphorylated levels were 
analyzed by immunoblotting with the phosphotyrosine-specific antibody 4G10.  
B: HeLa cells transiently transfected with the indicated plasmids were starved overnight in serum-free 
culture medium. Total phosphotyrosine content was analyzed as above.Total EGFR levels upon AUM 
overexpression were analyzed by stripping and reprobing the blot. AUM overexpression modulates 
EGFR levels in cells.  
Western blots shown here are representative of 3 independent experiments. The results show that 
AUM can act as a cellular protein tyrosine phosphatase Arrow indicates modulation of 
phosphotyrosine content upon AUM overexpression. 
 
Taken together, these data with pervanandate and EGF stimulations show that AUM can act 
as a protein tyrosine phosphatase in cells.  
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5.5 Ubiquitous expression of AUM in mouse tissues 
We next investigated the expression pattern of AUM at the RNA and protein level by multiple 
approaches. Searches in expressed sequence tag (EST) databases (Unigene) predicted a 
partially non-overlapping AUM and CIN expression pattern. During my diploma work, we 
compared AUM and CIN expression profiles by reverse transcriptase (RT)-PCR (see section 
1.3.2). CIN was found to be broadly expressed with highest levels in brain, whereas AUM 
was broadly expressed with highest levels found in testis. As a continuation of this 
preliminary analysis, we now employed quantitative real-time PCR, Northern blot, 
immunoblot and immunohistochemical analysis with AUM-specific antibodies in the present 
study.                                                                                                                                                                  
5.5.1 Real-time PCR  
In order to quantify the AUM expression in various tissues and to re-evaluate the expression 
pattern obtained in the initial RT-PCR experiments, we performed real-time PCR. We 
analyzed the AUM expression pattern in different mouse tissues and in mouse embryos. The 
relative abundance of the AUM transcript was quantified with GAPDH as an internal control 
and testis as a calibrator. Figure 22 shows a ubiquitous expression pattern of AUM in all 
major mouse tissues. AUM was found to be highly expressed in testis. The crossing point 
threshold cycle (Ct) value is the measure of transcript abundance (see section 4.2.8 in 
Methods). Testis has the lowest Ct value among all investigated tissues, implying an early 
attainment of the threshold cycle due to high transcript abundance. AUM expression can be 
detected as early as in seven days old mouse embryos. Together, these real-time data are in 
accordance with the RT-PCR analysis of AUM expression during preliminary characterization 
(see section 1.3.2 of introduction) 
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Figure 22: Relative quantification of AUM transcript by real-time PCR 
cDNA from the indicated tissues were subjected to real-time PCR with AUM and GAPDH primers. The 
data were normalized against GAPDH and calibrated against the AUM expression in testis. The 
crossing point threshold (Ct) value is an indicator of the relative abundance of the transcript in a given 
tissue. AUM is ubiquitously expressed with highest expression in testis. Values represents results from 
two independent experiments with each sample run in triplicates.    
 
5.5.2 Northern blot  
Along with semi quantitative real-time PCR analysis of AUM transcript, we also designed a 
digoxigenin (DIG)-labeled AUM riboprobe to analyze the expression pattern of AUM at the 
RNA level by Northern blot. We used a commercially available dot blot panel of mouse 
tissues containing total RNA crosslinked on a membrane. Figure 23A shows the validation of 
the AUM riboprobe using total RNA from mouse testis. The AUM riboprobe was found to 
detect a single major band at the expected size of AUM (0.96 Kbp). Thus, the AUM RNA 
probe specifically recognizes AUM. In addition to Northern blot analysis; this probe may also 
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be a useful tool to analyze the AUM expression pattern at the RNA level by methods such as 
in situ hybridization.  
The dot blot was probed with the AUM-specific riboprobe as shown in figure 23B. 
These results clearly confirm the ubiquitous AUM expression pattern as measured by real-
time PCR experiments (Fig. 22). Interestingly, AUM is not only highly expressed in testis, but 
it also shows high expression in other male and female reproductive organs, such as 
epididymis, prostate, uterus and ovary.     
 
Figure 23: AUM expression analysis by Northern blot  
A: AUM RNA probe validation. 
Purified AUM RNA probe was analyzed on an RNA agarose gel to check integrity and extent of purity. 
Total mouse testis RNA cross linked on membrane was probed with DIG labeled AUM riboprobe and 
the signal corresponding to size of AUM cDNA (966 bp) was obtained after exposing to X-ray film.  
B: AUM Northern blot  
DIG-labeled AUM riboprobe was probed against total RNA in various mouse tissues. AUM transcript 
was found to be ubiquitously expressed with highest expression in testis. Controls used were F1: 
Yeast total RNA; F2: Yeast tRNA; F3: E.coli rRNA; F4: E.coli DNA; G1: Poly r (A); G2: Cot DNA; G3: 
Mouse DNA; G4: Mouse DNA. Wells B4, B5 E5, F5, G5 are empty. Abbreviations used in the figure: 
Sk (Skeletal muscle); Sm (Smooth muscle); Sb (Submaxillary gland); Epi (Epididymis); E7-E17 
(mouse embryonal stages) 
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5.5.3 Western blot 
In order to investigate the expression and cellular distribution of AUM at the protein level, we 
next aimed to generate a sensitive and AUM-specific rabbit polyclonal antibody. For this 
purpose, we designed an AUM-specific peptide as as outlined in Methods (see section 
4.4.2).  
Figure 24 demonstrates that the affinity-purified AUM-antibody was able to reliably detect as 
little as 10 ng of recombinant, purified AUM protein. Furthermore, the AUM-directed antibody 
did not cross-react with CIN, its closest known homolog.  The affinity-purified AUM antibody 
has been successfully used for immunoblotting (1:1000), immunohistochemistry (1:250 – 
1:400) and for immunostaining (1:100), as will be shown in the following sections.  
 
 
Figure 24: Characterization of AUM rabbit polyclonal antibody 
Indicated amounts of recombinant AUM and CIN proteins were loaded on 12% SDS-PAGE and 
transferred to nitrocellulose membrane.  
Left panel: Nitrocellulose membrane probed with AUM specific antibody reconganizes 10 ng of 
recombinant protein but does not cross react with CIN. Faint band in the first lane (with CIN protein) is 
due to spill over from the adjacent well. 
Right panel: Nitrocellulose membrane probed with CIN specific antibody does not cross react with 100 
ng of AUM. The AUM antibody can be reliably used for biochemical and cellular assays as there is no 
cross reactivity with CIN. 
 
In order to analyze the AUM expression pattern at the protein level, we generated lysates of 
various mouse tissues as detailed in Methods (see 4.4.3). The lysates were then analyzed by 
immunoblotting using the AUM-directed antibody. In accordance with RT-PCR, real-time 
PCR and Northern blot analysis, AUM was found to be expressed ubiquitously with highest 
expression in testis as shown in figure 25. In all investigated tissues, the AUM antibody 
detected a single predominant band corresponding to the expected AUM size of ~34 kDa. In 
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addition, faint higher molecular weight bands were detected in kidney, liver and skeletal 
muscle suggesting the possible existence of AUM splice variants or isoforms. By Western 
blotting, the relative difference in the AUM expression in testis as compared to other tissues 
was not as big as detected by real-time PCR (see Fig. 22). This may suggest the existence 
of AUM splice variants or isoforms in testis that may not be detected by the AUM antibody.   
 
 
Figure 25: Analysis of AUM expression in mouse tissues 
Mouse tissue lysates (60 g) were separated by SDS-PAGE, transferred onto nitrocellulose 
membrane and then analyzed by immunoblotting for AUM expression. AUM was found to be 
ubiquitously expressed in mouse tissues with highest expression found in testis.  
 
Given the dominant AUM expression in testis, both at the RNA and at the protein level, we 
decided to investigate the AUM expression in testis in different stages of development, as 
well as in the male reproductive system of adult mice. Following schematic drawing 
illustrates the different regions of the male reproductive system and cells present in the 
seminiferous tubule of the testis. 
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Figure 26: Schematic representation of male reproductive system of mouse 
A: Major parts of male reproductive system consist of testis and sperm carrying duct called epididymis. 
Germ cells undergo maturation (spermatogenesis) in testis cords called seminiferous tubules. (Figure 
modified from Nature Reviews. Genetics 2006) 
B: Seminiferous tubules of testis have germinal cells (in different stages of development) and non 
germinal cells called Sertoli cells interspersed between germ cells. Testesteron secreting Leydig cells 
are present interspersed between the seminiferous tubules (not shown in the figure) 
 
Testis lysates were prepared from 1 day to 9 months old male mice. Whereas AUM protein 
expression was detectable at early embryonic stages by real-time PCR, the expression 
peaked at around four weeks of age as found by western blot (Fig. 27A). This time point 
corresponds to the age of puberty in the mouse (Murphy et al., 1994). Afterwards, the AUM 
protein levels reached a plateau, as shown in figure 27A. Spermatogenesis induces germ 
cell arrested in first meiotic division to undergo subsequent multiplication once mouse attains 
puberty. AUM expression corresponds to this process suggesting predominant expression in 
germ cells rather than non germinal cells like Sertoli or Leydig cells.  
    We further analyzed the AUM expression in various regions of the epididymis (the 
sperm carrying duct), as well as in mature mouse spermatozoa. Spermatozoa from the 
different regions of male reproductive system were isolated and lysates were prepared as 
detailed in methods (see section 4.4.4) Immature spermatozoa, formed at end of 
spermiogenesis undergo a maturation process called capacitation while being transported 
through the epididymis (Breitbart et al., 2005) The head of the epididymis is called caput 
whereas the tail is known as cauda epididymis.  Caput sperms are less motile and cannot 
undergo capacitaton whereas cauda epididymis contains mature spermatozoa (Bellve 1993). 
Interestingly, the AUM expression is higher in testis than in the epididymis or in sperm, as 
shown in figure 27B and 27C. Furthermore, the highest AUM abundance was detected in 
isolated seminiferous tubules (Fig. 27C), which contain germ cells at various stages of 
development (Hess et al., 1990), before the spermatozoa mature in the epididymis (Seligman 
et al., 2004). These results indicate that the AUM levels decrease along with process of 
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spermatozoa maturation. We also tested AUM antibody on the two clinical samples of normal 
human sperm as shown in figure 27B. 
 
Figure 27: AUM protein expression analysis in mouse testis 
A: Expression of AUM protein in mouse testis in different developmental stages.   
20 µg of testis lysate from indicated age of mouse were separated by SDS-PAGE, transferred onto 
nitrocellulose membrane and then analyzed by immunoblotting for AUM expression. AUM level was 
found to be peaking up at the age of puberty (4 weeks) in mouse.  
B: AUM expression in different regions of the male reproductive system 
Lysates of indicated tissues prepared in lysis buffer and were separated by SDS-PAGE, transferred 
onto nitrocellulose membrane and then analyzed by immunoblotting for AUM expression. Highest 
AUM expression was found in the seminiferous tubules of testis. The AUM antibody also recognized 
endogenous AUM in human sperm.  
C: AUM expression during sperm maturation. 
Sperm lysates were separated by SDS-PAGE, transferred onto nitrocellulose membrane and then 
analyzed by immunoblotting. AUM expression decreases along with process of spermatozoa 
maturation in the epididymis. Corresponding ponceau staining is shown as a loading control  
 
  
Taken together, we have analyzed AUM expression both at the RNA and protein level in 
various mouse tissues. AUM is found to be expressed in ubiquitously right from early 
developmental stages with highest expression in seminiferous tubules of testis. 
 
5.6 Immunohistochemical analysis of AUM in mouse testes 
In order to identify the AUM-expressing cells in testis, we next performed 
immunohistochemical analysis on paraffin-embedded mouse testis sections. AUM was 
detected using the AUM-specific antibody (see Figs. 28, 29), together with either DAB 
detection or with fluorescently labeled secondary goat anti-rabbit antibodies as detailed in 
Methods (see 4.4.10). Please refer to the schematic representation of different cell types in 
testis in figure 26. 
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5.6.1 Expression pattern of AUM in mouse seminiferous tubules 
In order to analyze the AUM expression pattern in mouse seminiferous tubules, paraffin-
embedded sections of mouse testis were stained with the AUM-specific antibody. AUM 
expression was found to be restricted inside the seminiferous tubule as shown in figure 28B. 
In the seminiferous tubules, AUM was first detectable in round spermatids (see black star in 
Fig. 28C), and was maximally expressed in elongated spermatids (see red arrow in Fig. 28C) 
and in spermatozoa oriented towards the lumen of the tubules). In contrast, AUM was not 
detectably expressed in spermatogonia or in spermatocytes. These results indicate that the 
expression of AUM peaks only during the later stages of spermatogenesis.  
 
Figure 28: Immunohistochemical analysis of AUM in mouse testis 
A: AUM antibody specificity. Rabbit IgG was used as isotype control.  
B: AUM expression in germinal cells of seminiferous tubules. AUM-specific rabbit polyclonal antibody 
was used to detect the expression of AUM in mouse testis. Brown color represents AUM signal. 
Overiew picture at 16 x magnification indicates that AUM expression is restricted to the inside of the 
seminiferous tubules. 
C: High resolution picture shows that AUM is predominantly expressed in elongated spermatids during 
spermatogenesis as indicated by the red arrow. The black arrow indicates the beginning of AUM 
expression in round spermatids. Earlier stages of spermatogenesis such as spermatocytes present 
beyond black star do not show detectable AUM expression.  
 
5.6.2 Expression pattern of AUM in male reproductive system 
In order to analyze AUM expression pattern in the male reproductive system in more detail, 
sections of mouse testis were compared to mouse epididymis sections. In addition, mouse 
spermatozoa from caput and cauda epididymis were isolated, fixed on coverslips and stained 
with AUM-specific antibody as described in methods (see section 4.4.4). Mouse epididymis 
sections were also co-stained for tubulin as detailed in Methods (see 4.3.3). As shown earlier 
(Fig. 28), the AUM was not detected in germinal cells at the early stages of spermatogenesis. 
AUM expression was maximal in elongated spermatids. No AUM signal was detected in 
Sertoli or Leydig cells as shown in figure 29A and B. Expression of AUM in mature cauda 
sperms was found to be less than in immature caput sperms as shown in figure 29E and 
29F. This was also confirmed by analyzing AUM expression in sections of caput and cauda 
epididymis as shown in figure 29C and 29D. This expression pattern supports the 
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biochemical data of highest AUM expression in seminiferous tubules and reduction of signal 
along with the sperm maturation (see Figs. 27B, C).    
 
Figure 29: Expression pattern of AUM in the male reproductive system 
Male reproductive tissues were stained for AUM expression using an AUM-specific rabbit polyclonal 
antibody. AUM signal was detected with a fluorescently-labeled secondary antibody. Antibody 
specificity was checked by rabbit IgG isotype control (data not shown). 
A, B: Expression of AUM in testis is restricted to the germinal cells inside the seminiferous tubule. 
C, D: Expression of AUM in epididymis:  AUM expression goes down along with maturation from the 
head (caput) towards the tail (cauda). 
E, F: Expression of AUM in sperms isolated from caput and cauda epididymis. Immature caput sperm 
have more AUM expression as compared to mature cauda sperm, suggesting a differential AUM 
expression during maturation process called capacitation. Scale bar represents 25 µm.   
 
5.6.3 Expression of AUM in developing germ cells 
Germinal cells in seminiferous tubules undergo massive nuclear and cytoplasmic 
reorganization to form haploid, motile spermatozoa from diploid, non motile spermatogonia. 
This process is termed as spermatogenesis (Hess 1990). The term spermiogenesis refers to 
a specialized process during spermatogenesis, which is defined by the formation of mature 
spermatozoa from round spermatids. Spermiogenesis can be divided into 16 distinct stages 
in the rat (Hess et al., 1990; Zheng et al., 2007), as shown schematically in the upper panel 
of figure 30. During spermiogenesis, round and nonmotile spermatids (stage number 4-7 in 
Fig. 14) are gradually converted into motile spermatozoa (stage number 16 in Fig. 30). This 
differentiation process involves cell-cell interactions between germ cells and Sertoli cells 
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(Wang et al., 2006). Sertoli cells are the only non-germinal cells inside seminiferous tubules 
and play critical roles in the formation of the blood-testis barrier and for nourishing the germ 
cells during the process of spermatogenesis(Wang et al., 2006). In the final stages of 
spermiogenesis, the cytoplasm of the germ cells is reorganized, and excess cytoplasm is 
removed. Finally, individual spermatozoa are released into the lumen of the seminiferous 
tubule due to a reorganization of cell-cell adhesion junctions by a process referred to as 
individualization in Drosophila (Cagan 2003) or as spermiation in mammals (Mruk et al., 
1997). 
To analyze the AUM expression profile during spermiogenesis in more detail, multiple 
testis sections were stained for AUM and were analyzed to correlate the AUM expression 
with the 16 developmental stages of spermatogenesis. The lower panel of figure 30 shows 
representative cells. The expression of AUM peaks between stage 10 & 15 of 
spermiogenesis when excess cytoplasm is phagocytosed by Sertoli cells 
 
 
Figure 30: Expression pattern of AUM during spermiogenesis 
Upper panel: Schematic prepresentation of the process of rat spermiogenesis, divided in to 16 distinct 
developmental stages, starting from round, non-motile spermatids (stage 4-7) up to elongated, motile 
spermatozoa (stage 16).Schematic representation of spermiogenesis. Numbers represents steps of 
spermatid development.  (modified from Zheng H. et. al., 2007) 
Lower panel: AUM expression pattern was analyzed from at least three separate images of 
seminiferous tubules stained for AUM and nucleus. Based on the nuclear shape and cell morphology, 
individual cells were assigned to respective stages of spermiogenesis. The AUM expression peaks 
between stage 10 and 15 when excess cytoplasm is shed off, giving rise to motile spermatozoa. 
    
 
Taken together, our expression analysis shows that AUM is a ubiquitously expressed protein 
that is highly abundant in the maturing male germ cells. AUM expression peaks between 
stages 10 – 15 of spermiogenesis, suggesting that AUM might have a role in the 
reorganization of cell-cell adherence junctions between germ cells and Sertoli cells. These 
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expression data may be useful in the future to device a strategy to understand the potential 
role of AUM in the molecular mechanism of the poorly understood processes of spermiation 
or capacitation.    
 
5.7 AUM knockdown by RNA interference 
To analyze the functions of AUM in male germ cells, we transiently or stably depleted the 
endogenous protein by RNA interference in the murine spermatogonial cell line GC-1 spg 
(Hofmann et al., 1992). 
5.7.1 Transient AUM depletion  
AUM was transiently depleted in cells by the transfection of short interfering (si)RNAs. To this 
end, four different mouse AUM-directed synthetic siRNA oligoribonucleotides targeting 
different regions of AUM were tested in comparison to a non-targeting control siRNA. 
Different concentrations (12.5 – 75 nM) of each siRNA oligoribonucleotide were tested in 
transfection experiments. The best knockdown efficiency was achieved by using siRNA 
oligoribonucleotides in the concentration range of 12.5 to 50 nM as shown in figure 31. 
An efficient AUM knockdown was achieved with three out of the four tested siRNA 
oligos -041844-10 (AUM siRNA #1), J-041844-11 (AUM siRNA #3) and J-041844-12 (AUM 
siRNA #4). The sequences of these siRNA oligoribonucleotides along with control siRNA are 
shown in table 1 (section 4.3.7).  
 
Figure 31: Transient AUM depletion by siRNA 
GC-1 spermatogonial cells were transfected with 12.5 - 50 nM of control siRNA or AUM siRNAs #1-4 
as described in the Methods (see 4.3.7). Cells were lyzed 48 to 72 hours after transfection. Equal 
protein amounts (20 g) of the lysates were separated by SDS-PAGE, transferred onto nitrocellulose 
membranes and endogenous AUM levels were analyzed by immunoblotting with an AUM-specific 
antibody. Equal loading was controlled by immunoblotting for tubulin. SiRNA #2 and #3 showed 
highest knock down efficiencies.  
       
These results demonstrate that the transient transfection of siRNA oligoribonucleotides leads 
to a robust AUM knock-down efficiency in cells. Nevertheless, this approach only allows the 
transient suppression of AUM protein expression. Furthermore, the efficiency of transfection 
may vary in between experiments. Together, these factors may affect the final outcome of 
the experiment. To solve this problem, and to achieve uniform AUM down regulation over 
extended time periods, we decided to use a vector-based system to express short hairpin 
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(sh)RNA (see 4.3.7) in cells. Such a vector-based system may also allow us to establish 
stable cell lines. 
5.7.2 Stable AUM depletion 
For a long-term and uniform depletion of AUM protein expression in GC1 cells, five different 
AUM-specific shRNA sequences targeting different regions of murine AUM were tested. The 
sequences of these shRNA constructs are shown in table 2 (see section 4.3.7). As detailed 
in Methods (see 4.3.6), lentiviruses harboring five different shRNAs and one established 
control shRNA were generated, and used for the transduction of GC1 cells. Cells stably 
expressing the respective shRNAs were then selected using puromycin.  
Figure 32, upper panel shows that two out of five tested shRNA constructs 
TRCN0000081473 and TRCN0000081477 (#73 & #77), yielded an effective AUM 
knockdown. All further experiments were done using the stably AUM-depleted GC1 cell line 
obtained after the transduction of the shRNA construct #77 (referred to as M77) and with the 
control shRNA GC1 cell line expressing the control shRNA construct SHC002. 
 
Figure 32: Stable AUM depletion by shRNA 
Upper panel: GC1 cells were transduced with lentiviruses encoding for control shRNA (CshRNA) or for 
five different AUM-directed shRNA constructs (#73-77). Cells were lyzed and equal protein amounts 
(20 g) of the lysates were separated by SDS-PAGE and were transferred onto nitrocellulose 
membranes. AUM levels were analyzed by immunoblotting with the AUM-specific antibody. Equal 
loading was assessed by immunoblotting for tubulin. 
Lower panel: Densitometrical evaluation of AUM knock-down efficiency from three different Western 
blots. 
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In order to validate AUM shRNA cell lines and to test the potential function of AUM as a 
protein tyrosine phosphatase as shown before by overexpression studies (see 5.4.2), we 
induced the EGFR signaling cascade with epidermal growth factor (EGF) after overnight 
starvation of shRNA-expressing GC1 cells as detailed under Methods (see 4.4.14). EGF was 
used as a typical growth factor that is well-known to trigger cellular tyrosine phosphorylation 
cascades (Schlessinger 2002). GC1 cells were stimulated with 85 nM of EGF for various 
time points and were probed for global changes in tyrosine-phosphorylated proteins as 
shown in figure 33. These data suggest that AUM seems to transiently act on tyrosine-
phosphorylated proteins, in particular during the initial phase after EGF stimulation. 
Compared to AUM overexpression studies, the depletion of endogenous AUM triggered 
more prominent changes in EGF-induced tyrosine phosphorylation. 
 
 
Figure 33: Effect of AUM on cellular tyrosine phosphorylation in EGF-stimulated cells 
GC1 cells expressing with the indicated shRNAs were starved overnight in serum-free culture medium. 
Cells were stimulated with 85 nM of EGF for the indicated time points, and were subsequently lyzed in 
lysis buffer. Equal protein amounts (20 μg) of the lysates were separated by SDS-PAGE, transferred 
onto nitrocellulose membranes and tyrosine-phosphorylated levels were analyzed by immunoblotting 
with the phosphotyrosine-specific antibody 4G10.  
Western blots shown here are representative of 3 independent experiments. The results show that 
AUM can act as a cellular protein tyrosine phosphatase Arrow indicates modulation of 
phosphotyrosine content upon AUM depletion. 
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5.8 Potential role of AUM in epidermal growth factor signaling 
Since we observed an increased phosphorylation of high-molecular weight proteins 
corresponding to the size of the epidermal growth factor receptor (EGFR) in epidermal 
growth factor (EGF)-stimulated, AUM-depleted cells compared to control shRNA cells (see 
Fig. 33), we tested the hypothesis that the EGFR itself may be an AUM substrate. The EGFR 
is a ~180 kDa receptor tyrosine kinase that is phosphorylated on multiple tyrosine residues 
upon EGF binding (Bazley and Gullick 2005). EGFR phosphorylation triggers the association 
of various adaptors and scaffolding molecules that propagate the growth factor signal to 
affect e.g. cytoskeletal changes, cell adhesion and motility and cell growth (Biscardi et al., 
2000). The EGFR and some of its downstream signaling molecules had already appeared as 
a possible substrate in the phosphopeptide screen (Fig.19).  Cells overexpressing AUMwt or 
AUMD34N or stably AUM-depleted cells were starved overnight and were subsequently 
stimulated with EGF for the indicated time points as detailed in Methods (4.4.14).  
We analyzed the effect of AUM overexpression or depletion on total EGFR levels as 
well as on EGFR phosphorylation, using EGFR phospho-specific antibodies. Total EGFR 
levels were found to be increased in the absence of AUM as shown in figure 34A. Due to 
technical limitations, we could not reprobe the same blot for various phospho-specific EGFR 
antibodies. One of the  tyrosine phosphorylation sites on EGFR (Tyr1045) is of particular 
interest due to its potential role in EGFR ubiquitination and trafficking  (Levkowitz et al., 
1999). Cell lysates from the same experiment were loaded on separate gels and probed with 
the anti-pTyr1045-EGFR antibody. One min after EGF stimulation, AUM-depleted cells 
showed increased pTyr1045 phosphorylation, which had disappeared at 5 min, indicating a 
transient effect of AUM on the EGFR signaling pathway. We used two of our efficiently AUM-
depleted cell lines (#73 and #77), and found similar effects as shown in figure 34B.  
To rule out cell line-restricted effects of AUM on EGFR phosphorylation, we also 
analyzed the EGFR pTyr1045 levels in HeLa cells transiently transfected with AUMwt or 
AUMD34N plasmids. We observed a transient effect on pTyr1045-EGFR levels upon AUM 
overexpression but at different time points as compared to GC1 cells (Fig. 34C). Only 
catalytically active AUM was to found transiently affect pTyr1045 levels at 5 min upon EGF 
stimulation. 
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Figure 34: Effect of AUM on EGFR tyrosine phosphorylation 
A, B: GC1 cells expressing with the indicated shRNA were starved overnight in serum-free culture 
medium. Cells were stimulated with 85 nM of EGF for the indicated time points, and were 
subsequently lyzed in lysis buffer. Equal protein amounts (20 μg) of the lysates were separated by 
SDS-PAGE, transferred onto nitrocellulose membranes and tyrosine-phosphorylated levels were 
analyzed by immunoblotting with the phosphotyrosine-specific antibody 4G10.  
C: GC1 cells transiently transfected with the indicated plasmids were starved overnight in serum-free 
culture medium. Cells were stimulated with 85 nM of EGF for the indicated time points, and were 
subsequently lyzed in lysis buffer. Equal protein amounts (20 μg) of the lysates were separated by 
SDS-PAGE, transferred onto nitrocellulose membranes and tyrosine-phosphorylated levels were 
analyzed by immunoblotting with the phosphotyrosine-specific antibody 4G10. 
Western blots shown here are representative of 3 independent experiments. The results show that 
AUM has role in EGFR stabilization and activation. 
 
Taken together, these biochemical results indicate a role of AUM in EGF-mediated signaling 
pathways, including effects on the EGFR itself.  
 
5.9 Effect of AUM on actin dynamics 
Actin filaments are major components of at least 15 different structures such as stress fibres, 
endocytic pits and peri-organellar ring in multicellular organisms (Chhabra and Higgs 2007). 
These filaments assemble from a common pool of actin monomers depending upon the 
extracellular stimuli. Majority of cellular processes such as cell adhesion, migration, adhesion 
and proliferation involves coordinated and rapid changes in actin cytoskeketon (Mitra et al., 
2005). Because of the high homology between AUM and the cofilin activating (and thus actin 
remodeling) phosphatase Chronophin (CIN), we next investigated the effect of AUM on actin 
dynamics.  
We first examined the effects of AUMwt or AUMD34N  overexpression on the actin 
cytoskeleton of HeLa cells. To this end, HeLa cells were spread on fibronectin (FN) coated 
surfaces. Serum starved cells were spread on FN coated glass coverslips and fixed at 
different time points. Cells were stained for microscopic observations as detailed in Methods 
(section 4.3.3). Figure 35 upper panel shows that AUMwt overexpressing cells were small in 
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size, with less elaborated actin cytoskeleton and hence less adherent on fibronectin at 40 
min as compared to non-transfected or AUMD34N overexpressing cells as shown lower panel 
of figure 35.  
 
Figure 35: Effect of AUM overexpression on actin cytoskeleton in spreading HeLa cells 
HeLa cells were transfected with either AUMwt or AUMD34N and spread on FN coated surface for 40 
min. Cells were fixed in PFA and stained as indicated. AUMwt transfected cells are small in size with 
less prominent actin cytoskeleton where as AUMD34N transfected cells has no such effect as compared 
to non transfected cells.  Scale bar represent 25 µm. 
 
In order to understand the potential effect of AUM overexpression (Fig. 35) on the dynamics 
of actin cytoskeletal reorganization, we used the G-actin sequestering drug called latrunculin 
A. This compound binds to G-actin monomers and thus does not allow new actin 
polymerization. As the actin cytoskeleton is in constant flux between filament polymerization 
and depolymerization (Andrianantoandro and Pollard 2006), latrunculin A treatment allows 
the analysis of the effect of AUM on actin dynamics. AUM overexpressing HeLa cells were 
treated with latrunculin A as described in Methods (see section 4.4.14).  
We found that HeLa cells transfected with AUMwt contain less polymerized F-actin 
(Fig. 36 upper panel vehicle control). Upon treatment with latrunculin A to sequester actin 
monomers, this effect becomes more evident as shown in the lower panel of figure 36. The 
differences between the F-actin structures observed upon latrunculin A treatment between 
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transfected and non transfected cells suggest a probable role of AUM in actin dynamics. 
AUMwt transfected cells are characterized by a dramatic loss of polymerized actin upon 
latrunculin A treatment, as shown in figure 36 lower panel. Interestingly, in the absence of F-
actin, AUM appears to relocalize to fibrous structures of unknown identity, as shown in 
latrunculin A treated cells. This effect was not observed in AUMD34N transfected cells (data 
not shown). 
 
 
Figure 36: Effect of AUM overexpression on actin dynamics in HeLa cells 
Upper panel: HeLa cells transfected with AUMwt were grown in normal growth medium were treated 
with 2 µl of DMSO as a vehicle control (1:1000) fixed and stained as indicated. 
Lower panel: HeLa cells transfected with AUMwt were grown in normal growth medium were treated 
with 2 µM of latrunculin A for 20 min at 37°C. Cells were fixed and stained as indicated. Scale bar 
represents 50 µm. 
Latrunculin A sequesters G-actin. AUMwt transfected cells shows less F-actin structures as compared 
to non transfected cells indicating role of AUM in actin dynamics. In absence of F-actin, AUM 
localization is changed.  
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To investigate the effect of AUM depletion on actin dynamics in GC1 cells, the latrunculin 
concentration and incubation time points had to be optimized, because GC1 cells were found 
to be more sensitive to latrunculin A than HeLa cells. 2 to 10 min incubation at 37°C with 100 
nM of latrunculin was found to be optimal for GC1 cells, because it did not cause cell 
detachment from the substrate or a complete destruction of the cytoskeleton.  
Under basal conditions, AUM depleted cells show alteration of the actin cytoskeleton 
in the form of enhanced stress fibre formation and less cortical actin as compared to control 
shRNA expressing cells, as shown in upper panel of figure 37. The effect is more evident 
upon treatment with 100 nM of latrunculin A. Interestingly, AUM depleted cells show 
lamellopodia formation upon latrunculin A treatment, as shown in lower panel of figure 37. 
Taken together, these data indicate that AUM activity affects actin cytoskeletal turnover.   
 
Figure 37: Effect of stable AUM depletion by shRNA on steady-state actin dynamics  
Upper panel: GC1 cells stably expressing either control shRNA or AUM shRNA were grown in normal 
growth medium were treated with 2 µl of DMSO as a vehicle control (1:1000), fixed and stained as 
indicated. Lower panel: GC1 cells transduced either with control shRNA or AUM shRNA were treated 
with 100 nM of latrunculin A for 10 min at 37°C. Cells were fixed and stained as indicated. Scale bar 
represents 25 µm. AUM depleted cells shows more F-actin filaments as compared to control shRNA 
expressing cells 
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5.10 Role of AUM for cell adhesion 
Actin cytoskeletal dynamics coordinate cell adhesion and migration by regulating the 
turnover  of cellular adhesion complexes (Mitra et al., 2005). While working with AUMD34N-
expressing and AUM-depleted cells, we observed that these cells appeared more spread 
than their corresponding controls, and took longer to detach by trypsinization during standard 
subculturing. These observations suggested a potential role for AUM in cell adhesion.  
5.10.1 Effect of AUM activity on cell adhesion to fibronectin 
To investigate a possible effect of on AUM activity on cell adhesion, we transfected HeLa 
cells with AUMwt and AUMD34N, and tested the adhesion of these cells to fibronectin. 
Fibronectin is a high molecular weight extracellular matrix glycoprotein that is known to be 
essential for cell adhesion, migration, growth and differentiation (Sieg et al., 1998). 
Fibronectin binds to the surface of cells via integrin receptors (Schlaepfer et al., 1998). 
Integrins are clustered in adhesive structures known as focal adhesions (Zaidel-Bar 2009). 
Focal adhesions are composed of multiple structural and signaling molecules (Geiger et al., 
2009) that provide a physical linkage to the actin cytoskeleton (Mitra et al., 2005).  
Serum starved AUMwt and AUMD34N, transfected HeLa cells were spread on FN 
coated surface for 20 and 40 min and then fixed in PFA for microscopic analysis as detailed 
in section (4.3.3). Most of the proteins in focal adhesion complexes are tyrosine 
phosphorylated hence we stained cells with pTyr specific antibody. AUMwt transfected cells 
shows less pTyr proteins and were less adherent to the extracellular matrix (ECM) as 
compared to AUMD34N transfected cells (Fig. 38A). This observation suggests that AUM 
phosphatase activity regulates cell – ECM adhesion and that in the absence of catalytically 
active AUM, cells are strongly adherent to the substratum. As a first approach to quantify this 
effect, we washed cells after spreading on FN for 20 or 40 min and then measured the 
protein content of the cell lysates. Figure 38B shows that more AUMD34N transfected cells 
attached to the substratum as compared to empty vector or AUMwt -transfected cells, as 
reflected by the higher protein content.   
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Figure 38: Effect of AUM activity on cell adhesion 
A: HeLa cells either transfected with AUMwt or AUMD34N were spread on fibronectin coated surface 
upon overnight starvation. After 40 min cells were fixed in 4% PFA and stained as indicated. AUMwt 
transfected cells have less prominent pTyr containing proteins, as compared to AUMD34N transfected 
cells. The arrows indicate AUMwt or AUMD34N myc-His6-transfected cells which were identified by 
staining for the myc-tag (not shown). Scale bar represents 25 µm. 
B: HeLa cells either transfected with AUMwt or AUMD34N were starved overnight and spread on 
fibronectin coated surfaces for 20 or 40 min. The total protein content of the cell lysates in AUMD34N 
transfected cells is higher at both time points as compared to AUMwt or empty vector transfected cells 
at corresponding time point. 
 
5.10.2 Effect of AUM depletion on cell adhesion to fibronectin 
To test whether the depletion of endogenous AUM would also affect cell adhesion on 
fibronectin we performed microtitre plate adhesion assay. We used calcein AM (Invitrogen 
Karlsruhe), a nontoxic, cell permeable compound for quantitative measurement of cell 
adhesion.  Calcein AM gets converted into negatively charged green fluorescent calcein by 
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esterases once entered into live cells and stained cells can be quantified fluorimetrically at 
535 nm. Control shRNA or AUM shRNA expressing cells were treated with 0.1 µM calcein for 
30 min at 37°C and then equal number of cells were spread on FN coated surface for 10, 20 
or 40 min. AUM depleted cells were found to be more adherent at 10 min of spreading on FN 
as compared to control shRNA expressing cells. This effect was less prominent at later time 
points suggesting that AUM has role in early events of spreading on FN (data not shown). In 
absence of AUM, cells appeared to be strongly adhere to the substratum and this 
phenomenon is being investigated in further details at the moment in our lab.    
5.10.3 Effect of AUM depletion on cell area during spreading  
To test the potential effect of AUM depletion on cell spreading, we next analyzed the kinetics 
of cell spreading by cell area measurements using a semiautomated microscopic approach. 
For this, cells were serum-starved, detached by limited trysinization as described in Methods 
(see 4.3.1), seeded on FN-coated surfaces and were finally fixed at various time points. Cells 
were then stained for polymerized actin using phalloidin and nuclei were labeled using DAPI 
(see 4.3.3). As detailed in Methods (see 4.4.15), the cell area was detected using the stained 
actin, and each cell was identified by its nuclear stain. Cells were spread on 96 well plates 
(15 µ ibidi plates, ibidi, Munich) coated with FN. Cells were fixed after 10, 20 and 40 min of 
spreading on FN, and cell areas were quantified by taking four fields of view per well. For 
quantification, 5 replicates of each condition were used. Data shown here are from 3 
independent experiments with a minimum 1000 cells counted per condition. Figure 39A 
shows representative pictures of each condition. AUM depleted GC1 cells at 10 min of 
spreading were found to be 21% larger in size as compared to control shRNA expressing 
cells as shown in figure 39B. The effect on cell size between control shRNA and AUM 
shRNA expressing cells diminishes at later time points, indicating a role of AUM in early 
events of spreading.  
The effect of AUM on cell size could even be observed under basal conditions (that 
is, adherent cells growing under standard conditions). The images indicating the effect of 
AUM on cell size under basal conditions are taken from a separate experiment and are 
included in this panel for comparison.    
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Figure 39: Effect of AUM on area of spreading cells 
A: GC1 cells expressing control shRNA or AUM shRNA were spread on FN-coated microtiter plates 
for 10, 20 and 40 min and fixed. Cells were stained as indicated. Scale bar represents 25 µm. Cells 
with AUM depletion are larger in size from early stage of spreading on, as compared to control cells. 
B: Quantification of cell area of spreading cells. Minimum of 1000 cells were counted per condition. 
Arbitrary units of cell area were obtained and were normalized against control shRNA expressing cells 
at 10 min of spreading and plotted as fold increase of size with respect to it for all conditions. Cells 
expressing AUM shRNA are larger in size at all time points but the only the difference at 10 min is 
statistically significant (P = 0.0241), as calculated by Student’s t-test. These results suggest a role of 
AUM in early events of cell spreading.  
 
5.10.4 AUM localization in spreading cells 
So far we have observed effect of AUM overexpression or depletion on cell spreading. The 
spreading of cells is largely governed by focal adhesion turnover (Geiger et al., 2009). So the 
next question was whether AUM is actually present in these structures. Focal adhesion (FA) 
structures are composed of many constitutively present proteins such as paxillin, vinculin or 
talin (Mitra et al., 2005). GFP-AUMwt expressing HeLa cells were fixed upon spreading on 
fibronectin for 40 min and stained with vinculin as a marker for FA as detailed in section 
(4.3.3). AUM was not found to colocalize with vinculin as shown in figure 40. Interestigly 
there are many focal adhesion associated proteins which are recruited to adhesion sites, 
(Zaidel-Bar et al., 2007) and very few are constitutively present in FA. AUM localization in 
fact was found to be around the structures of FA at 40 min of spreading on FN in HeLa cells.  
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Figure 40: AUM localization in spreading cells 
HeLa cells transfected with GFP-AUMwt were spread on fibronectin coated glass coverslips for 40 min. 
The PFA-fixed cells were then stained for the focal adhesion marker vinculin. The nucleus was stained 
with DAPI. AUM was localized by the fluorescence of its GFP-tag. Part of the merged image is 
magnified in lower right panel and shown AUM localization with respect to vinculin. AUM does not 
colocalize with vinculin in focal adhesions at 40 min of spreading on fibronectin. Scale bar represents 
10 µm. 
 
5.10.5 Effect of AUM depletion on phosphotyrosine content of focal adhesions in 
spreading cells 
Even though we did not find AUM localization in focal adhesion structures, we had consistent 
cell morphological effects in terms of cell area, and a distinct adhesion behavior of AUM 
depleted cells, indicating a role of AUM in these processes. Cell area determination of 
spreading cells at different time points already suggested a probable role for AUM in the 
early events of spreading. Instead of analyzing colocalization of AUM with one of the FA 
markers under various spreading conditions, we decided to analyze the levels of total 
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phosphotyrosine content of cells under spreading conditions. Control or AUM shRNA 
expressing GC1 cells were serum starved and spread on fibronectin coated glass coverslips 
for 10 min and fixed for microscopic observations as described in Methods (see 4.3.3). AUM 
depleted cells showed enhanced levels of phosphotyrosine content of focal adhesion 
structures, as shown in figure 41 when compared to control shRNA expressing cells. Many 
focal adhesion proteins are known to be tyrosyl phosphorylated upon activation, which leads 
to a strong adhesion to the ECM (Bass et al., 2008). Thus along with the experimental 
evidence of role of AUM on adhesion at 10 min of spreading on fibronectin (data not shown), 
this functional read out suggest that AUM is specifically acting in the signaling pathway 
involved in early cell spreading. 
 
 
Figure 41: Effect of AUM depletion on phosphotyrosine content of focal adhesion in spreading 
cells 
GC1 cells with either control shRNA or AUM shRNA were spread on fibronectin coated surface for 10 
min. PFA fixed cells are stained as indicated. AUM depleted cells have increased phosphotyrosine 
content of focal adhesions leading to strong cell-ECM adhesion at 10 min of spreading on fibronectin. 
Scale bar represents 25 µm. 
 
5.10.6 Effect of AUM depletion on focal adhesion maturation in spreading cells 
Focal adhesion structures are at the base of the cell surface anchoring the cell to 
substratum. To image these structures a variety of microscopic methods have been 
developed over the time (Holt et al., 2008) such as interference reflection microscopy (IRM) 
or total internal reflection microscopy (TIRF). We employed TIRF microscopy to visualize 
these structures in order to understand the effect of AUM depletion on focal adhesion 
maturation in spreading cells. TIRF microscopy uses an evanescent wave for the selective 
illumination of a fluorophore in a restricted region of the specimen immediately adjacent to 
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the glass-water interface. The evanescent wave is generated only when the incident light is 
totally reflected at the glass-water surface allowing selective visualization of surface regions. 
Control or AUM shRNA-expressing GC1 cells were spread on fibronectin coated glass 
surfaces for 40 min and fixed in PFA for microscopic anlysis as detailed in Methods (see 
4.3.3). Cells were then stained for polymerized actin using phalloidin, for focal adhesions 
using vinculin and nuclei were labeled using DAPI. As shown in figue 42 below, control 
shRNA expressing cells have predominantly small focal complexes at the cell periphery 
whereas AUM depleted cells show elongated focal adhesions oriented towards the center of 
the cell. Focal adhesion structures at the center are found to be at the base of F-actin stress 
fibres providing mechanical support to the cell during spreading and adhesion (Zaidel-Bar et 
al., 2007), thus allowing strong adhesion of the cells to the substratum.  
 
 
Figure 42: Effect of AUM on focal adhesion maturation in spreading cells 
GC1 cells expressing control or AUM shRNA were spread on fibronectin coated surfaces for 40 min. 
PFA fixed cells are stained as indicated. Images are taken on a TIRF microscope for visualization of 
focal adhesion structures stained with vinculin. AUM depleted cells have longer focal adhesion 
structures towards the center of the cell suggesting a role of AUM in focal adhesion maturation during 
spreading. Scale bar represents 25 µm. 
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5.11 AUM-Src phosphocycling  
In order to understand the molecular mechanisms underlying the spreading behavior of AUM 
depleted or overexpressed cells, we decided to investigate the status of downstream effector 
proteins in EGFR and integrin mediated pathways. We had an indication of Src as a probable 
AUM target from the genome-wide peptide screen (see section 5.3). Hence we decided to 
analyze the regulation of Src in further detail. Src is a non-receptor tyrosine kinase that acts 
as a proto-oncogene (Sheiness and Bishop 1979). There are multiple Src family members, 
i.e. c-Src, Fyn, Blk, c-Fgr, Hck, Lck, Lyn, c-Yes and Yrk that are well characterized for their 
role in various signaling pathways (Yeatman 2004). Src is ubiquitously expressed and plays 
key role in cell differentiation, motility, proliferation and survival. As Src is a central molecule 
in multiple signaling pathways, it is under tight regulation  governed by multiple regulatory 
mechanism (Roskoski 2005). 95% of Src in cells is in inactive form and can transiently be 
targeted to the plasma membrane upon activation. A direct role of Src in focal adhesion 
turnover has been well documented. Src initiates the activation of various proteins such as 
focal adhesion kinase (FAK) involved in cell-ECM adhesion (Obergfell et al., 2002). 
We first analyzed the effect of AUM of Src phosphorylation (on the phosphotyrosine 
sites which govern Src activity) upon FN stimulation or EGF stimulation in AUM 
overexpressed or depleted cells. There were no consistent results with this approach. Figure 
43 shows one of the representative blots where the level of phosphorylation of Tyr416 on 
Src, which is important for Src activation, shows minor variations. Due to experimental 
limitations, we were not able to reprobe blots developed with Src-phosphospecific antibodies 
for total Src. Hence the blot probed for pTyr416-Src is of the same cell lysate as the blot for 
total Src, but was loaded on a separate gel.   
 
Figure 43: Effect of AUM on Src phosphorylation upon fibronectin stimulation  
GC1 cells transfected with indicated plasmids or stably AUM depleted were starved overnight in serum 
free culture medium. Cells were spread on FN coated surfaces or stimulated with EGF for the 
indicated time points and lyzed in lysis buffer. Equal protein amounts (20 g) from lysates were 
separated by SDS-PAGE, transferred on nitrocellulose membranes and phosphotyrosine levels were 
analyzed by immunoblotting with 4G10 antibody. Western blots shown here are representative of 3 
independent experiments. There is no robust effect on Src phosphorylation under the given conditions. 
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Hence, we decided to investigate whether there is direct effect of purified AUM on activated 
Src as a potential substrate in in vitro assays. To that end, recombinantly expressed, purified 
GST-tagged Src was subjected to in vitro phosphatase assay along with recombinant AUM 
as detailed in Methods. AUM could partially dephosphorylate Src as shown in figure 44A. 
Interestingly, Src in turn was found to phosphorylate AUM. A few other phosphatases such 
as PTPε are known to be regulated by Src-mediated phosphorylation (Berman-Golan and 
Elson 2007). We also analyzed the effect of AUM on two regulatory phosphorylation sites on 
Src (pTyr 416 and pTyr527) in a separate experiment as shown in the lower panel of figure 
44A. Src-Tyr416 was not obviously dephosphorylated by AUM using this experimental 
approach. Also the Src-Tyr527 site was not reproducibly dephosphorylated. These results 
suggest that AUM may dephosphorylate Src on a different tyrosine residue, and/or that the 
chosen experimental approach is not sufficiently sensitive to monitor dynamic changes in the 
phosphorylation pattern.   
 
Figure 44: Cross talk between Src and AUM 
A: One hundred ng of phosphorylated GST-Src was incubated with 1 µg of purified, recombinant 
AUMwt protein for 30 min at 30°C. The reaction was stopped by Laemmli buffer and proteins were 
separated by SDS-PAGE, transferred onto nitrocellulose membranes and phosphotyrosine levels were 
analyzed by immunoblotting with 4G10 (pTyr) antibody. AUM partially dephosphorylates Src, and Src 
phosphorylates AUM on tyrosine residue(s). Src dephosphorylation on pTyr 416 and pTyr 527 sites 
was analyzed on separate gels. No consistent dephosphorylation of Src by AUM on either site was 
observed.  
B: Proposed model of Src-AUM interaction. In presence of ATP, active Src phosphorylates AUM on 
tyrosine residue and AUM in turn dephosphorylates Src at an as yet unidentified residue. 
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We next analyzed the potential effect of AUM on Src kinase activity. To that end we 
employed a biotinylated peptide which acts as Src substrate. Src kinase activity towards this 
substrate peptide was measured colorimetrically in the presence or absence of AUM as 
detailed in Methods (see section 4.4.13) Simultanenously AUM phosphatase activity was 
also measured in presence or absence of Src. Simultaneously, AUM phosphatase activity 
was also measured in presence or absence of Src. We found a strong increase in Src kinase 
activity towards the Src substrate peptide in the presence of AUM (Fig. 45). Unexpectedly, 
both AUMwt and AUMD34N activated Src kinase activity to a comparable extent (Fig. 45). 
These results indicate that AUM activates Src indepent of its phosphatase activity 
 
 
Figure 45: Effect of AUM on Src kinase activity 
Fifty nanograms of purified GST-Src and 250 ng of purified AUMwt or AUMD34N were incubated in the 
presence of a biotinyated Src substrate peptide for 40 min at RT. Src kinase activity towards the 
peptide was measured colorimetrically at 405 nm for 30 min. Samples were tested in duplicates and 
the end point values of three independent experiments are plotted. Src kinase activity is increased 3- 
fold in the presence of catalytically active or inactive AUM  
  
The effect of Src on AUM phosphatase activity was measured using the p-NPP assay as 
detailed in Methods (see section 4.4.11). AUM phosphatase activity towards p-NPP is 
reduced in presence of kinase-active Src, as shown in figure 46. When the Src kinase activity 
is inhibited by using the Src kinase inhibitor PP2, or when the Src kinase reaction is 
incubated with apyrase to degrade the ATP the AUM phosphatase activity towards p-NPP 
remains unaffected. Taken together, these data suggest that although AUM regulates Src 
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kinase activity in vitro in a phosphatase independent manner, Src regulates AUM 
phosphatase activity in kinase dependent manner.  
 
 
Figure 46: Effect of Src on AUM phosphatase activity 
Fifty nanograms of purified GST-Src and 250 ng of purified AUMwt or AUMD34N were incubated for 40 
min at RT. AUM phosphatase activity towards p-NPP was measured at 405 nm for 60 min and end 
point values were plotted. Samples were run in duplicates and values represent the mean of a single 
experiment. Active Src decreases AUM phosphatase activity. In the presence of the Src inhibitor PP2 
(5 M) or the ATPase apyrase (0.02 U/ml), Src does not affect AUM phosphatase activity. These 
results suggest that Src may regulate AUM phosphatase activity in a kinase dependent manner. 
 
 
Taken together, even though we are still far from concluding about the nature of the Src / 
AUM cross talk in cells, our in vitro data strongly suggest that AUM might be yet another 
player in the complex regulation of Src.  
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6 Discussion  
The evolution of enzyme-mediated chemical reactions relies on mutational changes within 
the catalytic domain or core chemistry of the entire catalytic mechanism (Lahiri et al., 2004). 
The HAD superfamily of hydrolases is one such classic example which represents all known 
extant phyla and has undergone extensive diversification to give rise to at least five distinct 
subfamilies: the haloalkanoate dehalogenases (C-Cl bond hydrolysis), 
phosphonoacealdehyde hydrolases (P-C bond hydrolysis), phosphate monoesterases (P-OC 
bond hydrolysis), ATPases (P-OP bond hydrolysis), and phosphomutases (P-OC cleavage 
with intramolecular phosphoryl group transfer (Allen and Dunaway-Mariano 2004). The core 
chemistry of this superfamily is nucleophilic catalysis mediated by an active-site aspartic acid 
carboxylate group. The majority of HAD hydrolases from lower organisms are assumed to be 
involved in nucleotidase activity, sugar and amino acid metabolism (Balakrishnan et al., 
1993; Kuznetsova et al., 2006).  
In addition to their phosphatase activity against sugars etc., HAD family members 
have also acquired protein phosphatase activity during eukaryotic evolution. Members of the 
HAD superfamily are therefore considered to be key players in providing raw material for the 
evolution of novel enzymes, leading to the diversification of enzymatic potential (Burroughs 
et al., 2006). These innovations were transmitted by lateral gene transfer at various time 
points and recruited for new functions as recently realized for many novel HAD 
phosphatases (aspartate-based phosphatases) in higher organisms (Collet et al., 1998; 
Selengut 2001; Rayapureddi et al., 2003; Singh et al., 2004; Gohla et al., 2005).  
The goal of this thesis was the characterization of a previously undescribed, 
Chronophin (CIN)-related HAD phosphatase, which we named AUM (actin remodeling, 
ubiquitously expressed, magnedium-dependent HAD phosphatase). This work shows that 
rather than being a CIN-isoform, AUM is a novel aspartate-based phosphatase with unique 
enzymatic qualities. 
 
6.1 AUM is not a CIN isoform   
HAD phosphatases are typified by a highly conserved, tripartite catalytic domain, composed 
of the HAD motifs I-III (Ridder and Dijkstra 1999). Outside of these small conserved motifs, 
rarely there is an overall homology among HAD phosphatases. In spite of this fact, CIN and 
AUM were found to be 45% identical and 61% similar at the amino acid level (see 1.3.1). 
Hence we started the characterization of AUM as a putative CIN homolog in the beginning. 
Unexpectedly, the results of the enzymatic characterization of AUM clearly showed the 
distinct characteristics of AUM in comparison to CIN. By comparing the results from work on 
the characterization of the serine-directed phosphatase CIN (Gohla et al., 2005) and 
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experimental evidence from the present work on AUM, AUM emerges as a novel tyrosine 
phosphatase in spite of being the closest CIN homolog. These results are listed in table 4.  
 
Table 4: Comparison of the characteristics of AUM and CIN 
AUM is a CIN homolog AUM is a novel tyrosine phosphatase 
high sequence similarity (Fig. 5)  
 
similar gene structure (Fig. 6) 
 
AUM and CIN map to different 
chromosomes in humans and mice (Fig. 6)  
 
evolutionarily conserved  
(Fig. 6 & (Gohla et al., 2005)) 
 
AUM has evolved independently in higher 
organisms (Fig. 15)  
 
HAD-type phosphatase  
(Figs.10,18 & (Gohla et al., 2005) 
 
 
AUM has (weak) activity toward  
the CIN substrate PLP (Fig. 17) 
 
 
AUM dephosphorylates the tyrosine-like 
substrate p-NPP much more efficiently than 
CIN (Fig. 17) 
 
AUM prefers pTyr residues in peptides and 
proteins as substrates (Figs. 19, 20) 
 
ubiquitously expressed  
(Fig. 25 & (Gohla et al., 2005)) 
 
tissue specific AUM expression is distinct 
from that of CIN (Fig. 25 & (Gohla et al., 
2005) 
 
role in actin cytoskeletal dynamics 
(Figs. 36, 37 & (Gohla et al., 2005)) 
 
 
 
AUM has a role in the early events of cell 
spreading that are mediated by tyrosine 
phosphorylation (Figs. 39, 41) 
 
AUM might have a role in signaling 
cascades initiated by transmembrane 
receptors (Fig. 48) 
predominantly cytosolic proteins  
(Fig. 36 & (Gohla et al., 2005) 
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We analyzed the evolutionary relationships between CIN and AUM phosphatase orthologs 
by constructing phylogenetic trees (Fig. 15) and found that both evolved together in lower 
organisms where they might exert similar functions. However, in vertebrates CIN and AUM 
orthologs have evolved independently and may thus have acquired novel functions.  
We then analyzed the pattern of CIN/AUM evolution in the context of other known 
human HAD phosphatases in two model organisms as shown in Fig.16. The availability of 
raw material in the form of novel catalytic characteristics is a prerequisite for the 
diversification of enzymatic potential during the course of evolution as discussed earlier 
(Burroughs et al., 2006). At least eight distinct signaling pathways are known to have evolved 
exclusively in multicellular organisms. These are nuclear hormone receptor pathways, WNT, 
TGF-β, JAK/STAT, Notch/Delta, hedgehog, toll-like receptors and phosphotyrosine (pTyr) 
mediated signaling pathways (Pires-daSilva and Sommer 2003).   
P-Tyr signaling has played a prominent role in the expansion of metazoans by  
creating a versatile three component system in the form of a “writer” (a tyrosine kinases), a 
“reader” [Src homology 2 (SH2) domain containing proteins], and an “eraser” (tyrosine 
phosphatases) (Pincus et al., 2008). Each component of this three component system has 
evolved at different stages of evolution. However, effective pTyr signaling was possible only 
when all three components were present together. Hence even though in yeast, proteins with 
SH2 domains and PTP domains were present, there was no pTyr signaling due to the 
absence of protein tyrosine kinase (PTK)-domain containing proteins. It is only in metazoans 
that all three components are present, which gave rise to efficient pTyr signaling (Pincus et 
al., 2008). Figure 16 and our data showing AUM as an efficient p-NPP phosphatase (Fig. 17) 
clearly suggest that the independent evolution of AUM was a prerequisite for AUM to act as 
novel pTyr phosphatase in metazoans. These results are corroborated by the data showing 
that AUM acts as a protein tyrosine phosphatase (see 6.5).    
 
6.2 AUM expression analysis             
In order to analyze the expression pattern of this novel protein, we generated an AUM 
specific rabbit polyclonal peptide antibody. The sensitivity and specificity of this antibody 
allowed us to analyze the AUM expression pattern in various mouse tissues and cells in 
culture by multiple approaches. AUM peptide antibody is able to detect as little as 10 ng of 
recombinant protein without cross reacting with its closest homolog CIN (Fig. 24). AUM was 
found to be a ubiquitously expressed protein of 34 kDa (Figs. 22, 23, 25, 27). Both at the 
RNA and protein level AUM expression was highest in male germinal cell (Figs. 27, 28, 29). 
AUM expression was maximal around 4 weeks of age in mouse testis (Fig. 27), 
corresponding to the age of puberty (Livera et al., 2006). This information indicated a 
probable physiological role for AUM in spermatogenesis. Immunohistochemical approaches 
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confirmed this assumption (Figs. 27, 28, 29). The AUM expression profile in male germ cells 
coincides with the poorly understood process of individualization or spermiation (Cagan 
2003).  
Nevertheless, this descriptive expression analysis can not be translated into a 
functional understanding of the role of AUM in testis without a primary knowledge of AUM 
biology. Given the ubiquitous expression of AUM, which suggests a broader and 
fundamental role for AUM outside testis, the subsequent functional analysis of AUM was 
conducted by biochemical and cell biological approaches using a mouse spermatogonial cell 
line, GC1-spg. Given the fact that spermiation is essentially an actin-dependent process 
involving massive cytoskeletal reorganization and cell-matrix and cell-cell adhesion 
modulations between germ cells and Sertoli cells (Xiao and Yang 2007), the role of AUM in 
cell adhesion to the extracellular matrix was analyzed in greater detail.  
 
6.3 Role of AUM in actin dynamics 
Actin filaments are polarized structures with fast growing barbed ends and slow growing 
pointed ends. The dynamics of actin filaments is under tight regulation which is necessary for 
cell migration, proliferation and polarity formation (Revenu et al., 2004). As CIN was shown 
to be cofilin phosphatase (Gohla et al., 2005) and AUM found to be at least partially affecting 
the cellular phosphocofilin pool (Duraphe Prashant, Diploma thesis 2006) we decided to 
analyze the effect of AUM on actin dynamics.  
In vitro polymerization or depolymerization assays of pyrene-labeled actin in the 
presence of recombinant, purified AUM did not show any direct effects of AUM on actin 
dynamics (data not shown). However, a preliminary analysis of AUM overexpressing cells by 
scanning electron microscopy suggested an effect of AUM on cell morphology (data not 
shown). AUM overexpressing or AUM depleted cells were consistently found to display 
altered F-actin structures (Fig. 35). Hence we concluded that AUM affected actin remodeling 
indirectly. This hypothesis was tested by employing the G-actin sequestering drug, 
latrunculin A. Cells treated with latrunculin A allowed us to analyze the effect of AUM on actin 
turnover by sequestering newly formed G-actin molecules. We found a stabilization of actin 
stress fibres in cells overexpressing AUMD34N (data not shown) as well as in AUM depleted 
cells (Fig. 37). In contrast, AUMwt overexpressing cells showed fewer F-actin structures than 
control cells (Fig. 36). These data strongly support the hypothesis that AUM is involved in the 
regulation of actin filament turnover in cells. 
Even though the exact role of AUM in these processes remains to be identified, we 
found that the subcellular AUM localization changes in the absence of F-actin structures (Fig. 
36). When we treated AUM depleted cells with latrunculin A, an interesting differential effect 
on cortical actin turnover and the formation of lamellipodia was observed. AUM depleted 
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cells were found to have less cortical actin but more stress fibres as compared to control 
shRNA expressing cells (Fig. 37).  
Another actin dependent process which was found to be modulated by AUM is cell 
adhesion. Actin cytoskeletal dynamics coordinate cell adhesion and migration by regulating 
the turnover of cellular adhesion complexes (Mitra et al., 2005) We found that AUMwt 
overexpressing cells were less adherent to the substratum and smaller in size when spread 
on fibronectin (Fig. 35). In contrast, AUMD34N expressing cells were found to be advanced in 
spreading under similar conditions. Focal adhesion structures formed at the end of actin 
stress fibres regulate cell adhesion and its turnover is an important measure of spreading 
behavior of the cell (Geiger et al. 2009). AUM depleted cells showed matured focal 
adhesions and advanced spreading as compared to control cells (Fig. 42). The majorities of 
the cell adhesion experiments were carried out in an AUM depleted cell line and are 
discussed in next section.       
 
6.4 Consequences of AUM depletion 
To investigate the physiological roles of AUM in cells, we realized that overexpression 
analysis has experimental limitations in terms of inconsistencies in transfection efficiency and 
the possibility of mislocalization of tagged AUM to unusual cellular compartments. We 
therefore depleted endogenous AUM by RNA intereference methods and investigated the 
cellular consequences of AUM depletion.  
We have established effective AUM knockdown both by siRNA as well as shRNA 
(Figs. 31, 32) methods by targeting different mRNA sequences (Fig.12). To avoid 
inconsistencies arising from varying transfection efficiencies in individual experiments, we 
primarily relied on the shRNA clone M77 that showed highest AUM knockdown efficiency 
(Fig. 32). All knockdown studies were done primarily in the mouse spermatogenic cell line 
GC1-spg. This AUM depleted, stable cell line proved to be a key tool for the functional 
characterization of AUM. We could reproducibly observe distinct morphological 
characteristics such as altered spreading behavior, effects on actin turnover and 
morphological differences in terms of cell size with AUM depleted cells. Similarly, the 
biochemical analysis of signaling pathways produced a more consistent picture after 
knocking down of AUM as compared to AUM overexpression studies.   
We analyzed the spreading pattern of AUM depleted cells both by live cell imaging 
and by immunofluorescence studies. Fibronectin (FN) is one of the broadly expressed ECM 
molecules which induce integrin mediated cell adhesion (Sieg et al., 1998). Cells were 
spread on FN and analyzed at different time points for focal adhesion (FA) marker proteins 
and the actin cytoskeleton. Vinculin, the first molecular component identified to be 
constitutively present in FA (Geiger 1979), was chosen as a primary marker for focal 
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adhesions for cellular studies along with other FA markers such as  focal adhesion kinase 
(FAK), Paxillin, Src and antibodies targeted against total tyrosine phosphorylated proteins.   
A wealth of information has been generated about the molecular components of focal 
adhesion plaques. There are more than 150 proteins involved in the formation, stability and 
dynamics of focal adhesions (Zaidel-Bar et al., 2007). Details can be found at 
http://www.adhesome.org/. These proteins are classified as focal adhesion components or as 
focal adhesion associated proteins. AUM was found to be localized around the FA structures 
(Fig. 40), suggesting AUM as a focal adhesion associated protein. Interestingly, AUM is not 
colocalizing with any of the FA proteins that we tested (data not shown for markers other 
than vinculin and pTyr). As FA structures act as anchors of the cells, FAs are present across 
the base of the cell under standard two-dimensional culture conditions and thus can be best 
visualized with specialized imaging techniques such as TIRF or IRM microscopy (Holt et al., 
2008).  
 
We used TIRF microscopy for FA imaging in this study. Focal adhesions are classified 
depending upon their size, location and molecular components (Worth and Parsons 2008). 
These distinct classes are referred to as focal complexes, focal adhesions and fibrillar 
adhesions. Focal complexes are small transient structures seen immediately behind the 
leading edge of a spreading cell. These structures support actin based events such as 
filopodial growth and lamellipodial protrusions (Geiger and Bershadsky 2001). Focal 
adhesions (FAs) are located across the base of an adherent cell and larger than focal 
complexes. FAs contain multiple signaling and actin-binding proteins responsible for 
mechanical stability (Geiger et al., 2009). Fibrillar adhesions have been described in three 
dimensional matrix systems and are thought to be derived from subset of FAs (Cukierman et 
al., 2001). 
We observed that when AUM depleted cells are spread on FN surface for different 
time points, they are always charaterized by extensive F-actin and mature FA structures as 
compared to control shRNA cells. One of the representative cells is shown in figure 42. AUM 
depleted cells contain larger FA structures oriented towards the centre of the cell, whereas 
control shRNA expressing cells contain more small focal complexes at the cell periphery. 
These data indicate a probable role of AUM in FA maturation. The potential involvement of 
AUM in FA turnover is currently under investigation. Here, the kinetics of the recruitment of 
various focal adhesion marker proteins (GFP-actinin, GFP-alpha 5 integrin, GFP-paxillin, 
GFP-vinculin) to focal adhesion structures is compared in AUM-depleted versus control cells. 
 
The cellular spreading behavior was analyzed at three distinct time points (10, 20 and 40 
min), which cover the early as well as the late spreading behaviour of cells (Figs. 39, 41). We 
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combined biochemical analysis, immunofluorescent staining and live cell imaging of AUM 
depleted cells to understand the potential role of AUM in this process. Interestingly, AUM 
depletion has characteristic effects in the early stages of cell spreading and migration. This 
effect was found to be specific for fibronectin, indicating a preferential activation α5β1 integrin 
(Bass et al., 2008) mediated signaling pathways. We consistently observed that after 10 min 
of spreading on FN, more cells were attached to the subtrate in the absence of AUM. The 
effect seemed to be less prominent at later time points (data not shown and Fig. 39). Most of 
the proteins in adhesion complex are tyrosyl phosphorylated (Geiger et al., 2009). Thus, the 
total phosphotyrosine content of FAs can be used as a functional readout for the spreading 
behavior of a cell. We found that AUM depleted cells are characterized by a higher pTyr 
content at 10 min after spreading on FN (Fig. 41). Upon phosphorylation, most of the 
proteins involved in FA signalling generate binding sites for downstream effectors and can 
thus be targeted to the plasma membrane (Parsons 2003).The elevated pTyr content in AUM 
depleted cells indicates an effect of AUM on the phosphorylation status of one or more 
proteins involved in focal adhesion signalling, thus leading to advanced adhesion as 
compared to control shRNA expressing cells.  
AUM depleted cells are characterized by a significantly larger cell area at 10 min after 
seeding on FN, as quantified by a Metamorph-based microscopic analysis (detailed in 
Methods, see section 4.4.15).  Consistent with the effect of AUM on the pTyr content in fixed 
cells at 10 min spreading on FN (Fig. 41), we observed a similar and statistically significant 
effect of AUM on the cell area at early stages of spreading as shown in figure 42. AUM 
depleted cells were larger in size up to 40 min of analysis, likely due to advanced spreading 
(Fig. 42B). 
 
Taken together, our data clearly demonstrate that AUM has a role in spreading and 
adhesion, likely due to a function in FA maturation and actin cytoskeletal dynamics. The 
phenotype of AUM depleted cells (increased stress fiber formation, increased focal adhesion 
formation) are suggestive of an increased activation of the small GTPase Rho (Raftopoulou 
and Hall 2004). Our current experimental efforts are directed at testing the role of AUM in 
Rho-GTPase signaling. 
 
6.5 Ways and means of finding AUM substrates 
Primary efforts of linking a novel enzyme to its biology are typically focused on substrate 
determination. It is widely accepted that disrupting the equilibrium of cellular tyrosine 
phosphorylation can cause a plethora of diseases and that both protein tyrosine kinases 
(PTKs) and protein tyrosine phosphatases (PTPs) have an equal stake in the process 
(Hunter 2002). Our understanding of PTKs is far advanced as compared to PTPs, not only 
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due to historical reasons but also due to existing experimental challenges in the PTP field 
(Tiganis and Bennett 2007). Even after substantial progress in the field of PTP research, 
physiological substrate identification still remains a major task. Particularly the identification 
of substrates for non-transmembrane PTPs is even today primarily governed by a trial and 
error approach.   
 
Although initially viewed as non-specific ‘housekeeping’ enzymes, it is now well established 
that PTPs are selective in their choice of substrates (Garton et al., 1996; Tonks 2003). The 
ability of PTPs to differentiate between individual substrates can be attributed to the 
specificity within the PTP catalytic domain. Traditionally, active-site sequence HC(X5)R has 
defined the PTP family, and a cysteine was known to act as nucleophile in their catalytic 
mechanism. An additional level of substrate specificity was achieved through non-catalytic N- 
and C-terminal residues which govern the spatial and temporal localization of PTPs (Tonks 
2006). Recently, a novel class of PTPs, traditionally known as HAD-type or aspartate-based 
phosphatases, has been reported (Aravind and Koonin 1998). These aspartate-based 
phosphatases are typified by an unconventional catalytic mechanism and are known to 
dephosphorylate both pSer/pThr (Gohla et al., 2005) or pTyr residues (Rayapureddi et al., 
2003). 
The approaches for defining the function of PTPs have heavily relied on a combination of 
biochemical and genetic techniques. The current consensus for assigning a bona fide PTP 
substrate is shown in figure 47 (Tiganis and Bennett 2007). It certainly will help to 
standardize the experimental set up as compared to current ‘best guess’ approach. 
 
We followed a similar approach in trying to identify AUM substrates. In the following section, 
the pros and cons of the tools that were generated in this thesis work and the assays that 
were performed will be discussed. 
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Figure 47: Approach for the characterization of PTP substrates 
Proposed criteria for the assignment of a tyrosine-phosphorylated protein as a PTP substrate. A 
combination of overexpression and knockdown studies of PTP can be employed in order to 
experimentally confirm bona fide PTP substrate (from Tiganis and Bennett 2007).  
 
Generation of a catalytically dead mutant of AUM 
A phosphatase dead mutant of AUM was generated by site directed mutagenesis, whereby 
the nucleophilic aspartate was mutated conservatively to asparagine (see section 4.2.9). The 
catalytical impairment was unequivocally shown by lack of activity towards p-NPP (Fig. 18). 
Plasmid containing AUMD34N was used in overexpression studies along with AUMwt 
constructs with suitable tags. We analyzed the effect of AUM overexpression on actin 
dynamics, cell spreading, and in biochemical studies. AUMD34N expressing cells show 
characteristically altered cell morphology in comparison to AUMwt expressing cells. The 
overexpression of catalytically dead AUM leads to more stabilized F-actin as well as to 
mature focal adhesions (Figs. 35, 38). AUMD34N expressing cells are advanced in spreading 
on FN coated surface. We also tested AUMD34N as a putative substrate trapping mutant in 
biochemical studies focusing on likely target molecules such as Src or EGFR which are 
known to play central role in cell adhesion and migration (Biscardi et al., 2000; Huveneers 
and Danen 2009) and also because we had indication of these molecules as probable AUM 
substrates in phosphopeptide screen (see Fig. 19).  So far we could not successfully show 
stable PTP-substrate complex formation using AUMD34N either indicating its limitations to act 
as efficient substrate trapping mutant. It is possible that additional mutations need to be 
introduced in order to stabilize the association of AUM with is substrates.   
PTP-substrate complexes could be isolated in the case of PTP-PEST or SHP2 (Garton et al., 
1996; Agazie and Hayman 2003). There are certain limitations to this approach owing to the 
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possibility of mislocalization of AUMD34N in cells, granting it access to substrates that might 
not otherwise be encountered under physiological conditions. Along with spatial issues of 
PTP-substrate complex formation in cells, there is another level of complexity in terms of 
temporal regulation of PTP activity in cells. Substrate trapping mutants might interfere with 
the propagation of downstream signaling, resulting in changes in net tyrosyl phosphorylation 
patterns of other PTP substrates and thus preventing their detection by this method. Hence 
this approach needs to be use with caution and complemented by knockdown studies which 
we established using RNA interference.        
 
High throughput peptide screen 
With the advent of genomic and proteomic scale screening technologies, we have yet 
another possibility of searching PTP substrates. Such screens are costly and demand 
dedicated instrumentations. Secondly, information generated at peptide level might not be 
translated directly into the biological context. In spite of these limitations, such screens may 
be a useful starting point for the characterization of novel proteins.  
We employed 720 pTyr, pSer or pThr-phosphorylated 13-mer human peptides and analyzed 
the dephosphorylation pattern in presence of recombinant, purified AUM. The relevance of 
the phosphopeptides contained in these screens has either experimentally confirmed at the 
protein level for about half of the peptides. The remaining phosphopeptides contained in the 
screen were experimentally identified by mass spectrophotometric analysis. Among all of the 
human phosphopeptides analyzed, we found that AUM prefers certain pTyr peptides 
indicating its enzymatic preferences and specificity. There are only 2% of pTyr peptides 
above a cut off limit of 66% as enlisted in figure 19, belonging to receptor tyrosine signaling 
proteins, adhesion proteins, and proteins involved in cytoskeletal dynamics. There are as 
many as ~150 pTyr peptides dephosphorylated by AUM as enlisted in supplementary data 
(10.1). This screening approach helped us to direct our efforts towards certain pathways and 
narrowing down the search for molecules involved therein. Predominantly we focused on 
EGFR signaling pathway and integrin mediated adhesion pathways for future substrate hunt.  
Interestingly, the putative “consensus sequence peptide” designed from this screen 
(see 10.1) could not be dephosphorylated by AUM (data not shown), raising questions about 
extrapolating the information and emphasizing the requirement for a physiological protein 
conformation for PTP catalysis.      
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Modulation of substrate tyrosine phosphorylation  
Demonstrating effect of PTP on endogenous tyrosine phosphorylation can be considered as 
unequivocal assignment of a PTP substrate used as starting point in many novel 
phosphatases such as Eyes absent (Rayapureddi et al., 2003). It is possible to analyze effect 
of overexpression or depletion of PTP by either demonstrating changes in global 
phosphotyrosine levels (Selengut 2001) or by discretely analyzing individual phosphosites on 
proteins (Lee and Chang 2008). We identified AUM as a bona fide phosphotyrosine protein 
phosphatase by overlay assay (Fig. 20) and by in vitro phosphatase assays (Figs. 21, 33) 
both by overexpression and depletion of AUM.  
We next decided to analyze the effect of AUM overexpression or loss-of-function 
approaches for individual phosphorylated sites on specific proteins for reasons discussed 
above. Epidermal growth factor receptor (EGFR) and Src, well known signaling molecules 
having central role in vital cellular processes are tyrosyl phosphorylated at multiple residues 
(Roskoski 2005; Wolf-Yadlin et al., 2006). We induced specific signaling pathways by ligands 
such as EGF or ECM molecules such as FN, and analyzed the effect on tyrosine 
phosphorylation upon overexpression or depletion of AUM. Unfortunately, we were not 
successful in obtaining consistent results with any of the phosphosites under various 
experimental conditions. We tried to immunoprecipitate either endogenous EGFR or Src at 
various time points after stimulation, but could not see the effect on tyrosine phosphorylation 
biochemically even when the obvious effect on cell adhesion by AUM overexpression or 
depletion was visible in cell biological analyses (Figs. 35-39). This can partly be attributed to 
unknown regulation of AUM in cells and to the transient effect of this phosphatase during cell 
spreading or EGF induced cell proliferation. It was evident in in vitro phosphatase assays 
that the effect of AUM overexpression or depletion can only be observed during the initial 
phases within 5 min (Figs. 21, 33) or within 10 min in FN spreading assays (Fig. 39). In spite 
of these limitations, we could consistently observe a stabilization of signaling molecules in 
absence of AUM such as EGFR (Fig. 34), and α5β1 integrins and Src (data not shown) 
under spreading conditions or upon growth factor stimulation. Tyr1045 is one of the 
phosphosites on EGFR which upon phosphorylation generates a major docking site for c-
Cbl, an adaptor protein and ubiquitin ligase that leads to receptor ubiquitination and 
degradation or trafficking (Biscardi et al., 1999). We found consistent modulation of 
phosphorylation status of Tyr1045 upon AUM depletion (Fig. 34) as compared to control 
shRNA expressing cells. We could not confirm the hyperphosphorylation status of Tyr1045 
with endogenous immunoprecipitated EGFR, and secondly there was concomitant increase 
in total EGFR level in the absence of AUM (Fig. 34) suggesting hyperphosphorylation of 
Tyr1045 as a consequence of increased EGFR levels and not due to depletion of AUM. We 
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have not systematically analyzed yet the reason of stabilization of EGFR in AUM depleted 
cells as early as 1 min after EGF stimulation.  
We now know that majority of signaling molecules are multisite phosphorylated (Cohen 
2000), which often has contrasting effects on the final outcome of protein activation. This 
may be one reason why it is difficult to correlate changes in the phosphorylation status of 
individual sites to certain functions by employing the currently available biochemical 
approaches. 
 
In vitro substrate dephosphorylation 
Probably the most straightforward approach of confirming the PTP substrate is an in vitro 
phosphatase assay where recombinant PTP and substrate are incubated together under 
defined conditions to monitor dephosphorylation of the potential substrate using anti-
phosphotyrosine antibodies or the release of phosphate colorimeterically or by release of 
radiolabelled phosphate.  
On the basis of the results of the phosphopeptide screen, we chose recombinant Src, 
FAK and phospholipids scramblase 1 for in vitro assays. Upon in vitro phosphorylation either 
alone with ATP or along with suitable upstream kinases, the phosphorylated protein was 
subjected to in vitro phosphatase reaction in the presence of recombinant, purified AUM as 
detailed in Methods (see section 4.4.13). There was no conclusive pattern with any of the 
proteins (data not shown), suggesting that either the data obtained on the peptide level many 
not be true at the protein level, or that there might be additional factors such as binding 
partners or phosphorylation status of PTP itself that govern the phosphatase efficiency (Chan 
et al., 2008) 
 
In case of in vitro phosphatase assay with Src, there are some interesting observations even 
though there was no unambiguous AUM mediated dephosphorylation on either of the two 
regulatory sites (Fig. 44A). Our data indicate the existence of AUM / Src cross talk in cells 
due to our observation of Src mediated AUM phosphorylation. Experiments aimed at 
investigating a potential physical interaction of AUM and Src are currently ongoing. 
 
We measured the effect of AUM on Src kinase activity towards a phosphorylated Src 
substrate peptide (for assay details, see section 4.4.13), and reproducibly found that AUM 
enhances Src kinase activity, albeit in a phosphatase-independent manner (Fig. 45). This 
finding may partially explain why we did not obtain consistent results when testing the effect 
of AUM on Src dephosphorylation in biochemical assays, as the AUM phosphatase activity 
might not be required for the regulation of Src kinase activity according to in vitro 
experiments.  
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We also analyzed the effect of Src on AUM phosphatase activity towards p-NPP 
because Src was found to phosphorylate AUM on a thus far unidentified tyrosine residue 
(Fig. 5). We found that Src inhibits AUM phosphatase activity. This effect is dependent on 
Src kinase activity as shown in figure 46.  
 
These results so far indicate a potential role of AUM as a structural component in Src 
regulation. Hence we put forward the hypothesis that AUM is involved in the regulation of Src 
activity by binding with one of its tyrosine residues to the Src SH2 domain as schematically 
shown in figure 48. It is known in the literature that there a few phosphatases such as PTPε 
that act as “competitive” Src activators by competing the intramolecular interaction between 
the pTyr527 residue and the Src SH2 domain, thus releasing the Src autoinhibitory loop 
(Berman-Golan and Elson 2007). This mechanism makes the Src autophosphorylation site 
Tyr416 accessible for phosphorylation and leads to a Src kinase activiation. 
 
 
Figure 48: Suggested mechanism for AUM acting as a novel Src kinase activator 
AUM may bind to the Src SH2 domain and thus release Src from its autoinhibited conformation.  
AUM may thus act as a Src kinase activator in a phosphatase independent manner.  
 
AUM is predicted to be tyrosine phosphorylated on 8 residues (figure 4) as analyzed by one 
of the available post translational modification prediction tools 
(http://www.cbs.dtu.dk/services/NetPhos/). Out of these 8 residues 3 have been 
experimentally confirmed by mass spectrophotometric analysis (http://www.phosida.com/). 
These sites are Tyr108, 178 and 308. Two tyrosine residues at the C-terminal region are 
found to be particularly interesting. Tyr248 is found to be conserved only in vertebrates 
whereas Tyr308 is found to be evolutionarily conserved from bacteria to humans. At present, 
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we are in the process of generating and testing the corresponding AUM mutants. The effect 
of these mutants on Src activity will allow us to experimentally test our proposed hypothesis. 
 
So far, our biochemical and cell biological data suggest that AUM has a role in the early 
spreading events of cells on FN coated surfaces. Src is known to be involved in the process 
of early stages of spreading by regulating the phosphorylation status of p190RhoGAP which 
in turn activates Rho activity of the cell (Huveneers and Danen 2009). If indeed our in vitro 
results indicating that AUM acts as a Src activator hold true under cellular and under in vivo 
conditions, then we should be able to observe an effect on Src kinase activity upon 
overexpression or depletion of AUM in cells. The use of pharmacological inhibitors of Src 
such as PP2 in cellular assays may be helpful to investigate the nature of the AUM / Src 
cross talk under physiological conditions.  
    
To summarize, our identification and characterization of AUM place this molecule as an 
interesting novel player in vital cellular processes such as cell adhesion and migration. A 
conditionally AUM-deficient mouse model has recently been generated by our laboratory. It 
can be expected that this model will hold the key to unlock the mystery of this novel 
aspartate based phosphotyrosine phosphatase. 
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Protein phosphatases can be classified into at least three major families based on amino 
acid sequences at their active sites. A newly emerging phosphatase family contains the 
active site sequence DXDX(T/V), and belongs to the haloacid dehalogenase (HAD) 
superfamily of hydrolases, a ubiquitous and evolutionarily conserved enzyme family. 
Although the existence of 58 human HAD enzymes has been predicted by database 
analysis, our understanding of their biological functions remains rudimentary. 
 
By database mining amd phylogenetic analysis of human HAD phosphatases, we have found 
a previously unidentified enzyme with homology to Chronophin, a cytoskeletal regulatory 
HAD phosphatase. We have cloned and characterized this novel enzyme and named it AUM, 
for actin remodeling, ubiquitously expressed, magnesium-dependent HAD phosphatase. By 
Northern blot, real-time PCR and Western blot analysis, we show that AUM is broadly 
expressed in all major human and mouse tissues with highest levels found in testis. Using 
immunohistochemistry, we can show that AUM is specifically expressed in maturing germ 
cells and that its expression peaks during spermiogenesis. 
To characterize the substrate preference of AUM, we have conducted an in vitro 
phosphatase substrate screen with 720 phosphopeptides derived from human 
phosphorylation sites. AUM exclusively dephosphorylates phosphotyrosine (pTyr)-containing 
peptides. Furthermore, only 17 pTyr peptides (~2% of all pTyr peptides investigated) acted 
as AUM substrates, indicating a high degree of substrate specificity. Putative AUM 
substrates include proteins involved in cytoskeletal dynamics and tyrosine kinase signaling. 
In accordance with the phosphopeptide screen, phosphatase overlay assays employing 
whole-cell extracts of pervanadate-treated HeLa cells show that AUM dephosphorylates only 
a limited number of tyrosyl-phosphorylated proteins.  
The role of AUM for cellular signaling was investigated in response to epidermal growth 
factor (EGF) stimulation in a spermatogonial cell line (GC-1 spg). The overexpression of 
AUM reduces, whereas the RNAi-mediated depletion of endogenous AUM increases EGF-
induced tyrosine phosphorylation, including changes in the phosphorylation of the EGF 
receptor itself. Interestingly, in vitro kinase/phosphatase assays with purified Src and AUM 
indicate that AUM can activate Src, which in turn phosphorylates and inactivates AUM. 
Although it is at present unclear how Src and AUM regulate each other, our initial findings 
suggests that AUM enhances Src kinase activity independently of its phosphatase activity, 
whereas Src diminishes AUM phosphatase activity in a kinase dependent manner. 
On a cellular level, AUM-depleted cells are characterized by altered actin cytoskeletal 
dynamics and adhesion, as indicated by stabilized actin filaments, enlarged focal adhesions, 
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a marked increase in cell area of spreading cells, as well as accelerated cell spreading on 
fibronectin.  
 
Taken together, we have identified and characterized AUM as a novel member of the 
emerging family of aspartate-dependent protein tyrosine phosphatases. Our findings 
implicate AUM as an important regulator of Src-dependent cytoskeletal dynamics during cell 
adhesion and migration. 
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8 Zusammenfassung   
Protein Phosphatasen werden aufgrund der Aminosäuresequenzen ihrer aktiven Zentren in 
drei große Familien unterteilt. In einer neu entdeckten Familie von Phosphatasen ist das 
aktive Zentrum durch die Sequenz DXDX(T/V) charakterisiert. Diese Aspartat-abhängigen 
Phosphatasen gehören zu der Superfamilie der Hydrolasen vom Haloazid Dehalogenase 
(HAD)-Typ, einer evolutionär konservierten und ubiquitär verbreiteten Enzymfamilie. Bislang 
konnten 58 menschliche HAD Enzyme durch Datenbankanalysen identifiziert werden. Ihre 
Funktionen sind jedoch nach wie vor nur rudimentär verstanden.  
 
Im Rahmen dieser Arbeit wurde zunächst das Komplement aller menschlichen HAD 
Phosphatasen durch Datenbank-Recherchen erfasst. Zusammen mit phylogenetischen 
Analysen gelang es, eine zum damaligen Zeitpunkt unbekannte, putative Phosphatase zu 
identifizieren, die eine vergleichsweise hohe Sequenz-Homologie zu der Zytoskelett-
regulierenden HAD Phosphatase Chronophin aufweist. Dieses neuartige Enzym wurde 
kloniert und mit biochemischen und zellbiologischen Methoden charakterisiert. Auf der Basis 
dieser Befunde bezeichnen wir dieses neuartige Protein als AUM (actin remodeling, 
ubiquitously expressed, magnesium-dependent HAD phosphatase). Mittels Northern blot, 
real-time PCR und Western blot Analysen konnte gezeigt werden, dass AUM in allen 
untersuchten menschlichen und murinen Geweben exprimiert wird. Die höchste Expression 
konnte in Hodengewebe nachgewiesen werden. Durch immunohistochemische 
Untersuchungen konnte gezeigt werden, dass AUM spezifisch in reifenden Keimzellen mit 
einem Expressionsmaximum zum Zeitpunkt der Spermiogenese exprimiert wird.  
 
Um die Substratpräferenz von AUM zu charakterisieren, wurde zunächst ein peptidbasierter 
in vitro Phosphatase-Substrat-Screen durchgeführt. Hierbei wurden 720 aus menschlichen 
Phosphoproteinen abgeleitete Phosphopeptide untersucht. Interessanterweise dephos-
phorylierte AUM ausschließlich Phosphotyrosin (pTyr)-enthaltende Peptide. Nur 17 pTyr-
Peptide (~2% aller untersuchten Peptide) fungierten als AUM-Substrate. Diese Daten legen 
eine hohe Substratspezifität von AUM nahe. Zu den putativen AUM Substraten gehören 
Proteine, die in die Dynamik der Zytoskelett-Reorganisation sowie in Tyrosin Kinase-
vermittelte Signalwege eingebunden sind. In Übereinstimmung mit den Ergebnissen dieses 
Phosphopeptid-Screens konnte mittels Phosphatase overlay assays sowie in Zellextrakten 
aus  Pervanadat-behandelten HeLa Zellen demonstriert werden, dass AUM eine begrenzte 
Anzahl  Tyrosin-phosphorylierter Proteinen dephosphorylieren kann. 
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In zellulären Untersuchungen wurde die mögliche Rolle von AUM im Rahmen der durch den 
epidermalen Wachstumsfaktor (EGF) ausgelösten Tyrosin-Phosphorylierung in einer 
Spermatogonien Zelllinie (GC-1 spg-Zellen) analysiert. So konnte nachgewiesen werden, 
dass die Überexpression von AUM zu einer moderaten Abnahme Tyrosin-phosphorylierter 
Proteine nach EGF-Stimulation führte. Im Gegensatz dazu löste jedoch die durch RNA-
Interferenz vermittelte Depletion von endogenem AUM einen robusten Anstieg Tyrosin-
phosphorylierter Proteine aus, zu denen auch der EGF-Rezeptor selbst zählt.  
Zusätzlich zu dem EGF-Rezeptor wurde die Src-Kinase im Zuge des Phosphopeptid-
Screens als mögliches AUM Substrat identifiziert. Daher wurden in vitro 
Kinase/Phosphatase-Assays mit gereinigtem Src und AUM durchgeführt. Mit diesem Ansatz 
konnte erstmals gezeigt werden, dass AUM in der Lage ist, die Src-Kinase zu aktivieren, 
während Src AUM phosphoryliert und die AUM Phosphatase-Aktivität blockiert. Diese 
Ergebnisse deuten auf eine gekoppelte, wechselseitige Regulation von AUM und Src hin. 
Obwohl die Details dieser Regulation derzeit noch unklar sind, zeigen unsere initialen 
Ergebnisse, dass AUM die Src-Aktivität unabhängig von seiner Phosphatase-Aktivität 
steigert, während Src die AUM Phosphatase-Aktivität Kinase-abhängig vermindert.  
Auf zellulärer Ebene sind AUM-depletierte Zellen durch Veränderungen der Aktin-
Zytoskelett-Dynamik und der Zelladhäsion charakterisiert. So weisen AUM-defiziente Zellen 
stabilisierte Aktin-Streßfasern und vergrößerte fokale Adhäsionen auf. Weiterhin sind AUM-
depletierte Zellen durch ein beschleunigtes spreading auf Fibronektin gekennzeichnet.  
 
Wir haben mit AUM ein bisher nicht beschriebenes Mitglied der Familie Aspartat-abhängiger 
Phosphatasen entdeckt. In dieser Arbeit ist es gelungen, AUM phylogenetisch, biochemisch 
und zellbiologisch zu charakterisieren. Unsere Ergebnisse legen nahe, dass AUM einen 
wichtigen, neuartigen Regulator der Src-vermittelten Zytoskelett-Dynamik im Rahmen der 
Zelladhäsion und Migration darstellt. 
 
References                                                                                                                            116 
9 References 
Agazie, Y. M. and M. J. Hayman (2003). "Development of an efficient "substrate-trapping" 
mutant of Src homology phosphotyrosine phosphatase 2 and identification of the 
epidermal growth factor receptor, Gab1, and three other proteins as target 
substrates." J Biol Chem 278(16): 13952-8. 
 
Allen, K. N. and D. Dunaway-Mariano (2004). "Phosphoryl group transfer: evolution of a 
catalytic scaffold." Trends in Biochemical Sciences 29(9): 495-503. 
 
Almo, S. C., J. B. Bonanno, J. M. Sauder, S. Emtage, T. P. Dilorenzo, et al. (2007). 
"Structural genomics of protein phosphatases." J Struct Funct Genomics 8(2-3): 121-
40. 
 
Alonso, A., J. Sasin, N. Bottini, I. Friedberg, A. Osterman, et al. (2004). "Protein tyrosine 
phosphatases in the human genome." Cell 117(6): 699-711. 
 
Altschul, S. F., W. Gish, W. Miller, E. W. Myers and D. J. Lipman (1990). "Basic local 
alignment search tool." J Mol Biol 215(3): 403-10. 
 
Andersen, J. N., R. L. Del Vecchio, N. Kannan, J. Gergel, A. F. Neuwald, et al. (2005). 
"Computational analysis of protein tyrosine phosphatases: practical guide to 
bioinformatics and data resources." Methods 35(1): 90-114. 
 
Andrianantoandro, E. and T. D. Pollard (2006). "Mechanism of actin filament turnover by 
severing and nucleation at different concentrations of ADF/cofilin." Mol Cell 24(1): 13-
23. 
 
Aravind, L. and E. V. Koonin (1998). "The HD domain defines a new superfamily of metal-
dependent phosphohydrolases." Trends Biochem Sci 23(12): 469-72. 
 
Archambault, J., G. Pan, G. K. Dahmus, M. Cartier, N. Marshall, et al. (1998). "FCP1, the 
RAP74-interacting subunit of a human protein phosphatase that dephosphorylates 
the carboxyl-terminal domain of RNA polymerase IIO." J Biol Chem 273(42): 27593-
601. 
 
Balakrishnan, R., M. Frohlich, P. T. Rahaim, K. Backman and R. R. Yocum (1993). 
"Appendix. Cloning and sequence of the gene encoding enzyme E-1 from the 
methionine salvage pathway of Klebsiella oxytoca." J Biol Chem 268(33): 24792-5. 
 
Bamburg, J. R. and G. S. Bloom (2009). "Cytoskeletal pathologies of Alzheimer disease." 
Cell Motil Cytoskeleton 66(8): 635-49. 
 
Bamburg, J. R. and O. P. Wiggan (2002). "ADF/cofilin and actin dynamics in disease." 
Trends Cell Biol 12(12): 598-605. 
 
Bass, M. D., M. R. Morgan, K. A. Roach, J. Settleman, A. B. Goryachev, et al. (2008). 
"p190RhoGAP is the convergence point of adhesion signals from alpha 5 beta 1 
integrin and syndecan-4." J Cell Biol 181(6): 1013-26. 
 
Bazley, L. A. and W. J. Gullick (2005). "The epidermal growth factor receptor family." Endocr 
Relat Cancer 12 Suppl 1: S17-27. 
 
References                                                                                                                            117   
 
Bellve, A. R. (1993). Recovery, Capacitation, Acrosome reaction, Fractionation of sperm. 
Methods in Enzymology. 225: 113 - 136. 
 
Berman-Golan, D. and A. Elson (2007). "Neu-mediated phosphorylation of protein tyrosine 
phosphatase epsilon is critical for activation of Src in mammary tumor cells." 
Oncogene 26(49): 7028-37. 
 
Biscardi, J. S., R. C. Ishizawar, C. M. Silva and S. J. Parsons (2000). "Tyrosine kinase 
signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in 
breast cancer." Breast Cancer Res 2(3): 203-10. 
 
Biscardi, J. S., M. C. Maa, D. A. Tice, M. E. Cox, T. H. Leu, et al. (1999). "c-Src-mediated 
phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is 
associated with modulation of receptor function." J Biol Chem 274(12): 8335-43. 
 
Blevins, T., R. Rajeswaran, P. V. Shivaprasad, D. Beknazariants, A. Si-Ammour, et al. 
(2006). "Four plant Dicers mediate viral small RNA biogenesis and DNA virus induced 
silencing." Nucleic Acids Res 34(21): 6233-46. 
 
Bradshaw, R., & Dennis, E., Ed. (2003). Handbook of Cell Signaling, Elsevier Science (USA). 
1: 373 - 377. 
 
Bradshaw, R., & Dennis, E., Ed. (2003). Handbook of Cell Signaling, Elsevier Science (USA). 
1: 593-600. 
 
Breitbart, H., G. Cohen and S. Rubinstein (2005). "Role of actin cytoskeleton in mammalian 
sperm capacitation and the acrosome reaction." Reproduction 129(3): 263-8. 
 
Burroughs, A. M., K. N. Allen, D. Dunaway-Mariano and L. Aravind (2006). "Evolutionary 
genomics of the HAD superfamily: understanding the structural adaptations and 
catalytic diversity in a superfamily of phosphoesterases and allied enzymes." J Mol 
Biol 361(5): 1003-34. 
 
Cagan, R. L. (2003). "Spermatogenesis: borrowing the apoptotic machinery." Curr Biol 
13(15): R600-2. 
 
Chan, G., D. Kalaitzidis and B. G. Neel (2008). "The tyrosine phosphatase Shp2 (PTPN11) in 
cancer." Cancer Metastasis Rev 27(2): 179-92. 
 
Chhabra, E. S. and H. N. Higgs (2007). "The many faces of actin: matching assembly factors 
with cellular structures." Nat Cell Biol 9(10): 1110-21. 
 
Chomczynski, P. and N. Sacchi (1987). "Single-step method of RNA isolation by acid 
guanidinium thiocyanate-phenol-chloroform extraction." Anal Biochem 162(1): 156-9. 
Cohen, P. (1992). "Signal integration at the level of protein kinases, protein phosphatases 
and their substrates." Trends in Biochemical Sciences 17(10): 408-413. 
 
Cohen, P. (2000). "The regulation of protein function by multisite phosphorylation - a 25 year 
update." Trends in Biochemical Sciences 25(12): 596-601. 
 
Collet, J. F., V. Stroobant, M. Pirard, G. Delpierre and E. Van Schaftingen (1998). "A new 
class of phosphotransferases phosphorylated on an aspartate residue in an amino-
terminal DXDX(T/V) motif." J Biol Chem 273(23): 14107-12. 
 
Cukierman, E., R. Pankov, D. R. Stevens and K. M. Yamada (2001). "Taking cell-matrix 
adhesions to the third dimension." Science 294(5547): 1708-12. 
References                                                                                                                            118   
 
Das, A. K., N. R. Helps, P. T. Cohen and D. Barford (1996). "Crystal structure of the protein 
serine/threonine phosphatase 2C at 2.0 A resolution." EMBO J 15(24): 6798-809. 
 
Eckhart, W., M. A. Hutchinson and T. Hunter (1979). "An activity phosphorylating tyrosine in 
polyoma T antigen immunoprecipitates." Cell 18(4): 925-33. 
 
Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, et al. (2001). "Duplexes of 
21-nucleotide RNAs mediate RNA interference in cultured mammalian cells." Nature 
411(6836): 494-8. 
 
Gao, G. J. and M. L. Fonda (1994). "Kinetic analysis and chemical modification of vitamin B6 
phosphatase from human erythrocytes." J Biol Chem 269(10): 7163-8. 
 
Garton, A. J., A. J. Flint and N. K. Tonks (1996). "Identification of p130(cas) as a substrate 
for the cytosolic protein tyrosine phosphatase PTP-PEST." Mol Cell Biol 16(11): 
6408-18. 
 
Geiger, B. (1979). "A 130K protein from chicken gizzard: its localization at the termini of 
microfilament bundles in cultured chicken cells." Cell 18(1): 193-205. 
 
Geiger, B. and A. Bershadsky (2001). "Assembly and mechanosensory function of focal 
contacts." Curr Opin Cell Biol 13(5): 584-92. 
 
Geiger, B., J. P. Spatz and A. D. Bershadsky (2009). "Environmental sensing through focal 
adhesions." Nat Rev Mol Cell Biol 10(1): 21-33. 
 
Gohla, A., J. Birkenfeld and G. M. Bokoch (2005). "Chronophin, a novel HAD-type serine 
protein phosphatase, regulates cofilin-dependent actin dynamics." Nat Cell Biol 7(1): 
21-9. 
 
Gordon, J., Ed. (1991). Methods in Enzymology. 201: 477-482. 
 
Guo, Y., N. Cheong, Z. Zhang, R. De Rose, Y. Deng, et al. (2004). "Tim50, a component of 
the mitochondrial translocator, regulates mitochondrial integrity and cell death." J Biol 
Chem 279(23): 24813-25. 
 
Hanahan, D. (1983). "Studies on transformation of Escherichia coli with plasmids." J Mol Biol 
166(4): 557-80. 
 
Hanks, S. K. and T. Hunter (1995). "Protein kinases 6. The eukaryotic protein kinase 
superfamily: kinase (catalytic) domain structure and classification." FASEB J 9(8): 
576-96. 
 
Hendrickx, A., M. Beullens, H. Ceulemans, T. Den Abt, A. Van Eynde, et al. (2009). "Docking 
motif-guided mapping of the interactome of protein phosphatase-1." Chem Biol 16(4): 
365-71. 
 
Hess, R. A. (1990). "Quantitative and qualitative characteristics of the stages and transitions 
in the cycle of the rat seminiferous epithelium: light microscopic observations of 
perfusion-fixed and plastic-embedded testes." Biol Reprod 43(3): 525-42. 
 
Hess, R. A., D. J. Schaeffer, V. P. Eroschenko and J. E. Keen (1990). "Frequency of the 
stages in the cycle of the seminiferous epithelium in the rat." Biol Reprod 43(3): 517-
24. 
References                                                                                                                            119   
 
Hofmann, M. C., S. Narisawa, R. A. Hess and J. L. Millan (1992). "Immortalization of germ 
cells and somatic testicular cells using the SV40 large T antigen." Exp Cell Res 
201(2): 417-35. 
 
Holt, M. R., Y. Calle, D. H. Sutton, D. R. Critchley, G. E. Jones, et al. (2008). "Quantifying 
cell-matrix adhesion dynamics in living cells using interference reflection microscopy." 
J Microsc 232(1): 73-81. 
 
Hornberg, J. J., F. J. Bruggeman, B. Binder, C. R. Geest, A. J. de Vaate, et al. (2005). 
"Principles behind the multifarious control of signal transduction. ERK 
phosphorylation and kinase/phosphatase control." Febs J 272(1): 244-58. 
 
Hotulainen, P., E. Paunola, M. K. Vartiainen and P. Lappalainen (2005). "Actin-
depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin 
depolymerization in mammalian nonmuscle cells." Mol Biol Cell 16(2): 649-64. 
 
Hunter, T. (1998). "The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: 
its role in cell growth and disease." Philos Trans R Soc Lond B Biol Sci 353(1368): 
583-605. 
 
Hunter, T. (2000). "Signaling--2000 and Beyond." Cell 100(1): 113-127. 
 
Hunter, T. (2002). "Tyrosine phosphorylation in cell signaling and disease." Keio J Med 51(2): 
61-71. 
 
Hunter, T., Ed. (2004). Protein phosphorylation: What does the future hold in life sciences for 
the 21st century? NJ, Wiley Hoboken pp 191-223. 
 
Hunter, T. (2007). "The Age of Crosstalk: Phosphorylation, Ubiquitination, and Beyond." 
Molecular Cell 28(5): 730-738. 
 
Huveneers, S. and E. H. Danen (2009). "Adhesion signaling - crosstalk between integrins, 
Src and Rho." J Cell Sci 122(Pt 8): 1059-69. 
 
Jang, Y. M., D. W. Kim, T. C. Kang, M. H. Won, N. I. Baek, et al. (2003). "Human pyridoxal 
phosphatase. Molecular cloning, functional expression, and tissue distribution." J Biol 
Chem 278(50): 50040-6. 
 
Kannan, N. and S. S. Taylor (2008). "Rethinking pseudokinases." Cell 133(2): 204-5. 
 
Kim, Y., M. S. Gentry, T. E. Harris, S. E. Wiley, J. C. Lawrence, Jr., et al. (2007). "A 
conserved phosphatase cascade that regulates nuclear membrane biogenesis." Proc 
Natl Acad Sci U S A 104(16): 6596-601. 
 
Kolokoltsov, A. A., S. C. Weaver and R. A. Davey (2005). "Efficient functional pseudotyping 
of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus 
envelope proteins." J Virol 79(2): 756-63. 
 
Koonin, E. V. and R. L. Tatusov (1994). "Computer analysis of bacterial haloacid 
dehalogenases defines a large superfamily of hydrolases with diverse specificity. 
Application of an iterative approach to database search." J Mol Biol 244(1): 125-32. 
 
Kuznetsova, E., M. Proudfoot, C. F. Gonzalez, G. Brown, M. V. Omelchenko, et al. (2006). 
"Genome-wide analysis of substrate specificities of the Escherichia coli haloacid 
dehalogenase-like phosphatase family." J Biol Chem 281(47): 36149-61. 
References                                                                                                                            120   
 
Laemmli, U. K. (1970). "Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4." Nature 227(5259): 680-5. 
 
Lahiri, S. D., G. Zhang, J. Dai, D. Dunaway-Mariano and K. N. Allen (2004). "Analysis of the 
substrate specificity loop of the HAD superfamily cap domain." Biochemistry 43(10): 
2812-20. 
 
Lahiri, S. D., G. Zhang, D. Dunaway-Mariano and K. N. Allen (2002). "Caught in the act: the 
structure of phosphorylated beta-phosphoglucomutase from Lactococcus lactis." 
Biochemistry 41(26): 8351-9. 
 
Larkin, M. A., G. Blackshields, N. P. Brown, R. Chenna, P. A. McGettigan, et al. (2007). 
"Clustal W and Clustal X version 2.0." Bioinformatics 23(21): 2947-8. 
 
Lee, H. H. and Z. F. Chang (2008). "Regulation of RhoA-dependent ROCKII activation by 
Shp2." J Cell Biol 181(6): 999-1012. 
 
Levkowitz, G., H. Waterman, S. A. Ettenberg, M. Katz, A. Y. Tsygankov, et al. (1999). 
"Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth 
factor signaling by c-Cbl/Sli-1." Mol Cell 4(6): 1029-40. 
 
Livera, G., G. Delbes, C. Pairault, V. Rouiller-Fabre and R. Habert (2006). "Organotypic 
culture, a powerful model for studying rat and mouse fetal testis development." Cell 
Tissue Res 324(3): 507-21. 
 
Manning, G., G. D. Plowman, T. Hunter and S. Sudarsanam (2002). "Evolution of protein 
kinase signaling from yeast to man." Trends Biochem Sci 27(10): 514-20. 
 
Mitra, S. K., D. A. Hanson and D. D. Schlaepfer (2005). "Focal adhesion kinase: in command 
and control of cell motility." Nat Rev Mol Cell Biol 6(1): 56-68. 
 
Moffat, J., D. A. Grueneberg, X. Yang, S. Y. Kim, A. M. Kloepfer, et al. (2006). "A lentiviral 
RNAi library for human and mouse genes applied to an arrayed viral high-content 
screen." Cell 124(6): 1283-98. 
 
Moorhead, G. B., V. De Wever, G. Templeton and D. Kerk (2009). "Evolution of protein 
phosphatases in plants and animals." Biochem J 417(2): 401-9. 
 
Morrison, D. K., M. S. Murakami and V. Cleghon (2000). "Protein kinases and phosphatases 
in the Drosophila genome." J Cell Biol 150(2): F57-62. 
 
Mruk, D., L. J. Zhu, B. Silvestrini, W. M. Lee and C. Y. Cheng (1997). "Interactions of 
proteases and protease inhibitors in Sertoli-germ cell cocultures preceding the 
formation of specialized Sertoli-germ cell junctions in vitro." J Androl 18(6): 612-22. 
 
Murphy, L., I. A. Jeffcoate and P. J. O'Shaughnessy (1994). "Abnormal Leydig cell 
development at puberty in the androgen-resistant Tfm mouse." Endocrinology 135(4): 
1372-7. 
 
Obergfell, A., K. Eto, A. Mocsai, C. Buensuceso, S. L. Moores, et al. (2002). "Coordinate 
interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin 
signaling to the cytoskeleton." J Cell Biol 157(2): 265-75. 
 
Okabe, Y., T. Sano and S. Nagata (2009). "Regulation of the innate immune response by 
threonine-phosphatase of Eyes absent." Nature 460(7254): 520-4. 
References                                                                                                                            121   
 
Olsen, J. V., B. Blagoev, F. Gnad, B. Macek, C. Kumar, et al. (2006). "Global, in vivo, and 
site-specific phosphorylation dynamics in signaling networks." Cell 127(3): 635-48. 
 
Pardo, M. and P. Nurse (2005). "The nuclear rim protein Amo1 is required for proper 
microtubule cytoskeleton organisation in fission yeast." J Cell Sci 118(Pt 8): 1705-14. 
 
Parsons, J. T. (2003). "Focal adhesion kinase: the first ten years." J Cell Sci 116(Pt 8): 1409-
16. 
 
Peisach, E., J. D. Selengut, D. Dunaway-Mariano and K. N. Allen (2004). "X-ray crystal 
structure of the hypothetical phosphotyrosine phosphatase MDP-1 of the haloacid 
dehalogenase superfamily." Biochemistry 43(40): 12770-9. 
 
Pincus, D., I. Letunic, P. Bork and W. A. Lim (2008). "Evolution of the phospho-tyrosine 
signaling machinery in premetazoan lineages." Proc Natl Acad Sci U S A 105(28): 
9680-4. 
 
Pires-daSilva, A. and R. J. Sommer (2003). "The evolution of signalling pathways in animal 
development." Nat Rev Genet 4(1): 39-49. 
 
Raftopoulou, M. and A. Hall (2004). "Cell migration: Rho GTPases lead the way." Dev Biol 
265(1): 23-32. 
 
Rayapureddi, J. P., C. Kattamuri, B. D. Steinmetz, B. J. Frankfort, E. J. Ostrin, et al. (2003). 
"Eyes absent represents a class of protein tyrosine phosphatases." Nature 
426(6964): 295-8. 
 
Revenu, C., R. Athman, S. Robine and D. Louvard (2004). "The co-workers of actin 
filaments: from cell structures to signals." Nat Rev Mol Cell Biol 5(8): 635-46. 
 
Ridder, I. S. and B. W. Dijkstra (1999). "Identification of the Mg2+-binding site in the P-type 
ATPase and phosphatase members of the HAD (haloacid dehalogenase) superfamily 
by structural similarity to the response regulator protein CheY." Biochem J 339 ( Pt 
2): 223-6. 
 
Roskoski, R., Jr. (2005). "Src kinase regulation by phosphorylation and dephosphorylation." 
Biochem Biophys Res Commun 331(1): 1-14. 
 
Schlaepfer, D. D., K. C. Jones and T. Hunter (1998). "Multiple Grb2-mediated integrin-
stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation 
of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events." 
Mol Cell Biol 18(5): 2571-85. 
 
Schlessinger, J. (2002). "Ligand-induced, receptor-mediated dimerization and activation of 
EGF receptor." Cell 110(6): 669-72. 
 
Selengut, J. D. (2001). "MDP-1 is a new and distinct member of the haloacid dehalogenase 
family of aspartate-dependent phosphohydrolases." Biochemistry 40(42): 12704-11. 
 
Seligman, J., Y. Zipser and N. S. Kosower (2004). "Tyrosine phosphorylation, thiol status, 
and protein tyrosine phosphatase in rat epididymal spermatozoa." Biol Reprod 71(3): 
1009-15. 
 
Sheiness, D. and J. M. Bishop (1979). "DNA and RNA from uninfected vertebrate cells 
contain nucleotide sequences related to the putative transforming gene of avian 
myelocytomatosis virus." J Virol 31(2): 514-21. 
References                                                                                                                            122   
 
Sieg, D. J., D. Ilic, K. C. Jones, C. H. Damsky, T. Hunter, et al. (1998). "Pyk2 and Src-family 
protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated 
signaling events but Pyk2 does not fully function to enhance FAK- cell migration." 
EMBO J 17(20): 5933-47. 
 
Singh, S. K., K. Yang, S. Karthikeyan, T. Huynh, X. Zhang, et al. (2004). "The thrH gene 
product of Pseudomonas aeruginosa is a dual activity enzyme with a novel 
phosphoserine:homoserine phosphotransferase activity." J Biol Chem 279(13): 
13166-73. 
 
Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, et al. (1985). 
"Measurement of protein using bicinchoninic acid." Anal Biochem 150(1): 76-85. 
 
Soufi, B., F. Gnad, P. R. Jensen, D. Petranovic, M. Mann, et al. (2008). "The Ser/Thr/Tyr 
phosphoproteome of Lactococcus lactis IL1403 reveals multiply phosphorylated 
proteins." Proteomics 8(17): 3486-93. 
 
Stewart, S. A., D. M. Dykxhoorn, D. Palliser, H. Mizuno, E. Y. Yu, et al. (2003). "Lentivirus-
delivered stable gene silencing by RNAi in primary cells." Rna 9(4): 493-501. 
 
Taylor, D. L. and Y. L. Wang (1980). "Fluorescently labelled molecules as probes of the 
structure and function of living cells." Nature 284(5755): 405-10. 
 
Tiganis, T. and A. M. Bennett (2007). "Protein tyrosine phosphatase function: the substrate 
perspective." Biochem J 402(1): 1-15. 
 
Tonks, N. K. (2003). "PTP1B: From the sidelines to the front lines!" FEBS Letters 546(1): 
140-148. 
 
Tonks, N. K. (2006). "Protein tyrosine phosphatases: from genes, to function, to disease." 
Nat Rev Mol Cell Biol 7(11): 833-46. 
 
Towbin, H., T. Staehelin and J. Gordon (1979). "Electrophoretic transfer of proteins from 
polyacrylamide gels to nitrocellulose sheets: procedure and some applications." Proc 
Natl Acad Sci U S A 76(9): 4350-4. 
 
Tuschl, T. and A. Borkhardt (2002). "Small interfering RNAs: a revolutionary tool for the 
analysis of gene function and gene therapy." Mol Interv 2(3): 158-67. 
 
Wang, H., W. Xiong, Y. Chen, Q. Ma, J. Ma, et al. (2006). "Evaluation on the phagocytosis of 
apoptotic spermatogenic cells by Sertoli cells in vitro through detecting lipid droplet 
formation by Oil Red O staining." Reproduction 132(3): 485-92. 
 
Wishart, M. J. and J. E. Dixon (1998). "Gathering STYX: phosphatase-like form predicts 
functions for unique protein-interaction domains." Trends Biochem Sci 23(8): 301-6. 
 
Wolf-Yadlin, A., N. Kumar, Y. Zhang, S. Hautaniemi, M. Zaman, et al. (2006). "Effects of 
HER2 overexpression on cell signaling networks governing proliferation and 
migration." Mol Syst Biol 2: 54. 
 
Worth, D. C. and M. Parsons (2008). "Adhesion dynamics: Mechanisms and measurements." 
The International Journal of Biochemistry & Cell Biology 40(11): 2397-2409. 
 
Xiao, X. and W. X. Yang (2007). "Actin-based dynamics during spermatogenesis and its 
significance." J Zhejiang Univ Sci B 8(7): 498-506. 
References                                                                                                                            123   
 
Yamashita, M., K. Yamagata, K. Tsumura, T. Nakanishi and T. Baba (2007). "Acrosome 
reaction of mouse epididymal sperm on oocyte zona pellucida." J Reprod Dev 53(2): 
255-62. 
 
Yeatman, T. J. (2004). "A renaissance for SRC." Nat Rev Cancer 4(6): 470-80. 
 
Zaidel-Bar, R. (2009). "Evolution of complexity in the integrin adhesome." J Cell Biol 186(3): 
317-21. 
 
Zaidel-Bar, R., S. Itzkovitz, A. Ma'ayan, R. Iyengar and B. Geiger (2007). "Functional atlas of 
the integrin adhesome." Nat Cell Biol 9(8): 858-67. 
 
Zhang, G., A. S. Mazurkie, D. Dunaway-Mariano and K. N. Allen (2002). "Kinetic evidence for 
a substrate-induced fit in phosphonoacetaldehyde hydrolase catalysis." Biochemistry 
41(45): 13370-7. 
 
Zhang, W. and L. Shi (2004). "Evolution of the PPM-family protein phosphatases in 
Streptomyces: duplication of catalytic domain and lateral recruitment of additional 
sensory domains." Microbiology 150(Pt 12): 4189-97. 
 
Zheng, H., C. Ji, S. Gu, B. Shi, J. Wang, et al. (2005). "Cloning and characterization of a 
novel RNA polymerase II C-terminal domain phosphatase." Biochem Biophys Res 
Commun 331(4): 1401-7. 
 
Zheng, H., C. J. Stratton, K. Morozumi, J. Jin, R. Yanagimachi, et al. (2007). "Lack of Spem1 
causes aberrant cytoplasm removal, sperm deformation, and male infertility." Proc 
Natl Acad Sci U S A 104(16): 6852-7. 
 
 
 
 
 
 
 
 
 
 
Supplementary data                                                                                                              124 
10 Supplementary data 
10.1 JPT phosphopeptide screen analysis 
AUM was analyzed with Ser/Thr or Tyr phosphopeptides as a first approach to identify 
physiological substrates. As per convention, hits above a 66% cut off of the highest OD 
obtained in this assay were considered meaningful and were analyzed as possible AUM 
substrates as discussed in section 5.3. There are around 150 hits below this cut off. These 
hits may still be useful to understand the role of AUM in signaling pathways. 
Below is the complete list of phosphopeptides dephosphorylated by AUM in descending 
order of OD. For each phosphopeptide, the 13-mer sequence, SwissProt ID and the known 
main biological function of the respective proteins are listed. The phosphorylated tyrosine, 
serine or threonine residue is always the central amino acid. Physiologically relevant 
phosphorylation sites for the first 17 peptides (those above the 66% cut off) and for all EGFR 
family proteins were identified by BLAST analysis (Altschul et al., 1990) of the human protein 
data base. A theoretical AUM substrate “consensus peptide” sequence was derived from the 
first 17 hits and from all EGFR hits enlisted. Interesting hits were grouped under well 
characterized protein families. 
 
Table S1: Phosphotyrosine peptides dephosphorylated by AUM 
 
Phosphopetide SwissProt ID Details pTyrosine 
LSEDCLYLNIYTP P23141 Liver carboxylase 1 precursor Y118 
MEGQHNYLCAGRN P06401 Progesterone receptor Y601 
DGFYYLYANICFR O14788 TNF ligand superfamily member 11 Y217 
RDINSLYDVSRMY P16885 PLC-gamma-2 Y753 
ASSQDCYDIPRAF Q13480 GRB2-associated binding protein 1 Y406 
LLEQQKYTVTVDY O14920 Inhibitor of nuclear factor kappa B kinase beta subunit Y199 
RYQPGKYPMPNQS Q9NRQ2 Phospholipid scramblase 4 Y88 
AAFQFSYTAVFGA Q9Y256 CAAX prenyl protease 2 Y236 
NEDYAGYIIPPAP Q9UNH7 Sorting nexin 6 Y89 
LCQSGIYINVLDI O00476 Sodium-dependent phosphate transport protein 4 Y337 
EAALNEYLRVKTV O75891  10-formyltetrahydrofolate dehydrogenase Y892 
VPNQPVYNQPVYN O15162 Phospholipid scramblase 1 Y69 
SEEIRFYQLGEEA P22001 
Potassium voltage-gated channel subfamily A member 
3 Y187 
YCPDPLYEVMLKC P08581 Hepatocyte growth factor receptor precursor (c-met) Y1313 
DAEKPFYVNVEFH P11274 Breakpoint cluster region protein Y177 
DSPPALYAEPLDS Q99704 Docking protein 1 (p62dok) Y296 
AFDNLYYWDQDPP P04626 C-erbB-2 precursor Y1221  
ENPIDLYIYVIDM P55823 Cadherin-4 precursor  Y264 
LSEDCLYLNVWIP P06276 Cholinesterase  Y122 
LYAGDYYRVQGRA Q08345 Epithelial discoidin domain receptor 1 precursor Y797 
ESEEELYSSCRQL P16885 PLC-gamma-2 Y1197 
PSDKFIYATVKQS Q05586 Glutamate (NMDA) receptor subunit zeta 1 precursor  
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PLDSTFYRSLLED P04626 C-erbB-2 precursor Y1005  
LEEILAYQPDILC Q9UK39 Nocturnin (CCR4 protein homolog)  
DAEMTGYVVTRWY O15264 Mitogen -activated protein kinase 13   
IGVRESYVNLCSN Q93034 Cullin homolog 5   
WIRYHRYHGRSAA P11309 Proto-oncogene serine/threoine-protein kinase pim-1  
LKMKEKYLNVSAC O75343 Guanylate cyclase soluble, beta-2 chain  
FLRCINYVFFPSL P17181 Interferon-alpha/beta receptor alpha chain precursor  
AYQNTIYLNLWDH P15144 Aminopeptidase N  
PPERIIYANPCKQ P11926 Ornithine decarboxylase  
LLLANAYIYVVQL P32004 Neural cell adhesion molecule L1 precursor  
GPNNNNYANVELI O00763 Coactosin-like protein  
ALDNPEYHNASNG Q15303 erbB-4 precursor Y1188  
MLNSKGYTKSIDI P28482 Mitogen-activted protein kinase 1 (ERK-2)  
SIKMQQYTEHFMA P29317 Ephrin type-A receptor 2 precursor  
LMEKDSYPRFLKS Q08116 Regulator of G-protein signaling 1   
QLSDPDYINQYVI Q9Y5W8 Sorting nexin 13  
NLYAGDYYRVQGR Q08345 Epithelial discoidin domain receptor 1 precursor  
RSSLKAYGNGYSS P07550 Beta-2 adrenergic receptor  
EVHKSGYLSSERL P15311 Ezrin (Cytovillin)  
TAENAEYLRVAPQ P00533 ErbB-1 precursor Y1197 
TSSSSEYGSVSPD Q99683 Mitogen -activated protein kinase kinase kinse  
EDNVKSYMDMQRR Q13075 Neuronal apoptosis inhibitory protein  
SIESDIYAEIPDE Q14289 Focal adhesion kinase 2  
LNTTTATYAEPYRP Q99569 Plakophilin 4  
KKSLTIYAQVQKP Q13291 Signaling lymphocyte activation molecule precursor  
LSPAFRYQPDPWK P29473 Nitric-oxide synthase,endothelial  
TLPPCIYMAPMNQ P55286 Cadherin-8 precursor  
RLSGELYGRATAW Q99999 Galactosylceramide sulfotransferase  
NCTHDLYMIMREC P22607 Fibroblast growth factor receptor 3 precursor   
RQPFVKYATLISN P48357 Leptin receptor precursor   
EAPTTAYKKTTPI P14317 Hematopoietic lineage cell speific protein  
IHLEKKYVRRDSG P07333 Macrophage colony stimulating factor I receptor   
GVCAERYSQEVFE O15304 Apoptosis regulatoy protein Siva  
LNQSSGYRYGTDP P06241 Proto-oncogene tyrosine-protein kinase FYN  
FRHDSGYEVHHQK P05067 Amyloid beta A4 protei precursor   
SPGMKIYIDPFTY P54762 Ephrin type-B receptor 1 precursor  
ARTGILYVNASLD Q9NYQ8 Multiple epidermal growth factor-like domains 1  
GAFGTVYKGIWIP P04626 C-erbB-2 precursor Y735  
MTCAELYEKLPQG P35590 Tyrosine-protein kinase receptor Tie-1 precursor  
SDTDSSYCIPTAG Q13480 GRB2-associated binding protein 1  
MDLLRQYLRVETQ Q13085 Acetyl-CoA carboxylase 1  
LGTVMRYEEIELR Q9BZQ4 Nicotinamide mononucleotide adenylyltrasnferase 2  
AFDNPDYWHSRLF P21860 c-erbB-3 Y1328 
LASEEIYINQLEA Q12979 Active breakpoint cluster region-related protein  
STSLVGYLRVQGV Q9UKG9 Peroxisomal carnitine O-octanoyltrasferase  
YSTKYFYKQNGRI Q15303 erbB-4 precursor Y1268  
PPDHQYYNDFPGK P29353 SHC transforming protein 1  
SQEELHYATLNFP Q96LC7 Sialic acid binding Ig-like lectin 10 precursor  
CIVENEYGSINHT P11362 Basic fibroblast growth facor receptor 1 precursor  
HRQGHIYMEMNFT P63010 Adapter-related protein complex 2 beta 1 subunit  
EVTFHLYLIPSDC Q9C000 NACHT-. LRR-, and PYD- containing protein 2  
QRLDCIYLNAGIM P56937 Estradiol 17-beta-dehydrogenase 7  
WIEDTLYANVDFF P78363 Retinal-specific ATP-binding cassette trasporter   
AEPYNLYSSLKEL Q92569 PI3-kinase p85-gamma subunit  
EDCGGGYTPDCSS P11274 Breakpoint cluster region protein  
SYEGNSYTFIDPT P07333 Macrophage colony stimulating factor I receptor  
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MEDSTYYKASKGK Q05397 Focal adhesion kinase 1 (pp125FAK)  
NLYSGDYYRIQGR Q16832 Discoidin domain receptor 2 precursor  
TGENPIYKSAVTT P05556 Integrin beta-1 precursor (FN receptor beta subunit)  
YDVSRMYVDPSEI P16885 PLC-gamma-2  
GRNPGFYVEANPM P19174 PLC-gamma-1  
LMSEGLYKALEAA Q15750 Mitogen-activted protein kinase kinase kinase 7 interacting protein 1 
EENWSFYPNAVRT P78509 Reelin precursor  
MPSEEGYQDYEPE P37840 Alpha-synculein (Non-A4 component of amyloid precursor) 
SENFDDYMKEVGV P15090 Adipocyte lipid-binding protein  
SIRMKRYILHFHS P21709 Ephrin type-A receptor 1 precursor  
RSSLKAYGNGYSS P07550 Insulin receptor substrate-1  
TPGMKIYIDPFTY P29323 Ephrin type-B receptor 2 precursor  
YQYMETYMGPALF Q14974 Imortin beta-1 subunit  
LTPSFEYQPDPWN P29475 Nitric-oxide synthase  
ASVMQEYTQSGGV P25787 Proteosome subunit alpha type 2  
FERASEYQLNDSA P11488 
Guanine nucleotide-binding protein G(t) alpha-1 
subunit  
GIIATIYIIPGDI P82251 
Glycoprotein-associated amino acid transporter 
b0,+AT1  
KLSGEAYGFVARI P04275 Von Willebrand factor precursor  
IFPQPNYVDMLIS Q9Y5G6 Protocadherin gamma A7 precursor  
PNEDCLYLNVYVP Q9Z94 Neuroligin 3 precursor  
CFSPNRYWLCAAT P25388 Guanine nucleotide-binding protein beta subunit-like protein 12.3 
LTSNQEYLDLSMP P11362 Basic fibroblast growth facor receptor 1 precursor (FGFR-1) 
GEEDTEYMTPSSR P22681 CBL E3 ubiquitin protein ligase  
DPDNEAYEMPSEE P37840 Alpha-synculein (Non-A4 component of amyloid precursor) 
LEVGAPYLRVDGK Q08174 Protocadherin 1 precursor  
TFPPISYLNAISW P53602 Diphosphomevalonate decarboxylase  
GECSIDYVEMAVN O75891 10-formyltetrahydrofolate dehydrogenase  
TNSITVYASVTLP Q13291 Signaling lymphocyte activation molecule precursor  
AFDNPDYWNHSLP Q15303 erbB-4 precursor Y1242  
PPFKSAYSSFVNL Q9Y2I7 FYVE finger-containing phosphoinositide kinase  
CYLLIRYCSGKSK P29033 Gap junction beta-2 protein (Connexin 26)  
GTAEPDYGALYEG P19174 PLC-gamma-1  
LQMAQIYINALSE Q92858 Atonal protein homolog 1   
SIFFIIYIIIVAF Q01668 Voltage-dependent L-type calcium channel alpha-1D subunit 
IIQAEFYLNPDQS P01903 HLA class II histocompatibility antigen  
EETREAYANIAEL P33076 MHC class II transactivator  
LVIPDLYLNAGGV P49448 Glutamate dehydrogenase 2  
DCAHFHYENVDFG O14559 Sorting nexin 26  
TAENPEYLGLDVP P04626 C-erbB-2 precursor Y1248  
VAENPEYLSEFSL Q15303 erbB-4 precursor Y1268  
MVLKHPYPRKVEE Q9UN19 
Dual adapter for phosphotyrosine and 3 
phosphoinositide  
PAVPSIYATLAIH Q8NHL6 Leucocyte immunoglobulin-like receptor subfamily B member 1  
AAAAETYANISWE Q92823 Neuronal cell adhesion molecule precursor  
KHATGNYIIIMDA O60762 Dolichol-phosphate mannosyltrasferase  
TRICKIYDSPCLP Q06609 DNA repair protein RAD51homolog 1  
TFGAKPYDGIPAR P04626 C-erbB-2 precursor Y923  
DMGDEVYDDVDTS O15117 FYN-binding protein  
FITEEDYQALRTS Q00610 Clathrin heavy chain 1  
SENFDDYMKALGV P02689 Myelin P2 protein  
TSTEPQYQPGENL P12931 Proto-oncogene tyrosine-protein kinase Src (p60-Src)  
DIHVGDYIIPKNT O15528 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial precursor 
GIICTFYTAVGGM Q92911 Sodium/iodide cotransporter  
GLARDIYKDPDYV P35968 Vascular endothelial growth factor receptor 2 precursor (VEGFR-2) 
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NLEQEEYEDPDIP P02730 Band 3 anion transport protein (CD233 antigen)  
CSPPPDYNSVVLY P17948 Vascular endothelial growth factor receptor 1 precursor (VEGFR-1) 
SPGMKIYIDPFTY P54762 Ephrin type-B receptor 1 precursor  
DDFDGTYETQGGK P21709 Ephrin type-A receptor 1 precursor  
SIFFIIYIIIIAF Q13936 Voltage-dependent L-type calcium channel alpha-1C subunit 
QGEDQYYLRVTTV P10909 Clusterin precursor  
DKDLRHYLNLRFQ Q86UL8 Atrophin-1 interacting protein 1  
IAANCIYLNIPNK O94760 Dimethylarginine dimethylaminohydrolase 1  
MVIPDLYLNAGGV P00367 Glutamate dehydrogenase 1  
PASEQGYEEMRAF P21860 C-erbB-3 precursor Y1289 
SRGEEVYVKKTMG P35590 Tyrosine-protein kinase receptor Tie-1 precursor  
PTAGALYSGSEGD P11831 Serum response factor  
SQQTNDYMQPEED P12814 Non-muscle alpha-actinin 1 (F-actin cross linking protein) 
RPEDTFYFDPEFT P51812 Ribosomal protein S6 kinase alpha 3  
RRYGDRYINLRGP P12821 Angiotensin-converting enzyme  
TVVIALYDYQTND Q08881 
Tyrosine-protein kinase ITK/TSK (T-cell specific 
kinase)  
YQKLYTYIQSRFY O43781 Dual-specificity tyrosine-phosphorylation regulated kinase 3 
ATTDDFYDDPCFD P15172 Myoblast determination protein 1  
MDEELHYASLNFH P20138 Myeloid cell surface antigen CD33 precursor  
PKAEDEYVNEPLY Q15303 erbB-4 precursor Y1202  
LYEKFTYAGIDCS Q02763 Angiopoietin 1 receptor precursor  
SLDNPDYQQDFFP P00533 ErbB-1precursor  Y1172  
SFLDSGYRILGAV P18206 Vinculin Y822 
TLQHPDYLQEYST Q15303 erbB-4 precursor Y1258  
KIGEGTYGTVFKA Q00535 Cell division protein kinase 5  
SSSIDEYFSEQPL P17181 Interferon-alpha/beta receptor alpha chain precursor  
IMNDSNYIVKGNA P07333 Macrophage colony stimulating factor I receptor precursor 
PAFDNLYYWDQDP P04626 C-erbB-2 precursor Y1221 
EELGYEYMDVGSD P21860 c-erbB-3 precursor Y1222 
GAFGTVYKGLWIP P00533 ErbB-1 precursor Y727 
PSRDPHYQDPHST P00533 ErbB-1 precursor Y1056 
GAFGTVYKGIWVP Q15303 erbB-4 precursor Y733 
DKPKQEYLNPVEE Q15303 erbB-4 precursor Y1162 
    
AAEQPLYLNPLDP Q8N566 Arp8 homolog (Consensus AUM substrate peptide) Y173 
    
A/PADNPEYLGEDLP P04626 Consensus EGFR peptide Y1248 
    
 Total hits Class of proteins  
 16 EGF receptor family  
 12 EGFR downstream proteins  
 4 MAPK/ interacting proteins  
 13 cell adhesion molecules   
 7 Other growth factor receptors  
 3 Voltage gated channels  
 
 
 
 
 
 
 
 
 
Curriculum vitae                                                                                                                    128 
11 Curriculum Vitae 
 
Persönliche Daten: 
 
Nachname  Duraphe 
 
Vorname  Prashant 
 
Geschlecht  männlich 
 
Geburtstag  25/09/1973 
 
Geburtsort  Pune, Indien 
 
Staatsangehörigkeit indisch 
 
Familienstand  ledig 
 
Arbeitsplatz  Rudolf Virchow Zentrum für experimentelle Biomedizin 
   Universität Würzburg, Versbacherstr. 9 
   97078 Würzburg, Deutschland 
Tel.: 0931 201 48763 
Prashant.Duraphe@virchow.uni-wuerzburg.de 
 
Wohnsitz  Neutorstrasse 4 
   97070 Würzburg, Deutschland 
Tel.: 0176 800 36173 
 
Hochschulbildung und Berufstätigkeit: 
 
seit 08/2008 Doktorand am Rudolf Virchow Zentrum für experimentelle Biomedizin, 
Universität Würzburg 
 
07/2006 - 07/2008 Doktorand am Institut für Biochemie und Molekularbiologie II, Heinrich-
Heine Universität Düsseldorf 
 
Curriculum vitae                                                                                                                    129 
 
 
07/2006  Master of Science, Hauptfach Molekularbiologie, 
University of Skövde, Schweden 
 
02/2006 - 06/2006 Diplomand am Institut für Biochemie und Molekularbiologie II, Heinrich 
Heine Universität Düsseldorf 
 
01/2005 - 12/2005 Aufbaustudium am Institut für Molekularbiologie, Universität von 
Skövde, Schweden 
 
07/1999 - 06/1999 Wissenschaftlicher Assistent in der Abteilung für Molekulare 
Diagnostik, Grant Medical Foundation in Pune, Indien 
 
06/1996 - 06/1999 Privatlehrer für Studenten des Grundstudiums 
 
06/1994 - 04/1996 Hauptstudium im Hauptfach Zoologie an der Universität Pune, Indien 
 
06/1991 - 04/1996 Grundstudium der Naturwissenschaften an der Universität Pune, Indien 
 
 
Schulausbildung: 
 
06/1989 - 04/1991 Oberstufenkolleg in Pune, Indien 
 
06/1979 - 04/1989 Grund- und Mittelschule in Pune , Indien 
 
 
Liste von Vorträgen:  
 
Duraphe P., Odersky A., Jonkheijm P., Zanger K., Nürnberg B. and Gohla A. 
 
Titel:  Identification and characterization of AUM, a novel mammalian haloacid 
dehalogenase phosphatase involved in spermiogenesis 
 
Europhosphatase Meeting 2007, Aveiro, Portugal (EMBO Conference Series, 24-28/05/ 
2007) 
 
 
Curriculum vitae                                                                                                                    130 
 
 
Duraphe P., Odersky A., Jonkheijm P., Zanger K., Waldmann H., Nürnberg B. and Gohla A. 
 
Titel:  Identification and characterization of AUM, a novel mammalian haloacid 
dehalogenase phosphatase involved in spermiogenesis 
 
Jahrestagung der deutschen Gesellschaft für Pharmakologie und Toxikologie 2008, Mainz, 
Deutschland (11-13/03/2008) 
 
Duraphe P. and Gohla A. 
 
Titel:  Identification and characterization of AUM, a novel mammalian aspartate-based 
phosphatase  
 
Rudolf Virchow Zentrum Retreat 2009, Klöster Höchst, Deutschland (04-06/10/2009) 
 
Erklärung                                                                                                                               131 
Erklärung 
 
Hiermit erkläre ich an Eides statt dass ich die vorliegende Dissertation mit dem Title   
‘Identifizierung und Charakterisierung von AUM, einer neuen humanen Tyrosin-Phoshatase’ 
selbständig angefertigt und keine anderes als die von mir angegebenen Quellen und 
Hilfsmittel verwendet habe. 
Weiterhin erkläre ich dass diese dissertation weder in gleicher noch in ähnlicher form bereits 
ein einem anderren Prüfungsverfahren vorgelegen ist. 
 
Würzburg, November 2009         
 
 
 
Prashant S. Duraphe                                              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Curriculum vitae                                                                                                                    132 
 
 
 
Acknowledgments                                                                                                                 132 
12 Acknowledgments 
I would like to thank Prof. Dr. Antje Gohla for her inspiring guidance and providing me the 
opportunity to conduct this PhD thesis in her research group. Not everyone get opportunity to 
work on a novel protein and privilege of naming it. I had both, in spite of having nothing 
extraordinary track record. It is her commitment and perseverance could make it possible to 
complete the project. I am grateful to her for guiding me throughout the work.  
I would like to thank Prof. Dr. Dr. M. Schartl for his interest in this work and his willingness to 
represent this work at Natural science faculty of prestigious Würzburg University. 
 
I am thankful to Drs. Elisabeth Jeanclos, Oleg Fedorchenko, Axel Hoffmann and Ms. Andrea 
Odersky for stimulating discussions and showing keen interest in the project. I also would like 
to thank Prof. Dr. Dr. B. Nürnberg for providing me financial assistance during initial phase of 
my doctoral studies. 
 
I had an opportunity to work at universities of Düsseldorf and Würzburg. I am thankful to all 
the colleagues at both the laboratories for their kind support. I am particularly happy to pass 
on my project to compatriot, Ambrish Saxena and would like to thank him for his help during 
final stages of the project.  
It is of my great pleasure to see the project that I initiated along with all the colleagues is at 
very interesting stage. We will have AUM mouse soon and a young, enthusiastic graduate 
student, Annegrit Seifried had recently started working on structure of AUM. 
 
It would be unfair if I do not mention the affection I received everywhere in this great land der 
ideen. I would like to express my gratitude towards Germany and her people for establishing 
successful system and scientific atmosphere to help moving human knowledge ahead. 
 
At the end, I am indebted to everyone back home. I am what I am, is only because of my 
nation, and support of my family & friends. 
 
I dedicate this work to seers of eastern philosophy who gave us ‘AUM’  
                                                
 
 
                                                           |AUM…TAT…SAT| 
                                                                                (Bhagavad Gita 17.23) 
Curriculum vitae                                                                                                                    133 
 
 
  
